"","SeqName","length.prot","BLAST_Num_Hits","BLAST_Description","BLAST_e.Value","BLAST_simMean","BLAST_Num_GO","BLAST_GO_IDs","BLAST_GO_Names","BLAST_Enzyme_Codes","BLAST_Enzyme_Names","SwissProt_Num_Hits","SwissProt_Description","SwissProt_e.Value","SwissProt_simMean","SwissProt_Num_GO","SwissProt_GO_IDs","SwissProt_GO_Names","SwissProt_Enzyme_Codes","SwissProt_Enzyme_Names","InterPro_IDs","InterPro_GO_IDs","InterPro_GO_Names","category","over_represented_pvalue","under_represented_pvalue","numDEInCat","numInCat","term","ontology","X19_T33_Ac_WK","X25_ctl1_Ac_GF_1","X27_ctl2_Ac_YG_1","X31_T22_Ac_UV","X35_T43_Ac_MT","X37_T13_Ac_ML","X38_T23_Ac_IN","X41_ctl3_Ac_RN_1","X47_T31_Ac_JB","X52_T11_Ac_II","X53_T21_Ac_NH","X54_T42_Ac_JQ","X57_T32_Ac_NM","length.transcript","baseMean","log2FoldChange","lfcSE","stat","pvalue","padj","Treatment_Compare"
"1","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"2","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"3","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"4","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"5","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"6","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"7","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"8","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"9","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"10","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"11","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0050804",0.0452808168995192,0.991976702887256,3,35,"modulation of chemical synaptic transmission","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"12","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"13","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"14","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"15","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"16","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"17","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"18","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0050804",0.0452808168995192,0.991976702887256,3,35,"modulation of chemical synaptic transmission","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"19","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"20","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"21","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0050804",0.0452808168995192,0.991976702887256,3,35,"modulation of chemical synaptic transmission","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"22","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:1901698",0.0214063686741529,1,1,1,"response to nitrogen compound","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.49101680494707,0.536788030089989,-4.64059678180505,3.47404420667626e-06,0.00120803206432923,"CvsT4"
"23","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"24","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:1901698",0.0214063686741529,1,1,1,"response to nitrogen compound","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"25","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:1901698",0.0214063686741529,1,1,1,"response to nitrogen compound","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-2.29057355954668,0.514700022374093,-4.45030786861293,8.57472767507857e-06,0.00168530680239968,"CvsT2"
"26","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"27","Acerv_evm.model.Segkk1022_pilon.1",794,1,"XP_029190069.1",0,85.48,NA,NA,NA,NA,NA,5,"ACH10_HUMANNeuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1",1.6e-54,49.48,27,"P:GO:0001818; P:GO:0001932; F:GO:0005230; F:GO:0005515; P:GO:0006811; P:GO:0007600; P:GO:0007611; P:GO:0009966; P:GO:0010033; P:GO:0010647; P:GO:0016043; P:GO:0022414; P:GO:0023056; C:GO:0030424; P:GO:0031325; C:GO:0036477; P:GO:0042391; C:GO:0043226; P:GO:0044057; C:GO:0045211; P:GO:0050804; P:GO:0051247; C:GO:0098793; F:GO:0098960; C:GO:0099699; P:GO:1901698; P:GO:1901700","P:negative regulation of cytokine production; P:regulation of protein phosphorylation; F:extracellular ligand-gated ion channel activity; F:protein binding; P:ion transport; P:sensory perception; P:learning or memory; P:regulation of signal transduction; P:response to organic substance; P:positive regulation of cell communication; P:cellular component organization; P:reproductive process; P:positive regulation of signaling; C:axon; P:positive regulation of cellular metabolic process; C:somatodendritic compartment; P:regulation of membrane potential; C:organelle; P:regulation of system process; C:postsynaptic membrane; P:modulation of chemical synaptic transmission; P:positive regulation of protein metabolic process; C:presynapse; F:postsynaptic neurotransmitter receptor activity; C:integral component of synaptic membrane; P:response to nitrogen compound; P:response to oxygen-containing compound","EC:7",NA,"IPR006202 (PFAM); G3DSA:1.20.58.390 (GENE3D); IPR036734 (G3DSA:2.70.170.GENE3D); IPR018000 (PROSITE_PATTERNS); cd18997 (CDD); cd19051 (CDD); IPR036719 (SUPERFAMILY); IPR036734 (SUPERFAMILY)","F:GO:0005230; P:GO:0006811; C:GO:0016021","F:extracellular ligand-gated ion channel activity; P:ion transport; C:integral component of membrane","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",26,8,13,23,48,12,17,7,9,14,10,23,6,2385,16.7543130019435,-1.92582675466436,0.529597611437035,-3.63639622436878,0.00027647895304548,0.0455815873666253,"CvsT3"
"28","Acerv_evm.model.Segkk1078_pilon.63",1413,1,"XP_029199347.1",1e-252,95.82,NA,NA,NA,NA,NA,5,"HMCN1_HUMANHemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2",5.71e-15,40.8,2,"P:GO:0009987; C:GO:0071944","P:cellular process; C:cell periphery",NA,NA,"IPR003598 (SMART); IPR003599 (SMART); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PIRSF000615 (PIRSF); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); cd00096 (CDD); cd00096 (CDD); cd00096 (CDD); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY)",NA,NA,"GO:0071944",0.0149057401211656,0.997494650624873,4,41,"cell periphery","CC",40,19,26,19,44,18,32,19,16,25,18,42,7,4242,24.8323641007104,-1.57492273869818,0.414064150194464,-3.80357183291169,0.000142624610837806,0.0215340556956614,"CvsT4"
"29","Acerv_evm.model.Segkk1078_pilon.63",1413,1,"XP_029199347.1",1e-252,95.82,NA,NA,NA,NA,NA,5,"HMCN1_HUMANHemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2",5.71e-15,40.8,2,"P:GO:0009987; C:GO:0071944","P:cellular process; C:cell periphery",NA,NA,"IPR003598 (SMART); IPR003599 (SMART); PF13927 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); IPR013783 (G3DSA:2.60.40.GENE3D); PIRSF000615 (PIRSF); IPR007110 (PROSITE_PROFILES); IPR007110 (PROSITE_PROFILES); cd00096 (CDD); cd00096 (CDD); cd00096 (CDD); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY); IPR036179 (SUPERFAMILY)",NA,NA,"GO:0071944",0.0149057401211656,0.997494650624873,4,41,"cell periphery","CC",40,19,26,19,44,18,32,19,16,25,18,42,7,4242,24.8323641007104,-1.5732386199431,0.393867659585848,-3.99433307521964,6.48766090043203e-05,0.00782065896010747,"CvsT2"
"30","Acerv_evm.model.Segkk1271_pilon.4",1058,1,"XP_015776650.1",0,79.08,NA,NA,NA,NA,NA,5,"ANK1_HUMANAnkyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3",2.14e-90,47.22,19,"C:GO:0005856; P:GO:0010959; P:GO:0016043; P:GO:0016192; F:GO:0019899; C:GO:0030016; P:GO:0032412; P:GO:0042391; C:GO:0043231; C:GO:0044304; C:GO:0045202; P:GO:0048522; P:GO:0048666; P:GO:0050801; P:GO:0050896; P:GO:0051050; P:GO:0072659; C:GO:0098590; P:GO:1904062","C:cytoskeleton; P:regulation of metal ion transport; P:cellular component organization; P:vesicle-mediated transport; F:enzyme binding; C:myofibril; P:regulation of ion transmembrane transporter activity; P:regulation of membrane potential; C:intracellular membrane-bounded organelle; C:main axon; C:synapse; P:positive regulation of cellular process; P:neuron development; P:ion homeostasis; P:response to stimulus; P:positive regulation of transport; P:protein localization to plasma membrane; C:plasma membrane region; P:regulation of cation transmembrane transport",NA,NA,"IPR002110 (SMART); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); PF13857 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0051050",0.0263362941167502,0.99815856742919,2,11,"positive regulation of transport","BP",176,204,201,129,241,91,123,160,106,84,80,185,47,3177,130.862215388397,-0.702109488195077,0.208050897858228,-3.37470059212873,0.000738960397527248,0.0480643234103874,"CvsT2"
"31","Acerv_evm.model.Segkk1271_pilon.4",1058,1,"XP_015776650.1",0,79.08,NA,NA,NA,NA,NA,5,"ANK1_HUMANAnkyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3",2.14e-90,47.22,19,"C:GO:0005856; P:GO:0010959; P:GO:0016043; P:GO:0016192; F:GO:0019899; C:GO:0030016; P:GO:0032412; P:GO:0042391; C:GO:0043231; C:GO:0044304; C:GO:0045202; P:GO:0048522; P:GO:0048666; P:GO:0050801; P:GO:0050896; P:GO:0051050; P:GO:0072659; C:GO:0098590; P:GO:1904062","C:cytoskeleton; P:regulation of metal ion transport; P:cellular component organization; P:vesicle-mediated transport; F:enzyme binding; C:myofibril; P:regulation of ion transmembrane transporter activity; P:regulation of membrane potential; C:intracellular membrane-bounded organelle; C:main axon; C:synapse; P:positive regulation of cellular process; P:neuron development; P:ion homeostasis; P:response to stimulus; P:positive regulation of transport; P:protein localization to plasma membrane; C:plasma membrane region; P:regulation of cation transmembrane transport",NA,NA,"IPR002110 (SMART); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); IPR036770 (G3DSA:1.25.40.GENE3D); PF13857 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR020683 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",176,204,201,129,241,91,123,160,106,84,80,185,47,3177,130.862215388397,-0.702109488195077,0.208050897858228,-3.37470059212873,0.000738960397527248,0.0480643234103874,"CvsT2"
"32","Acerv_evm.model.Segkk1318_pilon.7",563,1,"XP_029190057.1",0,96.26,NA,NA,NA,NA,NA,2,"SACS_HUMANSacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2",8.44e-62,61.64,9,"C:GO:0005634; C:GO:0005739; C:GO:0030424; C:GO:0030425; F:GO:0030544; F:GO:0051087; F:GO:0070628; C:GO:0070852; P:GO:0090084","C:nucleus; C:mitochondrion; C:axon; C:dendrite; F:Hsp70 protein binding; F:chaperone binding; F:proteasome binding; C:cell body fiber; P:negative regulation of inclusion body assembly",NA,NA,"IPR036890 (SUPERFAMILY)",NA,NA,"GO:0030544",0.00186451154599067,0.999912263942145,3,11,"Hsp70 protein binding","MF",79,143,111,77,158,51,103,110,27,31,59,117,25,1692,75.2971231510255,-0.86097256289238,0.250420446274773,-3.4381080926103,0.000585793810043497,0.0392308284192834,"CvsT2"
"33","Acerv_evm.model.Segkk1411_pilon.4",715,1,"XP_015775539.1",6.3e-296,93.96,NA,NA,NA,NA,NA,5,"IABF_STRAWExtracellular exo-alpha-(1-",6.5e-08,62.01,17,"P:GO:0001501; F:GO:0004222; F:GO:0005488; P:GO:0007566; P:GO:0009966; P:GO:0019953; P:GO:0030198; P:GO:0030335; P:GO:0030574; P:GO:0043065; P:GO:0043066; P:GO:0044238; P:GO:0065009; P:GO:0071704; C:GO:0110165; P:GO:1904645; P:GO:2000697","P:skeletal system development; F:metalloendopeptidase activity; F:binding; P:embryo implantation; P:regulation of signal transduction; P:sexual reproduction; P:extracellular matrix organization; P:positive regulation of cell migration; P:collagen catabolic process; P:positive regulation of apoptotic process; P:negative regulation of apoptotic process; P:primary metabolic process; P:regulation of molecular function; P:organic substance metabolic process; C:cellular anatomical entity; P:response to amyloid-beta; P:negative regulation of epithelial cell differentiation involved in kidney development","EC:3.4.24; EC:3.4; EC:3","Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Hydrolases","IPR000884 (SMART); IPR000562 (SMART); IPR036383 (G3DSA:2.20.100.GENE3D); IPR000884 (PFAM); IPR036943 (G3DSA:2.10.10.GENE3D); IPR000562 (PFAM); IPR007934 (PFAM); G3DSA:2.80.10.50 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000562 (PROSITE_PATTERNS); IPR000562 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000562 (CDD); IPR036383 (SUPERFAMILY); IPR036195 (SUPERFAMILY); IPR013806 (SUPERFAMILY)","P:GO:0046373; F:GO:0046556","P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity","GO:1904645",0.0427878726739444,0.999534417859254,1,2,"response to amyloid-beta","BP",1402,2479,2277,830,1573,1057,833,2257,550,1598,376,1365,617,2148,1185.11289826247,1.04231073404129,0.273681775925443,3.80847694559408,0.000139825379979968,0.0311013549908585,"T1vsT2"
"34","Acerv_evm.model.Segkk1411_pilon.4",715,1,"XP_015775539.1",6.3e-296,93.96,NA,NA,NA,NA,NA,5,"IABF_STRAWExtracellular exo-alpha-(1-",6.5e-08,62.01,17,"P:GO:0001501; F:GO:0004222; F:GO:0005488; P:GO:0007566; P:GO:0009966; P:GO:0019953; P:GO:0030198; P:GO:0030335; P:GO:0030574; P:GO:0043065; P:GO:0043066; P:GO:0044238; P:GO:0065009; P:GO:0071704; C:GO:0110165; P:GO:1904645; P:GO:2000697","P:skeletal system development; F:metalloendopeptidase activity; F:binding; P:embryo implantation; P:regulation of signal transduction; P:sexual reproduction; P:extracellular matrix organization; P:positive regulation of cell migration; P:collagen catabolic process; P:positive regulation of apoptotic process; P:negative regulation of apoptotic process; P:primary metabolic process; P:regulation of molecular function; P:organic substance metabolic process; C:cellular anatomical entity; P:response to amyloid-beta; P:negative regulation of epithelial cell differentiation involved in kidney development","EC:3.4.24; EC:3.4; EC:3","Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Hydrolases","IPR000884 (SMART); IPR000562 (SMART); IPR036383 (G3DSA:2.20.100.GENE3D); IPR000884 (PFAM); IPR036943 (G3DSA:2.10.10.GENE3D); IPR000562 (PFAM); IPR007934 (PFAM); G3DSA:2.80.10.50 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000562 (PROSITE_PATTERNS); IPR000562 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000562 (CDD); IPR036383 (SUPERFAMILY); IPR036195 (SUPERFAMILY); IPR013806 (SUPERFAMILY)","P:GO:0046373; F:GO:0046556","P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity","GO:0046556",0.0214092421271054,1,1,1,"alpha-L-arabinofuranosidase activity","MF",1402,2479,2277,830,1573,1057,833,2257,550,1598,376,1365,617,2148,1185.11289826247,1.04231073404129,0.273681775925443,3.80847694559408,0.000139825379979968,0.0311013549908585,"T1vsT2"
"35","Acerv_evm.model.Segkk1411_pilon.4",715,1,"XP_015775539.1",6.3e-296,93.96,NA,NA,NA,NA,NA,5,"IABF_STRAWExtracellular exo-alpha-(1-",6.5e-08,62.01,17,"P:GO:0001501; F:GO:0004222; F:GO:0005488; P:GO:0007566; P:GO:0009966; P:GO:0019953; P:GO:0030198; P:GO:0030335; P:GO:0030574; P:GO:0043065; P:GO:0043066; P:GO:0044238; P:GO:0065009; P:GO:0071704; C:GO:0110165; P:GO:1904645; P:GO:2000697","P:skeletal system development; F:metalloendopeptidase activity; F:binding; P:embryo implantation; P:regulation of signal transduction; P:sexual reproduction; P:extracellular matrix organization; P:positive regulation of cell migration; P:collagen catabolic process; P:positive regulation of apoptotic process; P:negative regulation of apoptotic process; P:primary metabolic process; P:regulation of molecular function; P:organic substance metabolic process; C:cellular anatomical entity; P:response to amyloid-beta; P:negative regulation of epithelial cell differentiation involved in kidney development","EC:3.4.24; EC:3.4; EC:3","Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Hydrolases","IPR000884 (SMART); IPR000562 (SMART); IPR036383 (G3DSA:2.20.100.GENE3D); IPR000884 (PFAM); IPR036943 (G3DSA:2.10.10.GENE3D); IPR000562 (PFAM); IPR007934 (PFAM); G3DSA:2.80.10.50 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000562 (PROSITE_PATTERNS); IPR000562 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000562 (CDD); IPR036383 (SUPERFAMILY); IPR036195 (SUPERFAMILY); IPR013806 (SUPERFAMILY)","P:GO:0046373; F:GO:0046556","P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity","GO:2000697",0.0214092421271054,1,1,1,"negative regulation of epithelial cell differentiation involved in kidney development","BP",1402,2479,2277,830,1573,1057,833,2257,550,1598,376,1365,617,2148,1185.11289826247,1.04231073404129,0.273681775925443,3.80847694559408,0.000139825379979968,0.0311013549908585,"T1vsT2"
"36","Acerv_evm.model.Segkk1411_pilon.4",715,1,"XP_015775539.1",6.3e-296,93.96,NA,NA,NA,NA,NA,5,"IABF_STRAWExtracellular exo-alpha-(1-",6.5e-08,62.01,17,"P:GO:0001501; F:GO:0004222; F:GO:0005488; P:GO:0007566; P:GO:0009966; P:GO:0019953; P:GO:0030198; P:GO:0030335; P:GO:0030574; P:GO:0043065; P:GO:0043066; P:GO:0044238; P:GO:0065009; P:GO:0071704; C:GO:0110165; P:GO:1904645; P:GO:2000697","P:skeletal system development; F:metalloendopeptidase activity; F:binding; P:embryo implantation; P:regulation of signal transduction; P:sexual reproduction; P:extracellular matrix organization; P:positive regulation of cell migration; P:collagen catabolic process; P:positive regulation of apoptotic process; P:negative regulation of apoptotic process; P:primary metabolic process; P:regulation of molecular function; P:organic substance metabolic process; C:cellular anatomical entity; P:response to amyloid-beta; P:negative regulation of epithelial cell differentiation involved in kidney development","EC:3.4.24; EC:3.4; EC:3","Acting on peptide bonds (peptidases); Acting on peptide bonds (peptidases); Hydrolases","IPR000884 (SMART); IPR000562 (SMART); IPR036383 (G3DSA:2.20.100.GENE3D); IPR000884 (PFAM); IPR036943 (G3DSA:2.10.10.GENE3D); IPR000562 (PFAM); IPR007934 (PFAM); G3DSA:2.80.10.50 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000562 (PROSITE_PATTERNS); IPR000562 (PROSITE_PROFILES); IPR000884 (PROSITE_PROFILES); IPR000562 (CDD); IPR036383 (SUPERFAMILY); IPR036195 (SUPERFAMILY); IPR013806 (SUPERFAMILY)","P:GO:0046373; F:GO:0046556","P:L-arabinose metabolic process; F:alpha-L-arabinofuranosidase activity","GO:0046373",0.0214092421271054,1,1,1,"L-arabinose metabolic process","BP",1402,2479,2277,830,1573,1057,833,2257,550,1598,376,1365,617,2148,1185.11289826247,1.04231073404129,0.273681775925443,3.80847694559408,0.000139825379979968,0.0311013549908585,"T1vsT2"
"37","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"38","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0030544",0.00186451154599067,0.999912263942145,3,11,"Hsp70 protein binding","MF",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"39","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0051879",0.0396283256766858,0.996424662695642,2,14,"Hsp90 protein binding","MF",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"40","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0034381",0.02424851633823,1,1,1,"plasma lipoprotein particle clearance","BP",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"41","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0097242",0.0479408127579788,0.999413956733906,1,2,"amyloid-beta clearance","BP",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"42","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0010744",0.02424851633823,1,1,1,"positive regulation of macrophage derived foam cell differentiation","BP",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"43","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0034362",0.02424851633823,1,1,1,"low-density lipoprotein particle","CC",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"44","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0010886",0.0469956325446513,0.999437114527609,1,2,"positive regulation of cholesterol storage","BP",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"45","Acerv_evm.model.Segkk1424_pilon.6",284,1,"XP_029189655.1",7.9e-165,98.94,NA,NA,NA,NA,NA,2,"MSRE_BOVINMacrophage scavenger receptor types I and II OS=Bos taurus OX=9913 GN=MSR1 PE=1 SV=1",3.61e-06,57.46,28,"F:GO:0001540; F:GO:0004252; F:GO:0005044; C:GO:0005576; C:GO:0005581; C:GO:0005886; P:GO:0006897; P:GO:0006898; P:GO:0006911; P:GO:0007155; P:GO:0010629; P:GO:0010744; P:GO:0010886; C:GO:0016020; C:GO:0016021; F:GO:0019899; F:GO:0030169; P:GO:0030301; F:GO:0030544; P:GO:0031638; C:GO:0034362; P:GO:0034381; F:GO:0038024; F:GO:0042802; P:GO:0042953; F:GO:0051879; P:GO:0070207; P:GO:0097242","F:amyloid-beta binding; F:serine-type endopeptidase activity; F:scavenger receptor activity; C:extracellular region; C:collagen trimer; C:plasma membrane; P:endocytosis; P:receptor-mediated endocytosis; P:phagocytosis, engulfment; P:cell adhesion; P:negative regulation of gene expression; P:positive regulation of macrophage derived foam cell differentiation; P:positive regulation of cholesterol storage; C:membrane; C:integral component of membrane; F:enzyme binding; F:low-density lipoprotein particle binding; P:cholesterol transport; F:Hsp70 protein binding; P:zymogen activation; C:low-density lipoprotein particle; P:plasma lipoprotein particle clearance; F:cargo receptor activity; F:identical protein binding; P:lipoprotein transport; F:Hsp90 protein binding; P:protein homotrimerization; P:amyloid-beta clearance",NA,NA,"PR01217 (PRINTS); IPR008160 (PFAM)",NA,NA,"GO:0030169",0.02424851633823,1,1,1,"low-density lipoprotein particle binding","MF",285,626,341,125,245,202,83,387,106,280,49,285,139,855,213.466170369132,1.55061075932362,0.359293924228013,4.31571661740536,1.59085960188511e-05,0.00990928733289509,"T1vsT2"
"46","Acerv_evm.model.Segkk1509_pilon.11",128,1,"XP_015776400.1",3.9e-63,99.22,NA,NA,NA,NA,NA,5,"T170B_RATTransmembrane protein 170B OS=Rattus norvegicus OX=10116 GN=Tmem170b PE=2 SV=2",7.5e-25,61.88,6,"F:GO:0005515; C:GO:0005886; P:GO:0006996; C:GO:0012505; C:GO:0043231; P:GO:0090090","F:protein binding; C:plasma membrane; P:organelle organization; C:endomembrane system; C:intracellular membrane-bounded organelle; P:negative regulation of canonical Wnt signaling pathway",NA,NA,"IPR019334 (PFAM)",NA,NA,"GO:0006996",0.00399445560224313,0.999554020421145,4,28,"organelle organization","BP",384,870,449,134,291,218,164,948,250,177,113,293,138,387,283.780118870659,0.996634902134837,0.287947658821401,3.46116688780928,0.00053783928091087,0.0371191216695815,"CvsT2"
"47","Acerv_evm.model.Segkk1575_pilon.7",651,1,"XP_029184140.1",0,97.08,NA,NA,NA,NA,NA,5,"DCAF1_HUMANDDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3",0,51.57,14,"P:GO:0000122; C:GO:0001650; C:GO:0005654; C:GO:0008180; P:GO:0009791; P:GO:0010154; P:GO:0030183; F:GO:0030331; P:GO:0033151; P:GO:0035212; P:GO:0048827; C:GO:0080008; F:GO:1990244; P:GO:1990245","P:negative regulation of transcription by RNA polymerase II; C:fibrillar center; C:nucleoplasm; C:COP9 signalosome; P:post-embryonic development; P:fruit development; P:B cell differentiation; F:estrogen receptor binding; P:V(D)J recombination; P:cell competition in a multicellular organism; P:phyllome development; C:Cul4-RING E3 ubiquitin ligase complex; F:histone kinase activity (H2A-T120 specific); P:histone H2A-T120 phosphorylation","EC:2.7.1; EC:2.7; EC:2","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases","IPR006594 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR006594 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0008180",0.0324166105895982,0.997430552587002,2,12,"COP9 signalosome","CC",18,22,9,24,42,15,19,8,12,14,11,20,10,1956,17.8707116113022,-1.94556320612351,0.494905872384025,-3.93117825971933,8.45305649113783e-05,0.00943507206621939,"CvsT2"
"48","Acerv_evm.model.Segkk1575_pilon.7",651,1,"XP_029184140.1",0,97.08,NA,NA,NA,NA,NA,5,"DCAF1_HUMANDDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3",0,51.57,14,"P:GO:0000122; C:GO:0001650; C:GO:0005654; C:GO:0008180; P:GO:0009791; P:GO:0010154; P:GO:0030183; F:GO:0030331; P:GO:0033151; P:GO:0035212; P:GO:0048827; C:GO:0080008; F:GO:1990244; P:GO:1990245","P:negative regulation of transcription by RNA polymerase II; C:fibrillar center; C:nucleoplasm; C:COP9 signalosome; P:post-embryonic development; P:fruit development; P:B cell differentiation; F:estrogen receptor binding; P:V(D)J recombination; P:cell competition in a multicellular organism; P:phyllome development; C:Cul4-RING E3 ubiquitin ligase complex; F:histone kinase activity (H2A-T120 specific); P:histone H2A-T120 phosphorylation","EC:2.7.1; EC:2.7; EC:2","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases","IPR006594 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR006594 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0010154",0.0214107484494155,1,1,1,"fruit development","BP",18,22,9,24,42,15,19,8,12,14,11,20,10,1956,17.8707116113022,-1.94556320612351,0.494905872384025,-3.93117825971933,8.45305649113783e-05,0.00943507206621939,"CvsT2"
"49","Acerv_evm.model.Segkk1575_pilon.7",651,1,"XP_029184140.1",0,97.08,NA,NA,NA,NA,NA,5,"DCAF1_HUMANDDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3",0,51.57,14,"P:GO:0000122; C:GO:0001650; C:GO:0005654; C:GO:0008180; P:GO:0009791; P:GO:0010154; P:GO:0030183; F:GO:0030331; P:GO:0033151; P:GO:0035212; P:GO:0048827; C:GO:0080008; F:GO:1990244; P:GO:1990245","P:negative regulation of transcription by RNA polymerase II; C:fibrillar center; C:nucleoplasm; C:COP9 signalosome; P:post-embryonic development; P:fruit development; P:B cell differentiation; F:estrogen receptor binding; P:V(D)J recombination; P:cell competition in a multicellular organism; P:phyllome development; C:Cul4-RING E3 ubiquitin ligase complex; F:histone kinase activity (H2A-T120 specific); P:histone H2A-T120 phosphorylation","EC:2.7.1; EC:2.7; EC:2","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases","IPR006594 (SMART); IPR011989 (G3DSA:1.25.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR006594 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0048827",0.0214107484494155,1,1,1,"phyllome development","BP",18,22,9,24,42,15,19,8,12,14,11,20,10,1956,17.8707116113022,-1.94556320612351,0.494905872384025,-3.93117825971933,8.45305649113783e-05,0.00943507206621939,"CvsT2"
"50","Acerv_evm.model.Segkk1630_pilon.6",899,1,"XP_029196792.1",0,86.39,NA,NA,NA,NA,NA,1,"ALP1_ARATHProtein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1",4.91e-09,56.25,4,"F:GO:0003682; F:GO:0005515; C:GO:0035098; C:GO:0035102","F:chromatin binding; F:protein binding; C:ESC/E(Z) complex; C:PRC1 complex",NA,NA,NA,NA,NA,"GO:0035098",0.00798405368936271,0.99974569015649,2,6,"ESC/E(Z) complex","CC",112,10,15,99,178,97,80,8,56,134,48,179,62,2700,94.0690851613865,-4.58861074777731,0.379354440516021,-12.0958403479754,1.11099546798373e-33,3.34817000868029e-30,"CvsT4"
"51","Acerv_evm.model.Segkk1630_pilon.6",899,1,"XP_029196792.1",0,86.39,NA,NA,NA,NA,NA,1,"ALP1_ARATHProtein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1",4.91e-09,56.25,4,"F:GO:0003682; F:GO:0005515; C:GO:0035098; C:GO:0035102","F:chromatin binding; F:protein binding; C:ESC/E(Z) complex; C:PRC1 complex",NA,NA,NA,NA,NA,"GO:0035098",0.00798405368936271,0.99974569015649,2,6,"ESC/E(Z) complex","CC",112,10,15,99,178,97,80,8,56,134,48,179,62,2700,94.0690851613865,-4.3047837196881,0.364606757969853,-11.8066481917596,3.60653921700777e-32,1.08689070203224e-28,"CvsT3"
"52","Acerv_evm.model.Segkk1630_pilon.6",899,1,"XP_029196792.1",0,86.39,NA,NA,NA,NA,NA,1,"ALP1_ARATHProtein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1",4.91e-09,56.25,4,"F:GO:0003682; F:GO:0005515; C:GO:0035098; C:GO:0035102","F:chromatin binding; F:protein binding; C:ESC/E(Z) complex; C:PRC1 complex",NA,NA,NA,NA,NA,"GO:0035098",0.00798405368936271,0.99974569015649,2,6,"ESC/E(Z) complex","CC",112,10,15,99,178,97,80,8,56,134,48,179,62,2700,94.0690851613865,-4.23781293379458,0.364173675861868,-11.6367909453236,2.67907066525565e-31,8.07382596152545e-28,"CvsT2"
"53","Acerv_evm.model.Segkk1630_pilon.6",899,1,"XP_029196792.1",0,86.39,NA,NA,NA,NA,NA,1,"ALP1_ARATHProtein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1",4.91e-09,56.25,4,"F:GO:0003682; F:GO:0005515; C:GO:0035098; C:GO:0035102","F:chromatin binding; F:protein binding; C:ESC/E(Z) complex; C:PRC1 complex",NA,NA,NA,NA,NA,"GO:0035098",0.00798405368936271,0.99974569015649,2,6,"ESC/E(Z) complex","CC",112,10,15,99,178,97,80,8,56,134,48,179,62,2700,94.0690851613865,-4.89515178342068,0.38346737963803,-12.7654972583102,2.55513693095633e-37,7.70033099759206e-34,"CvsT1"
"54","Acerv_evm.model.Segkk1656_pilon.3",290,1,"XP_015748850.1",1.8e-23,96.55,NA,NA,NA,NA,NA,4,"MRD1_CANGAMultiple RNA-binding domain-containing protein 1 OS=Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) OX=284593 GN=MRD1 PE=3 SV=1",3.21e-08,56.4,3,"P:GO:0006364; C:GO:0031981; P:GO:0042274","P:rRNA processing; C:nuclear lumen; P:ribosomal small subunit biogenesis",NA,NA,"IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000504 (PROSITE_PROFILES); IPR000504 (PROSITE_PROFILES); cd00590 (CDD); IPR035979 (SUPERFAMILY); IPR035979 (SUPERFAMILY)","F:GO:0003676","F:nucleic acid binding","GO:0042274",0.0240739890465254,1,1,1,"ribosomal small subunit biogenesis","BP",144,40,66,98,185,54,48,49,16,22,69,117,18,873,68.5659955591582,-1.98183700274194,0.561294061768547,-3.53083550625405,0.000414249280557513,0.0304490060611421,"CvsT2"
"55","Acerv_evm.model.Segkk1732_pilon.65",619,1,"XP_015761324.1",2.5e-256,86.82,NA,NA,NA,NA,NA,5,"B4GN4_MOUSEN-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1",5.04e-69,59.89,3,"C:GO:0005794; F:GO:0008376; C:GO:0016020","C:Golgi apparatus; F:acetylgalactosaminyltransferase activity; C:membrane","EC:2.4; EC:2; EC:2.4.1","Glycosyltransferases; Transferases; Glycosyltransferases","IPR008428 (PFAM); IPR029044 (G3DSA:3.90.550.GENE3D); IPR029044 (SUPERFAMILY)","F:GO:0008376; C:GO:0032580","F:acetylgalactosaminyltransferase activity; C:Golgi cisterna membrane","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",33,151,104,19,38,25,27,100,16,33,13,47,12,1860,36.4763660174834,1.12145019199981,0.311721441941561,3.59760363295784,0.000321162547196004,0.0261588341369286,"CvsT2"
"56","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.64688473949684,0.522311169670211,-6.9822070659517,2.90578412652653e-12,4.37853238132106e-09,"CvsT1"
"57","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.342112867859,0.488904249312729,-6.83592517871779,8.14774629295052e-12,6.69670674859688e-09,"CvsT2"
"58","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.342112867859,0.488904249312729,-6.83592517871779,8.14774629295052e-12,6.69670674859688e-09,"CvsT2"
"59","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0002574",0.026292165099568,1,1,1,"thrombocyte differentiation","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-2.98672220368715,0.516873149139213,-5.7784433350062,7.53949273990963e-09,4.5443035907682e-06,"CvsT4"
"60","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-2.98672220368715,0.516873149139213,-5.7784433350062,7.53949273990963e-09,4.5443035907682e-06,"CvsT4"
"61","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-2.98672220368715,0.516873149139213,-5.7784433350062,7.53949273990963e-09,4.5443035907682e-06,"CvsT4"
"62","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0002574",0.026292165099568,1,1,1,"thrombocyte differentiation","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.44992983255853,0.488798293809378,-7.05798255896519,1.68937256430611e-12,2.18194533627022e-09,"CvsT3"
"63","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.44992983255853,0.488798293809378,-7.05798255896519,1.68937256430611e-12,2.18194533627022e-09,"CvsT3"
"64","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0002574",0.026292165099568,1,1,1,"thrombocyte differentiation","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.342112867859,0.488904249312729,-6.83592517871779,8.14774629295052e-12,6.69670674859688e-09,"CvsT2"
"65","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.44992983255853,0.488798293809378,-7.05798255896519,1.68937256430611e-12,2.18194533627022e-09,"CvsT3"
"66","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0002574",0.026292165099568,1,1,1,"thrombocyte differentiation","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.64688473949684,0.522311169670211,-6.9822070659517,2.90578412652653e-12,4.37853238132106e-09,"CvsT1"
"67","Acerv_evm.model.Segkk1793_pilon.1",226,1,"XP_015766416.1",6.8e-26,52.67,NA,NA,NA,NA,NA,5,"EMSY_DANREBRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1",4.48e-41,68.25,9,"C:GO:0000793; P:GO:0002574; F:GO:0003682; C:GO:0005654; P:GO:0006974; F:GO:0042802; P:GO:0045944; P:GO:0048583; F:GO:0070577","C:condensed chromosome; P:thrombocyte differentiation; F:chromatin binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; F:identical protein binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of response to stimulus; F:lysine-acetylated histone binding",NA,NA,"IPR001487 (PRINTS); IPR001487 (SMART); IPR005491 (SMART); IPR036142 (G3DSA:1.10.1240.GENE3D); IPR005491 (PFAM); IPR001487 (PFAM); IPR036427 (G3DSA:1.20.920.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR005491 (PROSITE_PROFILES); IPR001487 (PROSITE_PROFILES); cd04369 (CDD); IPR036142 (SUPERFAMILY); IPR036427 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",36,6,9,24,38,25,41,6,33,37,14,37,13,682,28.2148757275827,-3.64688473949684,0.522311169670211,-6.9822070659517,2.90578412652653e-12,4.37853238132106e-09,"CvsT1"
"68","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:1903220",0.0328906289036147,1,1,1,"positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"69","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0002165",0.0328906289036147,1,1,1,"instar larval or pupal development","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"70","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0007030",0.0169144280635555,0.998017358692076,3,22,"Golgi organization","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"71","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0007458",0.0328906289036147,1,1,1,"progression of morphogenetic furrow involved in compound eye morphogenesis","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"72","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0008362",0.0328906289036147,1,1,1,"chitin-based embryonic cuticle biosynthetic process","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"73","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"74","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0007591",0.0328906289036147,1,1,1,"molting cycle, chitin-based cuticle","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"75","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0048542",0.0328906289036147,1,1,1,"lymph gland development","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"76","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0048477",0.0289018395428741,0.997910127128071,2,10,"oogenesis","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"77","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0000398",0.0349575951395509,0.994443688270107,3,31,"mRNA splicing, via spliceosome","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"78","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0007390",0.0328906289036147,1,1,1,"germ-band shortening","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"79","Acerv_evm.model.Segkk1821_pilon.34",91,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"ECD_MOUSEProtein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2",6.54e-159,54.1,33,"P:GO:0000398; P:GO:0002165; P:GO:0002168; F:GO:0003674; F:GO:0005515; C:GO:0005575; C:GO:0005634; C:GO:0005654; C:GO:0005737; C:GO:0005829; P:GO:0006397; P:GO:0006697; P:GO:0007030; P:GO:0007281; P:GO:0007390; P:GO:0007443; P:GO:0007458; P:GO:0007591; P:GO:0008150; P:GO:0008258; P:GO:0008283; P:GO:0008362; P:GO:0008380; P:GO:0009608; P:GO:0016319; P:GO:0030154; F:GO:0035035; P:GO:0045944; P:GO:0048477; P:GO:0048542; F:GO:0070990; P:GO:1903220; P:GO:2000045","P:mRNA splicing, via spliceosome; P:instar larval or pupal development; P:instar larval development; F:molecular_function; F:protein binding; C:cellular_component; C:nucleus; C:nucleoplasm; C:cytoplasm; C:cytosol; P:mRNA processing; P:ecdysone biosynthetic process; P:Golgi organization; P:germ cell development; P:germ-band shortening; P:Malpighian tubule morphogenesis; P:progression of morphogenetic furrow involved in compound eye morphogenesis; P:molting cycle, chitin-based cuticle; P:biological_process; P:head involution; P:cell population proliferation; P:chitin-based embryonic cuticle biosynthetic process; P:RNA splicing; P:response to symbiont; P:mushroom body development; P:cell differentiation; F:histone acetyltransferase binding; P:positive regulation of transcription by RNA polymerase II; P:oogenesis; P:lymph gland development; F:snRNP binding; P:positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity; P:regulation of G1/S transition of mitotic cell cycle",NA,NA,"IPR010770 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0008258",0.0328906289036147,1,1,1,"head involution","BP",24,21,27,19,29,21,23,23,17,33,9,28,16,276,23.2015840639911,-1.68612303961563,0.422156882663122,-3.99406739262177,6.49493895413674e-05,0.0116292611999875,"CvsT1"
"80","Acerv_evm.model.Segkk1822_pilon.2",1026,1,"XP_029192428.1",0,98.64,NA,NA,NA,NA,NA,5,"HAUS1_BOVINHAUS augmin-like complex subunit 1 OS=Bos taurus OX=9913 GN=HAUS1 PE=2 SV=1",7.11e-25,51.38,6,"P:GO:0000226; C:GO:0005737; C:GO:0005815; C:GO:0005819; C:GO:0005874; P:GO:0022402","P:microtubule cytoskeleton organization; C:cytoplasm; C:microtubule organizing center; C:spindle; C:microtubule; P:cell cycle process",NA,NA,"Coil (COILS); IPR026243 (PRINTS)","P:GO:0051225; C:GO:0070652","P:spindle assembly; C:HAUS complex","GO:0070652",0.0212607052772925,1,1,1,"HAUS complex","CC",386,406,368,522,938,404,1163,250,96,224,739,1588,352,3081,599.904250476083,-2.74925435197546,0.49611784161171,-5.54153493662738,2.99831738261229e-08,1.50598819201098e-05,"CvsT2"
"81","Acerv_evm.model.Segkk1822_pilon.2",1026,1,"XP_029192428.1",0,98.64,NA,NA,NA,NA,NA,5,"HAUS1_BOVINHAUS augmin-like complex subunit 1 OS=Bos taurus OX=9913 GN=HAUS1 PE=2 SV=1",7.11e-25,51.38,6,"P:GO:0000226; C:GO:0005737; C:GO:0005815; C:GO:0005819; C:GO:0005874; P:GO:0022402","P:microtubule cytoskeleton organization; C:cytoplasm; C:microtubule organizing center; C:spindle; C:microtubule; P:cell cycle process",NA,NA,"Coil (COILS); IPR026243 (PRINTS)","P:GO:0051225; C:GO:0070652","P:spindle assembly; C:HAUS complex","GO:0070652",0.0212607052772925,1,1,1,"HAUS complex","CC",386,406,368,522,938,404,1163,250,96,224,739,1588,352,3081,599.904250476083,-2.47086024159738,0.553965664322637,-4.46031297737313,8.18400494402675e-06,0.00227523018835294,"CvsT4"
"82","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0004532",0.0442743661825154,0.999501121343662,1,2,"exoribonuclease activity","MF",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"83","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:1904872",0.0423880970743349,0.999543172061572,1,2,"regulation of telomerase RNA localization to Cajal body","BP",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"84","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"85","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0071035",0.0431804526431106,0.999525738558099,1,2,"nuclear polyadenylation-dependent rRNA catabolic process","BP",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"86","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0071034",0.0214092651155424,1,1,1,"CUT catabolic process","BP",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"87","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0071048",0.0214092651155424,1,1,1,"nuclear retention of unspliced pre-mRNA at the site of transcription","BP",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"88","Acerv_evm.model.Segkk1851_pilon.3",699,1,"XP_029210644.1",2.7e-238,89.17,NA,NA,NA,NA,NA,5,"EXOSX_MOUSEExosome component 10 OS=Mus musculus OX=10090 GN=Exosc10 PE=1 SV=2",0,53.11,21,"C:GO:0000176; P:GO:0000460; F:GO:0003723; F:GO:0004532; F:GO:0005515; C:GO:0005730; C:GO:0005829; F:GO:0008408; P:GO:0009048; P:GO:0010604; P:GO:0016074; P:GO:0031325; P:GO:0032211; P:GO:0032268; P:GO:0034472; C:GO:0035327; P:GO:0051173; P:GO:0071034; P:GO:0071035; P:GO:0071048; P:GO:1904872","C:nuclear exosome (RNase complex); P:maturation of 5.8S rRNA; F:RNA binding; F:exoribonuclease activity; F:protein binding; C:nucleolus; C:cytosol; F:3'-5' exonuclease activity; P:dosage compensation by inactivation of X chromosome; P:positive regulation of macromolecule metabolic process; P:sno(s)RNA metabolic process; P:positive regulation of cellular metabolic process; P:negative regulation of telomere maintenance via telomerase; P:regulation of cellular protein metabolic process; P:snRNA 3'-end processing; C:transcriptionally active chromatin; P:positive regulation of nitrogen compound metabolic process; P:CUT catabolic process; P:nuclear polyadenylation-dependent rRNA catabolic process; P:nuclear retention of unspliced pre-mRNA at the site of transcription; P:regulation of telomerase RNA localization to Cajal body","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","Coil (COILS); IPR002121 (SMART); IPR002562 (SMART); G3DSA:3.30.420.500 (GENE3D); G3DSA:1.10.150.80 (GENE3D); IPR002562 (PFAM); IPR002121 (PFAM); IPR012588 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR002121 (PROSITE_PROFILES); cd06147 (CDD); IPR010997 (SUPERFAMILY); IPR012337 (SUPERFAMILY)","F:GO:0000166; C:GO:0000176; F:GO:0003676; P:GO:0006139; P:GO:0006396; F:GO:0008408; P:GO:0044237","F:nucleotide binding; C:nuclear exosome (RNase complex); F:nucleic acid binding; P:nucleobase-containing compound metabolic process; P:RNA processing; F:3'-5' exonuclease activity; P:cellular metabolic process","GO:0016074",0.0214092651155424,1,1,1,"snoRNA metabolic process","BP",40,29,44,36,53,24,43,18,24,38,25,43,8,2100,33.1644365470079,-1.66367654601781,0.389960677346512,-4.26626745378097,1.98770474996372e-05,0.00326742520807673,"CvsT2"
"89","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:1901890",0.0296974220921703,1,1,1,"positive regulation of cell junction assembly","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"90","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0001934",0.00824320520368596,0.99884951183754,4,34,"positive regulation of protein phosphorylation","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"91","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0051580",0.0296974220921703,1,1,1,"regulation of neurotransmitter uptake","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"92","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0001934",0.00824320520368596,0.99884951183754,4,34,"positive regulation of protein phosphorylation","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"93","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0035023",0.0296974220921703,1,1,1,"regulation of Rho protein signal transduction","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"94","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0035023",0.0296974220921703,1,1,1,"regulation of Rho protein signal transduction","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"95","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:1901890",0.0296974220921703,1,1,1,"positive regulation of cell junction assembly","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"96","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0048643",0.0296974220921703,1,1,1,"positive regulation of skeletal muscle tissue development","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"97","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0032728",0.00746608462180307,0.999788633063835,2,5,"positive regulation of interferon-beta production","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"98","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0044854",0.0296974220921703,1,1,1,"plasma membrane raft assembly","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"99","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0071360",0.0296974220921703,1,1,1,"cellular response to exogenous dsRNA","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"100","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0051580",0.0296974220921703,1,1,1,"regulation of neurotransmitter uptake","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"101","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0071360",0.0296974220921703,1,1,1,"cellular response to exogenous dsRNA","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"102","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0032728",0.00746608462180307,0.999788633063835,2,5,"positive regulation of interferon-beta production","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"103","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0008180",0.0324166105895982,0.997430552587002,2,12,"COP9 signalosome","CC",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"104","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0008180",0.0324166105895982,0.997430552587002,2,12,"COP9 signalosome","CC",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"105","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0044854",0.0296974220921703,1,1,1,"plasma membrane raft assembly","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"106","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0044291",0.015719266612473,0.999217636998517,2,8,"cell-cell contact zone","CC",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"107","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0044291",0.015719266612473,0.999217636998517,2,8,"cell-cell contact zone","CC",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.3060326455052,0.323682686224193,-4.03491660533427,5.46216942987845e-05,0.010735537785985,"CvsT1"
"108","Acerv_evm.model.Segkk1895_pilon.6",152,1,"XP_029206669.1",3.3e-85,99.34,NA,NA,NA,NA,NA,5,"FLOT1_DROMEFlotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1",0,86.92,43,"C:GO:0001931; P:GO:0001934; F:GO:0002020; P:GO:0002090; F:GO:0005198; C:GO:0005769; C:GO:0005912; P:GO:0007409; C:GO:0008180; C:GO:0009897; C:GO:0016323; C:GO:0016600; P:GO:0022617; C:GO:0030027; C:GO:0030864; P:GO:0032092; P:GO:0032226; P:GO:0032728; P:GO:0033227; P:GO:0034116; P:GO:0034141; C:GO:0034451; P:GO:0034976; P:GO:0035023; C:GO:0042383; C:GO:0042470; C:GO:0044291; P:GO:0044854; C:GO:0045177; P:GO:0045807; P:GO:0048643; P:GO:0050821; P:GO:0051092; P:GO:0051580; P:GO:0060355; P:GO:0070528; P:GO:0071360; P:GO:0072659; C:GO:0098691; P:GO:1901741; P:GO:1901890; P:GO:1903044; P:GO:2000049","C:uropod; P:positive regulation of protein phosphorylation; F:protease binding; P:regulation of receptor internalization; F:structural molecule activity; C:early endosome; C:adherens junction; P:axonogenesis; C:COP9 signalosome; C:external side of plasma membrane; C:basolateral plasma membrane; C:flotillin complex; P:extracellular matrix disassembly; C:lamellipodium; C:cortical actin cytoskeleton; P:positive regulation of protein binding; P:positive regulation of synaptic transmission, dopaminergic; P:positive regulation of interferon-beta production; P:dsRNA transport; P:positive regulation of heterotypic cell-cell adhesion; P:positive regulation of toll-like receptor 3 signaling pathway; C:centriolar satellite; P:response to endoplasmic reticulum stress; P:regulation of Rho protein signal transduction; C:sarcolemma; C:melanosome; C:cell-cell contact zone; P:plasma membrane raft assembly; C:apical part of cell; P:positive regulation of endocytosis; P:positive regulation of skeletal muscle tissue development; P:protein stabilization; P:positive regulation of NF-kappaB transcription factor activity; P:regulation of neurotransmitter uptake; P:positive regulation of cell adhesion molecule production; P:protein kinase C signaling; P:cellular response to exogenous dsRNA; P:protein localization to plasma membrane; C:dopaminergic synapse; P:positive regulation of myoblast fusion; P:positive regulation of cell junction assembly; P:protein localization to membrane raft; P:positive regulation of cell-cell adhesion mediated by cadherin",NA,NA,"Coil (COILS); Coil (COILS); IPR001107 (SMART); G3DSA:3.30.479.30 (GENE3D); IPR001107 (PFAM); IPR031905 (PFAM); cd03399 (CDD); IPR036013 (SUPERFAMILY)",NA,NA,"GO:0048643",0.0296974220921703,1,1,1,"positive regulation of skeletal muscle tissue development","BP",106,116,145,64,136,116,91,128,94,113,44,123,91,459,108.038694294678,-1.18183823321385,0.291386487252983,-4.05591297096688,4.99388527291276e-05,0.0111050162432418,"CvsT3"
"109","Acerv_evm.model.Segkk1929_pilon.4",191,1,"XP_029193520.1",1.6e-105,96.86,NA,NA,NA,NA,NA,5,"CTND2_HUMANCatenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3",6.91e-148,64.89,22,"C:GO:0000922; C:GO:0001533; P:GO:0001763; C:GO:0005634; P:GO:0007043; P:GO:0007612; F:GO:0008013; C:GO:0009898; C:GO:0014069; C:GO:0030057; C:GO:0030496; P:GO:0032467; C:GO:0043204; P:GO:0043547; C:GO:0044291; P:GO:0048167; C:GO:0048471; C:GO:0051233; P:GO:0060828; P:GO:0060997; C:GO:0072686; P:GO:0098609","C:spindle pole; C:cornified envelope; P:morphogenesis of a branching structure; C:nucleus; P:cell-cell junction assembly; P:learning; F:beta-catenin binding; C:cytoplasmic side of plasma membrane; C:postsynaptic density; C:desmosome; C:midbody; P:positive regulation of cytokinesis; C:perikaryon; P:positive regulation of GTPase activity; C:cell-cell contact zone; P:regulation of synaptic plasticity; C:perinuclear region of cytoplasm; C:spindle midzone; P:regulation of canonical Wnt signaling pathway; P:dendritic spine morphogenesis; C:mitotic spindle; P:cell-cell adhesion",NA,NA,"IPR000225 (SMART); IPR001024 (SMART); IPR037060 (G3DSA:2.40.180.GENE3D); IPR000225 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001024 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY)","F:GO:0004096; F:GO:0005515; F:GO:0020037; P:GO:0055114","F:catalase activity; F:protein binding; F:heme binding; P:obsolete oxidation-reduction process","GO:0001763",0.027822697259761,1,1,1,"morphogenesis of a branching structure","BP",229,211,265,169,263,118,146,254,98,105,135,252,74,576,168.120660303619,-0.786410040888889,0.211927182126634,-3.71075589736753,0.000206641291149411,0.0189695858010449,"CvsT2"
"110","Acerv_evm.model.Segkk1929_pilon.4",191,1,"XP_029193520.1",1.6e-105,96.86,NA,NA,NA,NA,NA,5,"CTND2_HUMANCatenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3",6.91e-148,64.89,22,"C:GO:0000922; C:GO:0001533; P:GO:0001763; C:GO:0005634; P:GO:0007043; P:GO:0007612; F:GO:0008013; C:GO:0009898; C:GO:0014069; C:GO:0030057; C:GO:0030496; P:GO:0032467; C:GO:0043204; P:GO:0043547; C:GO:0044291; P:GO:0048167; C:GO:0048471; C:GO:0051233; P:GO:0060828; P:GO:0060997; C:GO:0072686; P:GO:0098609","C:spindle pole; C:cornified envelope; P:morphogenesis of a branching structure; C:nucleus; P:cell-cell junction assembly; P:learning; F:beta-catenin binding; C:cytoplasmic side of plasma membrane; C:postsynaptic density; C:desmosome; C:midbody; P:positive regulation of cytokinesis; C:perikaryon; P:positive regulation of GTPase activity; C:cell-cell contact zone; P:regulation of synaptic plasticity; C:perinuclear region of cytoplasm; C:spindle midzone; P:regulation of canonical Wnt signaling pathway; P:dendritic spine morphogenesis; C:mitotic spindle; P:cell-cell adhesion",NA,NA,"IPR000225 (SMART); IPR001024 (SMART); IPR037060 (G3DSA:2.40.180.GENE3D); IPR000225 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001024 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY)","F:GO:0004096; F:GO:0005515; F:GO:0020037; P:GO:0055114","F:catalase activity; F:protein binding; F:heme binding; P:obsolete oxidation-reduction process","GO:0001533",0.027822697259761,1,1,1,"cornified envelope","CC",229,211,265,169,263,118,146,254,98,105,135,252,74,576,168.120660303619,-0.786410040888889,0.211927182126634,-3.71075589736753,0.000206641291149411,0.0189695858010449,"CvsT2"
"111","Acerv_evm.model.Segkk1929_pilon.4",191,1,"XP_029193520.1",1.6e-105,96.86,NA,NA,NA,NA,NA,5,"CTND2_HUMANCatenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3",6.91e-148,64.89,22,"C:GO:0000922; C:GO:0001533; P:GO:0001763; C:GO:0005634; P:GO:0007043; P:GO:0007612; F:GO:0008013; C:GO:0009898; C:GO:0014069; C:GO:0030057; C:GO:0030496; P:GO:0032467; C:GO:0043204; P:GO:0043547; C:GO:0044291; P:GO:0048167; C:GO:0048471; C:GO:0051233; P:GO:0060828; P:GO:0060997; C:GO:0072686; P:GO:0098609","C:spindle pole; C:cornified envelope; P:morphogenesis of a branching structure; C:nucleus; P:cell-cell junction assembly; P:learning; F:beta-catenin binding; C:cytoplasmic side of plasma membrane; C:postsynaptic density; C:desmosome; C:midbody; P:positive regulation of cytokinesis; C:perikaryon; P:positive regulation of GTPase activity; C:cell-cell contact zone; P:regulation of synaptic plasticity; C:perinuclear region of cytoplasm; C:spindle midzone; P:regulation of canonical Wnt signaling pathway; P:dendritic spine morphogenesis; C:mitotic spindle; P:cell-cell adhesion",NA,NA,"IPR000225 (SMART); IPR001024 (SMART); IPR037060 (G3DSA:2.40.180.GENE3D); IPR000225 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001024 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY)","F:GO:0004096; F:GO:0005515; F:GO:0020037; P:GO:0055114","F:catalase activity; F:protein binding; F:heme binding; P:obsolete oxidation-reduction process","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",229,211,265,169,263,118,146,254,98,105,135,252,74,576,168.120660303619,-0.786410040888889,0.211927182126634,-3.71075589736753,0.000206641291149411,0.0189695858010449,"CvsT2"
"112","Acerv_evm.model.Segkk1929_pilon.4",191,1,"XP_029193520.1",1.6e-105,96.86,NA,NA,NA,NA,NA,5,"CTND2_HUMANCatenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3",6.91e-148,64.89,22,"C:GO:0000922; C:GO:0001533; P:GO:0001763; C:GO:0005634; P:GO:0007043; P:GO:0007612; F:GO:0008013; C:GO:0009898; C:GO:0014069; C:GO:0030057; C:GO:0030496; P:GO:0032467; C:GO:0043204; P:GO:0043547; C:GO:0044291; P:GO:0048167; C:GO:0048471; C:GO:0051233; P:GO:0060828; P:GO:0060997; C:GO:0072686; P:GO:0098609","C:spindle pole; C:cornified envelope; P:morphogenesis of a branching structure; C:nucleus; P:cell-cell junction assembly; P:learning; F:beta-catenin binding; C:cytoplasmic side of plasma membrane; C:postsynaptic density; C:desmosome; C:midbody; P:positive regulation of cytokinesis; C:perikaryon; P:positive regulation of GTPase activity; C:cell-cell contact zone; P:regulation of synaptic plasticity; C:perinuclear region of cytoplasm; C:spindle midzone; P:regulation of canonical Wnt signaling pathway; P:dendritic spine morphogenesis; C:mitotic spindle; P:cell-cell adhesion",NA,NA,"IPR000225 (SMART); IPR001024 (SMART); IPR037060 (G3DSA:2.40.180.GENE3D); IPR000225 (PFAM); IPR011989 (G3DSA:1.25.10.GENE3D); IPR001024 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); IPR001024 (PROSITE_PROFILES); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); cd01756 (CDD); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR016024 (SUPERFAMILY); IPR036392 (SUPERFAMILY); IPR036392 (SUPERFAMILY)","F:GO:0004096; F:GO:0005515; F:GO:0020037; P:GO:0055114","F:catalase activity; F:protein binding; F:heme binding; P:obsolete oxidation-reduction process","GO:0044291",0.015719266612473,0.999217636998517,2,8,"cell-cell contact zone","CC",229,211,265,169,263,118,146,254,98,105,135,252,74,576,168.120660303619,-0.786410040888889,0.211927182126634,-3.71075589736753,0.000206641291149411,0.0189695858010449,"CvsT2"
"113","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0038127",0.0216547461560398,1,1,1,"ERBB signaling pathway","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"114","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0061308",0.0216547461560398,1,1,1,"cardiac neural crest cell development involved in heart development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"115","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0010759",0.0216547461560398,1,1,1,"positive regulation of macrophage chemotaxis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"116","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070371",0.0482632009259829,0.999405948471261,1,2,"ERK1 and ERK2 cascade","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"117","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"118","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"119","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0038127",0.0216547461560398,1,1,1,"ERBB signaling pathway","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"120","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"121","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070371",0.0482632009259829,0.999405948471261,1,2,"ERK1 and ERK2 cascade","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"122","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070371",0.0482632009259829,0.999405948471261,1,2,"ERK1 and ERK2 cascade","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"123","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"124","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060324",0.0425926594393588,0.999538703207051,1,2,"face development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"125","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060324",0.0425926594393588,0.999538703207051,1,2,"face development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"126","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060324",0.0425926594393588,0.999538703207051,1,2,"face development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"127","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0038127",0.0216547461560398,1,1,1,"ERBB signaling pathway","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"128","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"129","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"130","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0001784",0.0113616432706379,0.999540856540644,2,7,"phosphotyrosine residue binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"131","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0001784",0.0113616432706379,0.999540856540644,2,7,"phosphotyrosine residue binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"132","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0001784",0.0113616432706379,0.999540856540644,2,7,"phosphotyrosine residue binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"133","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"134","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"135","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0010759",0.0216547461560398,1,1,1,"positive regulation of macrophage chemotaxis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"136","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0010759",0.0216547461560398,1,1,1,"positive regulation of macrophage chemotaxis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"137","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0071356",0.00572553304945496,0.999562969298826,3,17,"cellular response to tumor necrosis factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"138","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0071356",0.00572553304945496,0.999562969298826,3,17,"cellular response to tumor necrosis factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"139","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0071356",0.00572553304945496,0.999562969298826,3,17,"cellular response to tumor necrosis factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"140","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060440",0.0425926594393588,0.999538703207051,1,2,"trachea formation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"141","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"142","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"143","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"144","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005770",0.0377183773296265,0.993812215624208,3,32,"late endosome","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"145","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0061308",0.0216547461560398,1,1,1,"cardiac neural crest cell development involved in heart development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"146","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"147","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"148","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"149","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0015966",0.0216547461560398,1,1,1,"diadenosine tetraphosphate biosynthetic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"150","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0015966",0.0216547461560398,1,1,1,"diadenosine tetraphosphate biosynthetic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"151","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0015966",0.0216547461560398,1,1,1,"diadenosine tetraphosphate biosynthetic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"152","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0090170",0.0425926594393588,0.999538703207051,1,2,"regulation of Golgi inheritance","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"153","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0090170",0.0425926594393588,0.999538703207051,1,2,"regulation of Golgi inheritance","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"154","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060440",0.0425926594393588,0.999538703207051,1,2,"trachea formation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"155","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060440",0.0425926594393588,0.999538703207051,1,2,"trachea formation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"156","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0072584",0.0216547461560398,1,1,1,"caveolin-mediated endocytosis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"157","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0072584",0.0216547461560398,1,1,1,"caveolin-mediated endocytosis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"158","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"159","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"160","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"161","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070849",0.0430998141639245,0.999527528030496,1,2,"response to epidermal growth factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"162","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070849",0.0430998141639245,0.999527528030496,1,2,"response to epidermal growth factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"163","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0070849",0.0430998141639245,0.999527528030496,1,2,"response to epidermal growth factor","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"164","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"165","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"166","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"167","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0090170",0.0425926594393588,0.999538703207051,1,2,"regulation of Golgi inheritance","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"168","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"169","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0120041",0.0216547461560398,1,1,1,"positive regulation of macrophage proliferation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"170","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043330",0.00343041765546804,0.999944011394379,2,4,"response to exogenous dsRNA","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"171","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043330",0.00343041765546804,0.999944011394379,2,4,"response to exogenous dsRNA","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"172","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0043330",0.00343041765546804,0.999944011394379,2,4,"response to exogenous dsRNA","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"173","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0061308",0.0216547461560398,1,1,1,"cardiac neural crest cell development involved in heart development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"174","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0031143",0.0216547461560398,1,1,1,"pseudopodium","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"175","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060291",0.00967798161593436,0.999640440306866,2,7,"long-term synaptic potentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"176","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060291",0.00967798161593436,0.999640440306866,2,7,"long-term synaptic potentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"177","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0060291",0.00967798161593436,0.999640440306866,2,7,"long-term synaptic potentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"178","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"179","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0031143",0.0216547461560398,1,1,1,"pseudopodium","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"180","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"181","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"182","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"183","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0072584",0.0216547461560398,1,1,1,"caveolin-mediated endocytosis","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"184","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005770",0.0377183773296265,0.993812215624208,3,32,"late endosome","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"185","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005770",0.0377183773296265,0.993812215624208,3,32,"late endosome","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"186","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0120041",0.0216547461560398,1,1,1,"positive regulation of macrophage proliferation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"187","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"188","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.49558738735355,0.600891203235296,-4.15314348740155,3.27938961656946e-05,0.00470295028445673,"CvsT2"
"189","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0120041",0.0216547461560398,1,1,1,"positive regulation of macrophage proliferation","BP",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.97198302222227,0.59091760902446,-5.02943722920812,4.91921505897359e-07,0.00021178392070562,"CvsT3"
"190","Acerv_evm.model.Segkk1945_pilon.2",449,1,"XP_015747201.1",2.9e-161,82.42,NA,NA,NA,NA,NA,5,"MK01_HUMANMitogen-activated protein kinase 1 OS=Homo sapiens OX=9606 GN=MAPK1 PE=1 SV=3",0,91.92,87,"F:GO:0001784; F:GO:0003690; F:GO:0004707; F:GO:0004708; F:GO:0005524; C:GO:0005576; C:GO:0005654; C:GO:0005739; C:GO:0005769; C:GO:0005770; C:GO:0005788; C:GO:0005794; C:GO:0005815; C:GO:0005829; C:GO:0005901; C:GO:0005925; P:GO:0006915; P:GO:0006974; P:GO:0007094; P:GO:0007568; P:GO:0007611; F:GO:0008353; P:GO:0009636; P:GO:0010759; P:GO:0010800; C:GO:0014069; P:GO:0015966; P:GO:0018105; P:GO:0019233; P:GO:0019858; F:GO:0019902; P:GO:0030278; C:GO:0030424; P:GO:0030641; P:GO:0030878; C:GO:0031143; F:GO:0031435; P:GO:0031647; P:GO:0031663; P:GO:0032212; C:GO:0032839; P:GO:0032872; C:GO:0032991; P:GO:0033598; P:GO:0034198; P:GO:0034614; P:GO:0035094; C:GO:0035578; P:GO:0038127; P:GO:0042307; P:GO:0042473; F:GO:0042802; C:GO:0043204; P:GO:0043330; P:GO:0043627; P:GO:0045596; P:GO:0045727; P:GO:0045893; P:GO:0046697; P:GO:0048538; P:GO:0050852; P:GO:0050853; P:GO:0051090; P:GO:0051493; P:GO:0051973; P:GO:0060020; P:GO:0060045; P:GO:0060291; P:GO:0060324; P:GO:0060425; P:GO:0060440; P:GO:0060716; P:GO:0061308; P:GO:0070371; P:GO:0070849; P:GO:0071276; P:GO:0071356; P:GO:0072584; C:GO:0072686; P:GO:0090170; P:GO:0097011; F:GO:0106310; P:GO:0120041; P:GO:1903351; P:GO:1904355; C:GO:1904813; P:GO:2000641","F:phosphotyrosine residue binding; F:double-stranded DNA binding; F:MAP kinase activity; F:MAP kinase kinase activity; F:ATP binding; C:extracellular region; C:nucleoplasm; C:mitochondrion; C:early endosome; C:late endosome; C:endoplasmic reticulum lumen; C:Golgi apparatus; C:microtubule organizing center; C:cytosol; C:caveola; C:focal adhesion; P:apoptotic process; P:cellular response to DNA damage stimulus; P:mitotic spindle assembly checkpoint signaling; P:aging; P:learning or memory; F:RNA polymerase II CTD heptapeptide repeat kinase activity; P:response to toxic substance; P:positive regulation of macrophage chemotaxis; P:positive regulation of peptidyl-threonine phosphorylation; C:postsynaptic density; P:diadenosine tetraphosphate biosynthetic process; P:peptidyl-serine phosphorylation; P:sensory perception of pain; P:cytosine metabolic process; F:phosphatase binding; P:regulation of ossification; C:axon; P:regulation of cellular pH; P:thyroid gland development; C:pseudopodium; F:mitogen-activated protein kinase kinase kinase binding; P:regulation of protein stability; P:lipopolysaccharide-mediated signaling pathway; P:positive regulation of telomere maintenance via telomerase; C:dendrite cytoplasm; P:regulation of stress-activated MAPK cascade; C:protein-containing complex; P:mammary gland epithelial cell proliferation; P:cellular response to amino acid starvation; P:cellular response to reactive oxygen species; P:response to nicotine; C:azurophil granule lumen; P:ERBB signaling pathway; P:positive regulation of protein import into nucleus; P:outer ear morphogenesis; F:identical protein binding; C:perikaryon; P:response to exogenous dsRNA; P:response to estrogen; P:negative regulation of cell differentiation; P:positive regulation of translation; P:positive regulation of transcription, DNA-templated; P:decidualization; P:thymus development; P:T cell receptor signaling pathway; P:B cell receptor signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of cytoskeleton organization; P:positive regulation of telomerase activity; P:Bergmann glial cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:long-term synaptic potentiation; P:face development; P:lung morphogenesis; P:trachea formation; P:labyrinthine layer blood vessel development; P:cardiac neural crest cell development involved in heart development; P:ERK1 and ERK2 cascade; P:response to epidermal growth factor; P:cellular response to cadmium ion; P:cellular response to tumor necrosis factor; P:caveolin-mediated endocytosis; C:mitotic spindle; P:regulation of Golgi inheritance; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; F:protein serine kinase activity; P:positive regulation of macrophage proliferation; P:cellular response to dopamine; P:positive regulation of telomere capping; C:ficolin-1-rich granule lumen; P:regulation of early endosome to late endosome transport","EC:2.7.1; EC:2.7.11.23; EC:2.7.12.1; EC:2.7.11.24; EC:2.7.12.2; EC:2.7; EC:2","Transferring phosphorus-containing groups; [RNA-polymerase]-subunit kinase; Dual-specificity kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Transferring phosphorus-containing groups; Transferases","IPR008349 (PRINTS); IPR000719 (SMART); IPR000719 (PFAM); G3DSA:3.30.200.20 (GENE3D); G3DSA:1.10.510.10 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR003527 (PROSITE_PATTERNS); IPR008271 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); cd07849 (CDD); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0004707; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:MAP kinase activity; F:ATP binding; P:protein phosphorylation","GO:0031143",0.0216547461560398,1,1,1,"pseudopodium","CC",34,8,12,16,18,17,18,0,12,19,7,24,12,1350,16.8033194983796,-2.95364415423031,0.645065097699942,-4.57883113620917,4.67581480375564e-06,0.00169096166563019,"CvsT1"
"191","Acerv_evm.model.Segkk1947_pilon.7",324,1,"XP_029194617.1",5.8e-63,57.86,NA,NA,NA,NA,NA,5,"WNT2_MONDOProtein Wnt-2 OS=Monodelphis domestica OX=13616 GN=WNT2 PE=3 SV=1",1.03e-41,65.1,11,"C:GO:0005576; P:GO:0008284; P:GO:0009888; P:GO:0030182; P:GO:0030901; F:GO:0048018; P:GO:0051094; P:GO:0051240; P:GO:0060070; P:GO:0072359; P:GO:2000026","C:extracellular region; P:positive regulation of cell population proliferation; P:tissue development; P:neuron differentiation; P:midbrain development; F:receptor ligand activity; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:canonical Wnt signaling pathway; P:circulatory system development; P:regulation of multicellular organismal development",NA,NA,"IPR005817 (PRINTS); IPR005817 (SMART); IPR043158 (G3DSA:3.30.2460.GENE3D); IPR005817 (PFAM); IPR018161 (PROSITE_PATTERNS)","F:GO:0005102; C:GO:0005576; P:GO:0007275; P:GO:0016055","F:signaling receptor binding; C:extracellular region; P:multicellular organism development; P:Wnt signaling pathway","GO:0016055",0.041684849654316,0.996169134698508,2,13,"Wnt signaling pathway","BP",1871,5915,5070,1052,1953,1006,1377,4667,900,1181,808,2889,689,975,1781.45631116872,0.7523217670236,0.201213638730498,3.7389203424289,0.000184812271727002,0.0265220277568861,"CvsT1"
"192","Acerv_evm.model.Segkk1947_pilon.7",324,1,"XP_029194617.1",5.8e-63,57.86,NA,NA,NA,NA,NA,5,"WNT2_MONDOProtein Wnt-2 OS=Monodelphis domestica OX=13616 GN=WNT2 PE=3 SV=1",1.03e-41,65.1,11,"C:GO:0005576; P:GO:0008284; P:GO:0009888; P:GO:0030182; P:GO:0030901; F:GO:0048018; P:GO:0051094; P:GO:0051240; P:GO:0060070; P:GO:0072359; P:GO:2000026","C:extracellular region; P:positive regulation of cell population proliferation; P:tissue development; P:neuron differentiation; P:midbrain development; F:receptor ligand activity; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:canonical Wnt signaling pathway; P:circulatory system development; P:regulation of multicellular organismal development",NA,NA,"IPR005817 (PRINTS); IPR005817 (SMART); IPR043158 (G3DSA:3.30.2460.GENE3D); IPR005817 (PFAM); IPR018161 (PROSITE_PATTERNS)","F:GO:0005102; C:GO:0005576; P:GO:0007275; P:GO:0016055","F:signaling receptor binding; C:extracellular region; P:multicellular organism development; P:Wnt signaling pathway","GO:0016055",0.041684849654316,0.996169134698508,2,13,"Wnt signaling pathway","BP",1871,5915,5070,1052,1953,1006,1377,4667,900,1181,808,2889,689,975,1781.45631116872,0.740119135808912,0.179892080727051,4.1142396753523,3.88457664059842e-05,0.0092422256335922,"CvsT3"
"193","Acerv_evm.model.Segkk1947_pilon.7",324,1,"XP_029194617.1",5.8e-63,57.86,NA,NA,NA,NA,NA,5,"WNT2_MONDOProtein Wnt-2 OS=Monodelphis domestica OX=13616 GN=WNT2 PE=3 SV=1",1.03e-41,65.1,11,"C:GO:0005576; P:GO:0008284; P:GO:0009888; P:GO:0030182; P:GO:0030901; F:GO:0048018; P:GO:0051094; P:GO:0051240; P:GO:0060070; P:GO:0072359; P:GO:2000026","C:extracellular region; P:positive regulation of cell population proliferation; P:tissue development; P:neuron differentiation; P:midbrain development; F:receptor ligand activity; P:positive regulation of developmental process; P:positive regulation of multicellular organismal process; P:canonical Wnt signaling pathway; P:circulatory system development; P:regulation of multicellular organismal development",NA,NA,"IPR005817 (PRINTS); IPR005817 (SMART); IPR043158 (G3DSA:3.30.2460.GENE3D); IPR005817 (PFAM); IPR018161 (PROSITE_PATTERNS)","F:GO:0005102; C:GO:0005576; P:GO:0007275; P:GO:0016055","F:signaling receptor binding; C:extracellular region; P:multicellular organism development; P:Wnt signaling pathway","GO:0016055",0.041684849654316,0.996169134698508,2,13,"Wnt signaling pathway","BP",1871,5915,5070,1052,1953,1006,1377,4667,900,1181,808,2889,689,975,1781.45631116872,0.805202760316841,0.179791336200453,4.47854038650175,7.51551530440949e-06,0.00150995053038147,"CvsT2"
"194","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"195","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0010506",0.00576474779983078,0.999567152866091,3,15,"regulation of autophagy","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"196","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"197","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0060627",0.0030127162805093,0.999825416102579,3,13,"regulation of vesicle-mediated transport","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"198","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0098588",0.0256404082656132,0.996418532001015,3,27,"bounding membrane of organelle","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"199","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0098588",0.0256404082656132,0.996418532001015,3,27,"bounding membrane of organelle","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"200","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"201","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"202","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"203","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"204","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0060627",0.0030127162805093,0.999825416102579,3,13,"regulation of vesicle-mediated transport","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"205","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0031966",0.0113946667293086,0.998858582605281,3,20,"mitochondrial membrane","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"206","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0031966",0.0113946667293086,0.998858582605281,3,20,"mitochondrial membrane","CC",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"207","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0010506",0.00576474779983078,0.999567152866091,3,15,"regulation of autophagy","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"208","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0006996",0.00399445560224313,0.999554020421145,4,28,"organelle organization","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"209","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0009967",0.0232132695160049,0.996878338512387,3,27,"positive regulation of signal transduction","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"210","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0009967",0.0232132695160049,0.996878338512387,3,27,"positive regulation of signal transduction","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"211","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0006996",0.00399445560224313,0.999554020421145,4,28,"organelle organization","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"212","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:1902531",0.00116104356819137,0.999911652546393,4,20,"regulation of intracellular signal transduction","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"213","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.17152956174827,0.340101951644682,-3.44464227883117,0.000571815603455509,0.0386990602271957,"CvsT2"
"214","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"215","Acerv_evm.model.Segkk1991_pilon.4",178,1,"XP_029207355.1",1.1e-103,98.89,NA,NA,NA,NA,NA,4,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",6.55e-16,43.32,33,"F:GO:0000166; P:GO:0001932; F:GO:0004674; F:GO:0005515; P:GO:0006950; P:GO:0006996; P:GO:0007399; P:GO:0009967; P:GO:0010468; P:GO:0010506; P:GO:0010941; C:GO:0012505; F:GO:0016787; P:GO:0031324; P:GO:0031401; C:GO:0031410; C:GO:0031966; P:GO:0034613; C:GO:0036477; P:GO:0042391; C:GO:0043005; F:GO:0043167; P:GO:0044093; P:GO:0048513; P:GO:0050790; P:GO:0050793; P:GO:0051128; P:GO:0060341; P:GO:0060627; P:GO:0070887; C:GO:0098588; C:GO:0098793; P:GO:1902531","F:nucleotide binding; P:regulation of protein phosphorylation; F:protein serine/threonine kinase activity; F:protein binding; P:response to stress; P:organelle organization; P:nervous system development; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; P:regulation of cell death; C:endomembrane system; F:hydrolase activity; P:negative regulation of cellular metabolic process; P:positive regulation of protein modification process; C:cytoplasmic vesicle; C:mitochondrial membrane; P:cellular protein localization; C:somatodendritic compartment; P:regulation of membrane potential; C:neuron projection; F:ion binding; P:positive regulation of molecular function; P:animal organ development; P:regulation of catalytic activity; P:regulation of developmental process; P:regulation of cellular component organization; P:regulation of cellular localization; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:bounding membrane of organelle; C:presynapse; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","IPR000488 (SMART); IPR000488 (PFAM); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000488 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd01670 (CDD); IPR027417 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165","F:protein binding; P:signal transduction","GO:1902531",0.00116104356819137,0.999911652546393,4,20,"regulation of intracellular signal transduction","BP",129,166,161,104,202,67,144,100,28,59,94,356,43,537,115.796624160812,-1.55401734549397,0.373186108224199,-4.16418862129874,3.12461728302762e-05,0.00672611067996493,"CvsT4"
"216","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0007501",0.0427350347968549,0.999535579762595,1,2,"mesodermal cell fate specification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"217","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"218","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"219","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"220","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048538",0.00671967428151926,0.999804343001634,2,6,"thymus development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"221","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:1902732",0.0386770806207612,0.999620390491997,1,2,"positive regulation of chondrocyte proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"222","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:1902732",0.0386770806207612,0.999620390491997,1,2,"positive regulation of chondrocyte proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"223","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:1902732",0.0386770806207612,0.999620390491997,1,2,"positive regulation of chondrocyte proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"224","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:1902732",0.0386770806207612,0.999620390491997,1,2,"positive regulation of chondrocyte proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"225","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0035271",0.0214085677121724,1,1,1,"ring gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"226","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0035271",0.0214085677121724,1,1,1,"ring gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"227","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0035271",0.0214085677121724,1,1,1,"ring gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"228","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0035271",0.0214085677121724,1,1,1,"ring gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"229","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001744",0.0214085677121724,1,1,1,"optic lobe placode formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"230","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001744",0.0214085677121724,1,1,1,"optic lobe placode formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"231","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001744",0.0214085677121724,1,1,1,"optic lobe placode formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"232","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001744",0.0214085677121724,1,1,1,"optic lobe placode formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"233","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"234","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"235","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"236","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"237","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0043282",0.0214085677121724,1,1,1,"pharyngeal muscle development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"238","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0043282",0.0214085677121724,1,1,1,"pharyngeal muscle development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"239","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0043282",0.0214085677121724,1,1,1,"pharyngeal muscle development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"240","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0043282",0.0214085677121724,1,1,1,"pharyngeal muscle development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"241","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"242","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"243","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"244","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030878",0.00463761996904163,0.999897478551887,2,5,"thyroid gland development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"245","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0003337",0.0214085677121724,1,1,1,"mesenchymal to epithelial transition involved in metanephros morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"246","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0003337",0.0214085677121724,1,1,1,"mesenchymal to epithelial transition involved in metanephros morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"247","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0003337",0.0214085677121724,1,1,1,"mesenchymal to epithelial transition involved in metanephros morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"248","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0003337",0.0214085677121724,1,1,1,"mesenchymal to epithelial transition involved in metanephros morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"249","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0097168",0.0214085677121724,1,1,1,"mesenchymal stem cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"250","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0097168",0.0214085677121724,1,1,1,"mesenchymal stem cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"251","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0097168",0.0214085677121724,1,1,1,"mesenchymal stem cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"252","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0097168",0.0214085677121724,1,1,1,"mesenchymal stem cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"253","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"254","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"255","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"256","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045596",0.0301487928044789,0.997702213834594,2,12,"negative regulation of cell differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"257","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072161",0.0214085677121724,1,1,1,"mesenchymal cell differentiation involved in kidney development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"258","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072161",0.0214085677121724,1,1,1,"mesenchymal cell differentiation involved in kidney development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"259","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072161",0.0214085677121724,1,1,1,"mesenchymal cell differentiation involved in kidney development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"260","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072161",0.0214085677121724,1,1,1,"mesenchymal cell differentiation involved in kidney development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"261","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048935",0.0423670323166887,0.999543630978314,1,2,"peripheral nervous system neuron development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"262","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048935",0.0423670323166887,0.999543630978314,1,2,"peripheral nervous system neuron development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"263","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048935",0.0423670323166887,0.999543630978314,1,2,"peripheral nervous system neuron development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"264","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0048935",0.0423670323166887,0.999543630978314,1,2,"peripheral nervous system neuron development","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"265","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0032330",0.0423965489037347,0.999542987863787,1,2,"regulation of chondrocyte differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"266","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0032330",0.0423965489037347,0.999542987863787,1,2,"regulation of chondrocyte differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"267","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0032330",0.0423965489037347,0.999542987863787,1,2,"regulation of chondrocyte differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"268","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0032330",0.0423965489037347,0.999542987863787,1,2,"regulation of chondrocyte differentiation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"269","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0014857",0.0214085677121724,1,1,1,"regulation of skeletal muscle cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"270","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0014857",0.0214085677121724,1,1,1,"regulation of skeletal muscle cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"271","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0014857",0.0214085677121724,1,1,1,"regulation of skeletal muscle cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"272","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0014857",0.0214085677121724,1,1,1,"regulation of skeletal muscle cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"273","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072137",0.0423033128859259,0.999545017734879,1,2,"condensed mesenchymal cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"274","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072137",0.0423033128859259,0.999545017734879,1,2,"condensed mesenchymal cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"275","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072137",0.0423033128859259,0.999545017734879,1,2,"condensed mesenchymal cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"276","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072137",0.0423033128859259,0.999545017734879,1,2,"condensed mesenchymal cell proliferation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"277","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072038",0.0214085677121724,1,1,1,"mesenchymal stem cell maintenance involved in nephron morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"278","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072107",0.0214085677121724,1,1,1,"positive regulation of ureteric bud formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"279","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072107",0.0214085677121724,1,1,1,"positive regulation of ureteric bud formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"280","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072107",0.0214085677121724,1,1,1,"positive regulation of ureteric bud formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"281","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072107",0.0214085677121724,1,1,1,"positive regulation of ureteric bud formation","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"282","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"283","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"284","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"285","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0030278",0.004434431361712,0.99990421451234,2,5,"regulation of ossification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"286","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072095",0.0214085677121724,1,1,1,"regulation of branch elongation involved in ureteric bud branching","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"287","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072095",0.0214085677121724,1,1,1,"regulation of branch elongation involved in ureteric bud branching","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"288","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072095",0.0214085677121724,1,1,1,"regulation of branch elongation involved in ureteric bud branching","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"289","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072095",0.0214085677121724,1,1,1,"regulation of branch elongation involved in ureteric bud branching","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"290","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001746",0.0214085677121724,1,1,1,"Bolwig's organ morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"291","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001746",0.0214085677121724,1,1,1,"Bolwig's organ morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"292","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001746",0.0214085677121724,1,1,1,"Bolwig's organ morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"293","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0001746",0.0214085677121724,1,1,1,"Bolwig's organ morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"294","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0007501",0.0427350347968549,0.999535579762595,1,2,"mesodermal cell fate specification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"295","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0007501",0.0427350347968549,0.999535579762595,1,2,"mesodermal cell fate specification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"296","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0007501",0.0427350347968549,0.999535579762595,1,2,"mesodermal cell fate specification","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"297","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"298","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"299","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"300","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.12074157173849,0.195331601356425,5.73763571258216,9.60073416953046e-09,5.4250148516703e-06,"CvsT2"
"301","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072038",0.0214085677121724,1,1,1,"mesenchymal stem cell maintenance involved in nephron morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.04894910309027,0.210874909040561,4.97427175126135,6.54933804490868e-07,0.000311645080336944,"CvsT4"
"302","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072038",0.0214085677121724,1,1,1,"mesenchymal stem cell maintenance involved in nephron morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,0.96622144876892,0.219007379745837,4.41182141848482,1.02504644359172e-05,0.00319567065396991,"CvsT1"
"303","Acerv_evm.model.Segkk20_pilon.1",763,1,"XP_029181869.1",3e-171,88.72,NA,NA,NA,NA,NA,5,"SO_DROMEProtein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1",1.93e-78,74.63,48,"C:GO:0000785; F:GO:0000978; F:GO:0001228; P:GO:0001744; P:GO:0001745; P:GO:0001746; P:GO:0001759; P:GO:0002074; P:GO:0003337; C:GO:0005634; C:GO:0005667; P:GO:0006606; P:GO:0007283; P:GO:0007501; F:GO:0008134; P:GO:0008347; P:GO:0009649; P:GO:0009948; P:GO:0014857; P:GO:0021984; P:GO:0030278; P:GO:0030878; P:GO:0032330; P:GO:0035271; P:GO:0042472; P:GO:0042474; P:GO:0043282; P:GO:0043524; F:GO:0044877; P:GO:0045596; P:GO:0045664; P:GO:0045944; P:GO:0048538; P:GO:0048557; P:GO:0048701; P:GO:0048741; P:GO:0048935; P:GO:0051451; P:GO:0072038; P:GO:0072075; P:GO:0072095; P:GO:0072107; P:GO:0072137; P:GO:0072161; P:GO:0090190; P:GO:0090336; P:GO:0097168; P:GO:1902732","C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; P:insect visual primordium formation; P:compound eye morphogenesis; P:Bolwig's organ morphogenesis; P:organ induction; P:extraocular skeletal muscle development; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; C:nucleus; C:transcription regulator complex; P:protein import into nucleus; P:spermatogenesis; P:mesodermal cell fate specification; F:transcription factor binding; P:glial cell migration; P:entrainment of circadian clock; P:anterior/posterior axis specification; P:regulation of skeletal muscle cell proliferation; P:adenohypophysis development; P:regulation of ossification; P:thyroid gland development; P:regulation of chondrocyte differentiation; P:ring gland development; P:inner ear morphogenesis; P:middle ear morphogenesis; P:pharyngeal muscle development; P:negative regulation of neuron apoptotic process; F:protein-containing complex binding; P:negative regulation of cell differentiation; P:regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II; P:thymus development; P:embryonic digestive tract morphogenesis; P:embryonic cranial skeleton morphogenesis; P:skeletal muscle fiber development; P:peripheral nervous system neuron development; P:myoblast migration; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; P:metanephric mesenchyme development; P:regulation of branch elongation involved in ureteric bud branching; P:positive regulation of ureteric bud formation; P:condensed mesenchymal cell proliferation; P:mesenchymal cell differentiation involved in kidney development; P:positive regulation of branching involved in ureteric bud morphogenesis; P:positive regulation of brown fat cell differentiation; P:mesenchymal stem cell proliferation; P:positive regulation of chondrocyte proliferation",NA,NA,"Coil (COILS); IPR001356 (SMART); IPR001356 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR031701 (PFAM); IPR017970 (PROSITE_PATTERNS); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0000981; F:GO:0003677; P:GO:0006355","F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA binding; P:regulation of transcription, DNA-templated","GO:0072038",0.0214085677121724,1,1,1,"mesenchymal stem cell maintenance involved in nephron morphogenesis","BP",199,849,693,131,240,115,144,644,123,148,88,234,55,2294,212.109273438504,1.10559830539745,0.196332462270368,5.63125574147256,1.78902212479101e-08,1.01090931438972e-05,"CvsT3"
"304","Acerv_evm.model.Segkk2008_pilon.3",678,1,"XP_029183525.1",2.2e-258,83.3,NA,NA,NA,NA,NA,5,"RDR1_ARATHRNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1",1.74e-14,50.31,8,"F:GO:0005488; C:GO:0005634; F:GO:0016740; P:GO:0022414; P:GO:0030422; P:GO:0048367; P:GO:0051607; P:GO:1901576","F:binding; C:nucleus; F:transferase activity; P:reproductive process; P:production of siRNA involved in RNA interference; P:shoot system development; P:defense response to virus; P:organic substance biosynthetic process","EC:2","Transferases","IPR007855 (PFAM)","F:GO:0003968","F:RNA-directed 5'-3' RNA polymerase activity","GO:0003968",0.0423481939837696,0.999544041190534,1,2,"RNA-directed 5'-3' RNA polymerase activity","MF",502,719,589,374,656,342,344,434,202,315,286,594,164,2037,397.078494758759,-0.708447660771751,0.183709969758459,-3.85633758311111,0.000115098510653138,0.0123744881924496,"CvsT2"
"305","Acerv_evm.model.Segkk2008_pilon.3",678,1,"XP_029183525.1",2.2e-258,83.3,NA,NA,NA,NA,NA,5,"RDR1_ARATHRNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1",1.74e-14,50.31,8,"F:GO:0005488; C:GO:0005634; F:GO:0016740; P:GO:0022414; P:GO:0030422; P:GO:0048367; P:GO:0051607; P:GO:1901576","F:binding; C:nucleus; F:transferase activity; P:reproductive process; P:production of siRNA involved in RNA interference; P:shoot system development; P:defense response to virus; P:organic substance biosynthetic process","EC:2","Transferases","IPR007855 (PFAM)","F:GO:0003968","F:RNA-directed 5'-3' RNA polymerase activity","GO:0048367",0.0420133917582978,0.999551300203947,1,2,"shoot system development","BP",502,719,589,374,656,342,344,434,202,315,286,594,164,2037,397.078494758759,-0.708447660771751,0.183709969758459,-3.85633758311111,0.000115098510653138,0.0123744881924496,"CvsT2"
"306","Acerv_evm.model.Segkk2008_pilon.3",678,1,"XP_029183525.1",2.2e-258,83.3,NA,NA,NA,NA,NA,5,"RDR1_ARATHRNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1",1.74e-14,50.31,8,"F:GO:0005488; C:GO:0005634; F:GO:0016740; P:GO:0022414; P:GO:0030422; P:GO:0048367; P:GO:0051607; P:GO:1901576","F:binding; C:nucleus; F:transferase activity; P:reproductive process; P:production of siRNA involved in RNA interference; P:shoot system development; P:defense response to virus; P:organic substance biosynthetic process","EC:2","Transferases","IPR007855 (PFAM)","F:GO:0003968","F:RNA-directed 5'-3' RNA polymerase activity","GO:0051607",0.0103456307275163,0.999005857260926,3,19,"defense response to virus","BP",502,719,589,374,656,342,344,434,202,315,286,594,164,2037,397.078494758759,-0.708447660771751,0.183709969758459,-3.85633758311111,0.000115098510653138,0.0123744881924496,"CvsT2"
"307","Acerv_evm.model.Segkk2008_pilon.3",678,1,"XP_029183525.1",2.2e-258,83.3,NA,NA,NA,NA,NA,5,"RDR1_ARATHRNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1",1.74e-14,50.31,8,"F:GO:0005488; C:GO:0005634; F:GO:0016740; P:GO:0022414; P:GO:0030422; P:GO:0048367; P:GO:0051607; P:GO:1901576","F:binding; C:nucleus; F:transferase activity; P:reproductive process; P:production of siRNA involved in RNA interference; P:shoot system development; P:defense response to virus; P:organic substance biosynthetic process","EC:2","Transferases","IPR007855 (PFAM)","F:GO:0003968","F:RNA-directed 5'-3' RNA polymerase activity","GO:0030422",0.0423616991804233,0.999543747128614,1,2,"production of siRNA involved in RNA interference","BP",502,719,589,374,656,342,344,434,202,315,286,594,164,2037,397.078494758759,-0.708447660771751,0.183709969758459,-3.85633758311111,0.000115098510653138,0.0123744881924496,"CvsT2"
"308","Acerv_evm.model.Segkk2116_pilon.21",307,1,"XP_029181172.1",1.1e-156,92.18,NA,NA,NA,NA,NA,5,"G3ST3_MOUSEGalactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1",1.43e-20,51.4,10,"F:GO:0005515; P:GO:0005975; P:GO:0006664; P:GO:0006665; C:GO:0016020; P:GO:0044249; P:GO:0044260; F:GO:0050694; P:GO:1901137; P:GO:1901566","F:protein binding; P:carbohydrate metabolic process; P:glycolipid metabolic process; P:sphingolipid metabolic process; C:membrane; P:cellular biosynthetic process; P:cellular macromolecule metabolic process; F:galactose 3-O-sulfotransferase activity; P:carbohydrate derivative biosynthetic process; P:organonitrogen compound biosynthetic process","EC:2.8.2; EC:2; EC:2.8","Transferring sulfur-containing groups; Transferases; Transferring sulfur-containing groups","IPR009729 (PFAM)","F:GO:0001733; P:GO:0009247; C:GO:0016021","F:galactosylceramide sulfotransferase activity; P:glycolipid biosynthetic process; C:integral component of membrane","GO:0006664",0.0454503371966976,0.999473946436188,1,2,"glycolipid metabolic process","BP",461,1010,702,213,372,323,250,978,280,348,132,473,202,924,381.150039064491,0.730761808023572,0.203867502124055,3.58449385218296,0.000337732519331341,0.0270215903298642,"CvsT2"
"309","Acerv_evm.model.Segkk2116_pilon.21",307,1,"XP_029181172.1",1.1e-156,92.18,NA,NA,NA,NA,NA,5,"G3ST3_MOUSEGalactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1",1.43e-20,51.4,10,"F:GO:0005515; P:GO:0005975; P:GO:0006664; P:GO:0006665; C:GO:0016020; P:GO:0044249; P:GO:0044260; F:GO:0050694; P:GO:1901137; P:GO:1901566","F:protein binding; P:carbohydrate metabolic process; P:glycolipid metabolic process; P:sphingolipid metabolic process; C:membrane; P:cellular biosynthetic process; P:cellular macromolecule metabolic process; F:galactose 3-O-sulfotransferase activity; P:carbohydrate derivative biosynthetic process; P:organonitrogen compound biosynthetic process","EC:2.8.2; EC:2; EC:2.8","Transferring sulfur-containing groups; Transferases; Transferring sulfur-containing groups","IPR009729 (PFAM)","F:GO:0001733; P:GO:0009247; C:GO:0016021","F:galactosylceramide sulfotransferase activity; P:glycolipid biosynthetic process; C:integral component of membrane","GO:0001733",0.0454503371966976,0.999473946436188,1,2,"galactosylceramide sulfotransferase activity","MF",461,1010,702,213,372,323,250,978,280,348,132,473,202,924,381.150039064491,0.730761808023572,0.203867502124055,3.58449385218296,0.000337732519331341,0.0270215903298642,"CvsT2"
"310","Acerv_evm.model.Segkk2116_pilon.21",307,1,"XP_029181172.1",1.1e-156,92.18,NA,NA,NA,NA,NA,5,"G3ST3_MOUSEGalactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1",1.43e-20,51.4,10,"F:GO:0005515; P:GO:0005975; P:GO:0006664; P:GO:0006665; C:GO:0016020; P:GO:0044249; P:GO:0044260; F:GO:0050694; P:GO:1901137; P:GO:1901566","F:protein binding; P:carbohydrate metabolic process; P:glycolipid metabolic process; P:sphingolipid metabolic process; C:membrane; P:cellular biosynthetic process; P:cellular macromolecule metabolic process; F:galactose 3-O-sulfotransferase activity; P:carbohydrate derivative biosynthetic process; P:organonitrogen compound biosynthetic process","EC:2.8.2; EC:2; EC:2.8","Transferring sulfur-containing groups; Transferases; Transferring sulfur-containing groups","IPR009729 (PFAM)","F:GO:0001733; P:GO:0009247; C:GO:0016021","F:galactosylceramide sulfotransferase activity; P:glycolipid biosynthetic process; C:integral component of membrane","GO:0009247",0.0454503371966976,0.999473946436188,1,2,"glycolipid biosynthetic process","BP",461,1010,702,213,372,323,250,978,280,348,132,473,202,924,381.150039064491,0.730761808023572,0.203867502124055,3.58449385218296,0.000337732519331341,0.0270215903298642,"CvsT2"
"311","Acerv_evm.model.Segkk2116_pilon.21",307,1,"XP_029181172.1",1.1e-156,92.18,NA,NA,NA,NA,NA,5,"G3ST3_MOUSEGalactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1",1.43e-20,51.4,10,"F:GO:0005515; P:GO:0005975; P:GO:0006664; P:GO:0006665; C:GO:0016020; P:GO:0044249; P:GO:0044260; F:GO:0050694; P:GO:1901137; P:GO:1901566","F:protein binding; P:carbohydrate metabolic process; P:glycolipid metabolic process; P:sphingolipid metabolic process; C:membrane; P:cellular biosynthetic process; P:cellular macromolecule metabolic process; F:galactose 3-O-sulfotransferase activity; P:carbohydrate derivative biosynthetic process; P:organonitrogen compound biosynthetic process","EC:2.8.2; EC:2; EC:2.8","Transferring sulfur-containing groups; Transferases; Transferring sulfur-containing groups","IPR009729 (PFAM)","F:GO:0001733; P:GO:0009247; C:GO:0016021","F:galactosylceramide sulfotransferase activity; P:glycolipid biosynthetic process; C:integral component of membrane","GO:0050694",0.0454503371966976,0.999473946436188,1,2,"galactose 3-O-sulfotransferase activity","MF",461,1010,702,213,372,323,250,978,280,348,132,473,202,924,381.150039064491,0.730761808023572,0.203867502124055,3.58449385218296,0.000337732519331341,0.0270215903298642,"CvsT2"
"312","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0048585",0.0292781079694456,0.995674372847706,3,29,"negative regulation of response to stimulus","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.63348495366577,0.35720511710539,-4.57296067565524,4.80880418098546e-06,0.00144921328667632,"CvsT4"
"313","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.82067086185947,0.337522374593176,-5.3942227209499,6.88208114024082e-08,3.27478397836407e-05,"CvsT2"
"314","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.63348495366577,0.35720511710539,-4.57296067565524,4.80880418098546e-06,0.00144921328667632,"CvsT4"
"315","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0048585",0.0292781079694456,0.995674372847706,3,29,"negative regulation of response to stimulus","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.82067086185947,0.337522374593176,-5.3942227209499,6.88208114024082e-08,3.27478397836407e-05,"CvsT2"
"316","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.66119153291744,0.343435917915814,-4.83697670004524,1.31828874240965e-06,0.000496610355005236,"CvsT3"
"317","Acerv_evm.model.Segkk2117_pilon.21",116,1,"XP_029207195.1",3.1e-35,85,NA,NA,NA,NA,NA,5,"NLRC3_HUMANNLR family CARD domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NLRC3 PE=1 SV=2",1.4e-21,38.98,6,"P:GO:0001818; P:GO:0002376; F:GO:0005515; C:GO:0005737; P:GO:0048523; P:GO:0048585","P:negative regulation of cytokine production; P:immune system process; F:protein binding; C:cytoplasm; P:negative regulation of cellular process; P:negative regulation of response to stimulus",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR007111 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); SSF52047 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0048585",0.0292781079694456,0.995674372847706,3,29,"negative regulation of response to stimulus","BP",45,30,17,32,61,27,40,28,26,18,24,44,16,351,32.3489220780501,-1.66119153291744,0.343435917915814,-4.83697670004524,1.31828874240965e-06,0.000496610355005236,"CvsT3"
"318","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0045444",0.0434945669513915,0.995870774888241,2,14,"fat cell differentiation","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"319","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0045444",0.0434945669513915,0.995870774888241,2,14,"fat cell differentiation","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"320","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0005543",0.0011470856433709,0.999912367606281,4,21,"phospholipid binding","MF",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"321","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0033339",0.0304589252215585,1,1,1,"pectoral fin development","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"322","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0033339",0.0304589252215585,1,1,1,"pectoral fin development","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"323","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0016055",0.041684849654316,0.996169134698508,2,13,"Wnt signaling pathway","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"324","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0005543",0.0011470856433709,0.999912367606281,4,21,"phospholipid binding","MF",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"325","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0062063",0.0304589252215585,1,1,1,"BBSome binding","MF",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"326","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0016055",0.041684849654316,0.996169134698508,2,13,"Wnt signaling pathway","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"327","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:1903445",0.0304589252215585,1,1,1,"protein transport from ciliary membrane to plasma membrane","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"328","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:0062063",0.0304589252215585,1,1,1,"BBSome binding","MF",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.17024544520593,0.282248922594587,4.14614672200832,3.38117208815051e-05,0.00470295028445673,"CvsT2"
"329","Acerv_evm.model.Segkk2119_pilon.10",137,1,"XP_029196565.1",1.8e-69,96.35,NA,NA,NA,NA,NA,5,"ARL6_DANREADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1",6.16e-96,87.19,30,"F:GO:0003924; F:GO:0005515; F:GO:0005525; F:GO:0005543; C:GO:0005829; C:GO:0005879; P:GO:0006471; P:GO:0006612; P:GO:0007265; P:GO:0007368; P:GO:0007369; P:GO:0007420; P:GO:0007601; P:GO:0008589; P:GO:0008593; P:GO:0010842; P:GO:0016055; P:GO:0016192; C:GO:0030117; P:GO:0032402; P:GO:0033339; P:GO:0045444; F:GO:0046872; P:GO:0051258; C:GO:0060170; P:GO:0060271; F:GO:0062063; P:GO:0070121; P:GO:0097499; P:GO:1903445","F:GTPase activity; F:protein binding; F:GTP binding; F:phospholipid binding; C:cytosol; C:axonemal microtubule; P:protein ADP-ribosylation; P:protein targeting to membrane; P:Ras protein signal transduction; P:determination of left/right symmetry; P:gastrulation; P:brain development; P:visual perception; P:regulation of smoothened signaling pathway; P:regulation of Notch signaling pathway; P:retina layer formation; P:Wnt signaling pathway; P:vesicle-mediated transport; C:membrane coat; P:melanosome transport; P:pectoral fin development; P:fat cell differentiation; F:metal ion binding; P:protein polymerization; C:ciliary membrane; P:cilium assembly; F:BBSome binding; P:Kupffer's vesicle development; P:protein localization to non-motile cilium; P:protein transport from ciliary membrane to plasma membrane","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR006689 (PRINTS); SM00177 (SMART); SM00178 (SMART); IPR006689 (PFAM); G3DSA:3.40.50.300 (GENE3D); IPR005225 (TIGRFAM); PS51417 (PROSITE_PROFILES); IPR041839 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003924; F:GO:0005525","F:GTPase activity; F:GTP binding","GO:1903445",0.0304589252215585,1,1,1,"protein transport from ciliary membrane to plasma membrane","BP",68,156,149,29,54,22,34,159,38,35,13,49,25,414,50.5261656932498,1.02651594087155,0.288714559422089,3.55546995248973,0.000377304065767473,0.0477262336426998,"CvsT4"
"330","Acerv_evm.model.Segkk2166_pilon.1",107,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PDE6_DROPScGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Pde6 PE=3 SV=3",0,69.92,6,"F:GO:0005515; P:GO:0007165; C:GO:0016324; P:GO:0032240; P:GO:0046068; F:GO:0047555","F:protein binding; P:signal transduction; C:apical plasma membrane; P:negative regulation of nucleobase-containing compound transport; P:cGMP metabolic process; F:3',5'-cyclic-GMP phosphodiesterase activity","EC:3.1.4; EC:3.1.4.17; EC:3.1; EC:3.1.4.35; EC:3","Acting on ester bonds; 3',5'-cyclic-nucleotide phosphodiesterase; Acting on ester bonds; 3',5'-cyclic-GMP phosphodiesterase; Hydrolases","IPR023088 (PRINTS); IPR003018 (SMART); IPR003607 (SMART); IPR029016 (G3DSA:3.30.450.GENE3D); IPR003018 (PFAM); IPR029016 (G3DSA:3.30.450.GENE3D); IPR002073 (PFAM); IPR036971 (G3DSA:1.10.1300.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR023174 (PROSITE_PATTERNS); IPR002073 (PROSITE_PROFILES); IPR003607 (CDD); SSF109604 (SUPERFAMILY); SSF55781 (SUPERFAMILY); SSF55781 (SUPERFAMILY)","F:GO:0004114; F:GO:0005515; P:GO:0007165; F:GO:0008081","F:3',5'-cyclic-nucleotide phosphodiesterase activity; F:protein binding; P:signal transduction; F:phosphoric diester hydrolase activity","GO:0032240",0.0320494522211041,1,1,1,"negative regulation of nucleobase-containing compound transport","BP",105,148,188,85,180,103,85,111,61,128,54,145,55,323,106.669732563524,-1.1361957067642,0.264768491660044,-4.29127990132243,1.77646225401251e-05,0.00490794356619033,"CvsT1"
"331","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0000814",0.0435095970312307,0.999518398545685,1,2,"ESCRT II complex","CC",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"332","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0071985",0.0213645393341835,1,1,1,"multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"333","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0043328",0.0435095970312307,0.999518398545685,1,2,"protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"334","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0071985",0.0213645393341835,1,1,1,"multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"335","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0016247",0.0213645393341835,1,1,1,"channel regulator activity","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"336","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0016247",0.0213645393341835,1,1,1,"channel regulator activity","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"337","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0016247",0.0213645393341835,1,1,1,"channel regulator activity","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"338","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0000814",0.0435095970312307,0.999518398545685,1,2,"ESCRT II complex","CC",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"339","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0000814",0.0435095970312307,0.999518398545685,1,2,"ESCRT II complex","CC",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"340","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0000814",0.0435095970312307,0.999518398545685,1,2,"ESCRT II complex","CC",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"341","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0043328",0.0435095970312307,0.999518398545685,1,2,"protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"342","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0043328",0.0435095970312307,0.999518398545685,1,2,"protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"343","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0043328",0.0435095970312307,0.999518398545685,1,2,"protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"344","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"345","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"346","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"347","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"348","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0071985",0.0213645393341835,1,1,1,"multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"349","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:1903772",0.0213645393341835,1,1,1,"regulation of viral budding via host ESCRT complex","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"350","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:1903772",0.0213645393341835,1,1,1,"regulation of viral budding via host ESCRT complex","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"351","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0016247",0.0213645393341835,1,1,1,"channel regulator activity","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"352","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:1903772",0.0213645393341835,1,1,1,"regulation of viral budding via host ESCRT complex","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"353","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.14302879285286,0.429306296130823,-4.99184105187178,5.98064642174945e-07,0.000200263052959396,"CvsT2"
"354","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-2.10691848578796,0.478739459573537,-4.40097101597769,1.07767520767506e-05,0.00324775385086339,"CvsT1"
"355","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:1903772",0.0213645393341835,1,1,1,"regulation of viral budding via host ESCRT complex","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"356","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"357","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.90711784806022,0.432548481707457,-4.40902679979826,1.03836176524026e-05,0.00312927623984574,"CvsT3"
"358","Acerv_evm.model.Segkk223_pilon.4",913,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"SNF8_HUMANVacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1",1.13e-104,76.64,23,"C:GO:0000814; C:GO:0005654; C:GO:0005667; C:GO:0005829; C:GO:0005886; P:GO:0006357; F:GO:0008022; P:GO:0010628; P:GO:0016236; F:GO:0016247; C:GO:0031902; P:GO:0032456; P:GO:0036258; F:GO:0042803; P:GO:0043328; P:GO:0045022; P:GO:0045732; F:GO:0047485; C:GO:0048471; C:GO:0055037; P:GO:0061635; P:GO:1903543; P:GO:1903772","C:ESCRT II complex; C:nucleoplasm; C:transcription regulator complex; C:cytosol; C:plasma membrane; P:regulation of transcription by RNA polymerase II; F:protein C-terminus binding; P:positive regulation of gene expression; P:macroautophagy; F:channel regulator activity; C:late endosome membrane; P:endocytic recycling; P:multivesicular body assembly; F:protein homodimerization activity; P:protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; P:early endosome to late endosome transport; P:positive regulation of protein catabolic process; F:protein N-terminus binding; C:perinuclear region of cytoplasm; C:recycling endosome; P:regulation of protein complex stability; P:positive regulation of exosomal secretion; P:regulation of viral budding via host ESCRT complex",NA,NA,"IPR040608 (PFAM); IPR016689 (PIRSF); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036388 (G3DSA:1.10.10.GENE3D); IPR036390 (SUPERFAMILY); IPR036390 (SUPERFAMILY)","C:GO:0000814; P:GO:0071985","C:ESCRT II complex; P:multivesicular body sorting pathway","GO:0071985",0.0213645393341835,1,1,1,"multivesicular body sorting pathway","BP",84,22,77,76,119,54,105,38,68,86,45,100,33,2742,74.9843103016989,-1.81313043950222,0.47322555877957,-3.83142965519067,0.000127400801489256,0.0199912588510795,"CvsT4"
"359","Acerv_evm.model.Segkk2237_pilon.15",224,1,"XP_015754378.1",1.1e-65,94.31,NA,NA,NA,NA,NA,5,"ECI2_HUMANEnoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4",3.21e-100,52.97,6,"F:GO:0004165; F:GO:0005515; C:GO:0005739; C:GO:0005782; P:GO:0006635; P:GO:0060255","F:dodecenoyl-CoA delta-isomerase activity; F:protein binding; C:mitochondrion; C:peroxisomal matrix; P:fatty acid beta-oxidation; P:regulation of macromolecule metabolic process","EC:5.3; EC:5; EC:5.3.3.8; EC:5.3.3","Intramolecular oxidoreductases; Isomerases; Delta(3)-Delta(2)-enoyl-CoA isomerase; Intramolecular oxidoreductases","IPR000582 (PRINTS); IPR014748 (G3DSA:1.10.12.GENE3D); IPR000582 (PFAM); IPR001753 (PFAM); G3DSA:3.90.226.10 (GENE3D); IPR014352 (G3DSA:1.20.80.GENE3D); G3DSA:3.90.226.10 (GENE3D); IPR022408 (PROSITE_PATTERNS); IPR000582 (PROSITE_PROFILES); cd06558 (CDD); IPR000582 (CDD); IPR035984 (SUPERFAMILY); IPR029045 (SUPERFAMILY)","F:GO:0000062; F:GO:0003824","F:fatty-acyl-CoA binding; F:catalytic activity","GO:0004165",0.0263874434065503,1,1,1,"dodecenoyl-CoA delta-isomerase activity","MF",339,618,357,125,144,315,93,435,144,329,83,284,227,675,255.920328685111,1.68979899544182,0.39217542252325,4.30878351470801,1.64154949122265e-05,0.00990928733289509,"T1vsT2"
"360","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0097657",0.0268055068817325,1,1,1,"3',5'-nucleotide bisphosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.87080845623261,0.405920510508425,-4.60880494530661,4.04990048868119e-06,0.00130768393993452,"CvsT4"
"361","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0002063",0.0174884521003746,0.999053448579429,2,9,"chondrocyte development","BP",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.85170704039282,0.432356082333085,-4.28282870545179,1.845322324703e-05,0.00490794356619033,"CvsT1"
"362","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0002063",0.0174884521003746,0.999053448579429,2,9,"chondrocyte development","BP",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.87080845623261,0.405920510508425,-4.60880494530661,4.04990048868119e-06,0.00130768393993452,"CvsT4"
"363","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0052834",0.0268055068817325,1,1,1,"inositol monophosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.85170704039282,0.432356082333085,-4.28282870545179,1.845322324703e-05,0.00490794356619033,"CvsT1"
"364","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0002063",0.0174884521003746,0.999053448579429,2,9,"chondrocyte development","BP",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.8642515527379,0.391055010633149,-4.76723607177295,1.86770421313628e-06,0.000675436551638603,"CvsT3"
"365","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0002063",0.0174884521003746,0.999053448579429,2,9,"chondrocyte development","BP",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.71577841951481,0.392902800381653,-4.3669284562191,1.26005978280962e-05,0.00227844009927636,"CvsT2"
"366","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0097657",0.0268055068817325,1,1,1,"3',5'-nucleotide bisphosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.85170704039282,0.432356082333085,-4.28282870545179,1.845322324703e-05,0.00490794356619033,"CvsT1"
"367","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0097657",0.0268055068817325,1,1,1,"3',5'-nucleotide bisphosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.8642515527379,0.391055010633149,-4.76723607177295,1.86770421313628e-06,0.000675436551638603,"CvsT3"
"368","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0097657",0.0268055068817325,1,1,1,"3',5'-nucleotide bisphosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.71577841951481,0.392902800381653,-4.3669284562191,1.26005978280962e-05,0.00227844009927636,"CvsT2"
"369","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0052834",0.0268055068817325,1,1,1,"inositol monophosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.8642515527379,0.391055010633149,-4.76723607177295,1.86770421313628e-06,0.000675436551638603,"CvsT3"
"370","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0008254",0.0268055068817325,1,1,1,"3'-nucleotidase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.85170704039282,0.432356082333085,-4.28282870545179,1.845322324703e-05,0.00490794356619033,"CvsT1"
"371","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0008254",0.0268055068817325,1,1,1,"3'-nucleotidase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.8642515527379,0.391055010633149,-4.76723607177295,1.86770421313628e-06,0.000675436551638603,"CvsT3"
"372","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0008254",0.0268055068817325,1,1,1,"3'-nucleotidase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.71577841951481,0.392902800381653,-4.3669284562191,1.26005978280962e-05,0.00227844009927636,"CvsT2"
"373","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0052834",0.0268055068817325,1,1,1,"inositol monophosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.71577841951481,0.392902800381653,-4.3669284562191,1.26005978280962e-05,0.00227844009927636,"CvsT2"
"374","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0052834",0.0268055068817325,1,1,1,"inositol monophosphate phosphatase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.87080845623261,0.405920510508425,-4.60880494530661,4.04990048868119e-06,0.00130768393993452,"CvsT4"
"375","Acerv_evm.model.Segkk2370_pilon.2",214,1,"XP_029191788.1",4.6e-93,95.21,NA,NA,NA,NA,NA,5,"IMPA3_DANREInositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1",1.66e-96,62.03,9,"P:GO:0001958; P:GO:0002063; F:GO:0008254; P:GO:0009791; P:GO:0030204; C:GO:0032588; P:GO:0042733; F:GO:0052834; F:GO:0097657","P:endochondral ossification; P:chondrocyte development; F:3'-nucleotidase activity; P:post-embryonic development; P:chondroitin sulfate metabolic process; C:trans-Golgi network membrane; P:embryonic digit morphogenesis; F:inositol monophosphate phosphatase activity; F:3',5'-nucleotide bisphosphate phosphatase activity","EC:3.1; EC:3.1.3.25; EC:3; EC:3.1.3.6; EC:3.1.3.97; EC:3.1.3","Acting on ester bonds; Inositol-phosphate phosphatase; Hydrolases; 3'-nucleotidase; 3',5'-nucleoside bisphosphate phosphatase; Acting on ester bonds","G3DSA:3.30.540.10 (GENE3D); IPR000760 (PFAM); G3DSA:3.40.190.80 (GENE3D); IPR020550 (PROSITE_PATTERNS); SSF56655 (SUPERFAMILY)","P:GO:0046854; P:GO:0046855","P:phosphatidylinositol phosphate biosynthetic process; P:inositol phosphate dephosphorylation","GO:0008254",0.0268055068817325,1,1,1,"3'-nucleotidase activity","MF",38,21,16,30,38,18,24,16,20,27,10,49,13,645,25.2888475965967,-1.87080845623261,0.405920510508425,-4.60880494530661,4.04990048868119e-06,0.00130768393993452,"CvsT4"
"376","Acerv_evm.model.Segkk2518_pilon.2",322,1,"ABA28989.1",1.5e-175,96.27,2,"P:GO:0006457; F:GO:0051082","P:protein folding; F:unfolded protein binding",NA,NA,5,"RNH2B_XENLARibonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1",3.57e-58,60.9,4,"C:GO:0005654; P:GO:0006401; C:GO:0032299; P:GO:0050794","C:nucleoplasm; P:RNA catabolic process; C:ribonuclease H2 complex; P:regulation of cellular process",NA,NA,"G3DSA:1.10.20.120 (GENE3D); IPR019024 (PFAM); IPR041195 (PFAM); G3DSA:2.20.25.530 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR040456 (CDD)","C:GO:0032299","C:ribonuclease H2 complex","GO:0032299",0.0232649491275938,1,1,1,"ribonuclease H2 complex","CC",46,59,78,114,151,78,48,54,18,98,97,163,46,969,85.3391904283693,-1.98939956260186,0.47513702348121,-4.18700177903636,2.82663610939015e-05,0.00425926951083272,"CvsT2"
"377","Acerv_evm.model.Segkk2518_pilon.2",322,1,"ABA28989.1",1.5e-175,96.27,2,"P:GO:0006457; F:GO:0051082","P:protein folding; F:unfolded protein binding",NA,NA,5,"RNH2B_XENLARibonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1",3.57e-58,60.9,4,"C:GO:0005654; P:GO:0006401; C:GO:0032299; P:GO:0050794","C:nucleoplasm; P:RNA catabolic process; C:ribonuclease H2 complex; P:regulation of cellular process",NA,NA,"G3DSA:1.10.20.120 (GENE3D); IPR019024 (PFAM); IPR041195 (PFAM); G3DSA:2.20.25.530 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR040456 (CDD)","C:GO:0032299","C:ribonuclease H2 complex","GO:0032299",0.0232649491275938,1,1,1,"ribonuclease H2 complex","CC",46,59,78,114,151,78,48,54,18,98,97,163,46,969,85.3391904283693,-1.86780347899542,0.52561717716899,-3.55354345353693,0.000380078400870964,0.0477262336426998,"CvsT4"
"378","Acerv_evm.model.Segkk2518_pilon.2",322,1,"ABA28989.1",1.5e-175,96.27,2,"P:GO:0006457; F:GO:0051082","P:protein folding; F:unfolded protein binding",NA,NA,5,"RNH2B_XENLARibonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1",3.57e-58,60.9,4,"C:GO:0005654; P:GO:0006401; C:GO:0032299; P:GO:0050794","C:nucleoplasm; P:RNA catabolic process; C:ribonuclease H2 complex; P:regulation of cellular process",NA,NA,"G3DSA:1.10.20.120 (GENE3D); IPR019024 (PFAM); IPR041195 (PFAM); G3DSA:2.20.25.530 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR040456 (CDD)","C:GO:0032299","C:ribonuclease H2 complex","GO:0032299",0.0232649491275938,1,1,1,"ribonuclease H2 complex","CC",46,59,78,114,151,78,48,54,18,98,97,163,46,969,85.3391904283693,-1.96549487499799,0.530498319162573,-3.70499736568564,0.000211392929664647,0.0289576284408799,"CvsT1"
"379","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"380","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0097553",0.0452593611597633,0.999478409768996,1,2,"calcium ion transmembrane import into cytosol","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"381","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"382","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0042330",0.0212852786027605,1,1,1,"taxis","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"383","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0042330",0.0212852786027605,1,1,1,"taxis","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"384","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0042330",0.0212852786027605,1,1,1,"taxis","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"385","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0051050",0.0263362941167502,0.99815856742919,2,11,"positive regulation of transport","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"386","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"387","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"388","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0033554",0.00793136978860907,0.999313252323009,3,18,"cellular response to stress","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"389","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0033554",0.00793136978860907,0.999313252323009,3,18,"cellular response to stress","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"390","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0051050",0.0263362941167502,0.99815856742919,2,11,"positive regulation of transport","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"391","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0097553",0.0452593611597633,0.999478409768996,1,2,"calcium ion transmembrane import into cytosol","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"392","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0097553",0.0452593611597633,0.999478409768996,1,2,"calcium ion transmembrane import into cytosol","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"393","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050907",0.0212852786027605,1,1,1,"detection of chemical stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"394","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050907",0.0212852786027605,1,1,1,"detection of chemical stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"395","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"396","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0051050",0.0263362941167502,0.99815856742919,2,11,"positive regulation of transport","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"397","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0023056",0.0386460190743881,0.996592362935657,2,13,"positive regulation of signaling","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"398","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050955",0.0212852786027605,1,1,1,"thermoception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"399","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050955",0.0212852786027605,1,1,1,"thermoception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"400","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0033554",0.00793136978860907,0.999313252323009,3,18,"cellular response to stress","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"401","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050955",0.0212852786027605,1,1,1,"thermoception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"402","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"403","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"404","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050961",0.0212852786027605,1,1,1,"detection of temperature stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"405","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050907",0.0212852786027605,1,1,1,"detection of chemical stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"406","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050961",0.0212852786027605,1,1,1,"detection of temperature stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"407","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0050961",0.0212852786027605,1,1,1,"detection of temperature stimulus involved in sensory perception","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"408","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.28813258926835,0.309503669856316,-4.16192993726489,3.15569181761396e-05,0.00713265243076194,"CvsT1"
"409","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.42263916838076,0.273426635779674,-5.20300139861692,1.96095393204572e-07,8.44237357125015e-05,"CvsT2"
"410","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0010647",0.0225653331579186,0.998571474673857,2,10,"positive regulation of cell communication","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"411","Acerv_evm.model.Segkk2551_pilon.2",1004,1,"XP_015766080.1",8.8e-235,73.93,NA,NA,NA,NA,NA,5,"TRPA1_DROMETransient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=2 SV=4",2.59e-143,49.68,27,"F:GO:0005262; F:GO:0005515; C:GO:0005886; P:GO:0007165; P:GO:0007610; P:GO:0009408; P:GO:0009409; P:GO:0009416; P:GO:0009612; P:GO:0010035; P:GO:0010647; P:GO:0014070; F:GO:0015276; C:GO:0016021; P:GO:0023056; P:GO:0031644; P:GO:0033554; P:GO:0042330; P:GO:0050907; P:GO:0050955; P:GO:0050961; P:GO:0051050; P:GO:0062149; P:GO:0070887; P:GO:0097553; C:GO:0120025; P:GO:1901700","F:calcium channel activity; F:protein binding; C:plasma membrane; P:signal transduction; P:behavior; P:response to heat; P:response to cold; P:response to light stimulus; P:response to mechanical stimulus; P:response to inorganic substance; P:positive regulation of cell communication; P:response to organic cyclic compound; F:ligand-gated ion channel activity; C:integral component of membrane; P:positive regulation of signaling; P:regulation of nervous system process; P:cellular response to stress; P:taxis; P:detection of chemical stimulus involved in sensory perception; P:thermoception; P:detection of temperature stimulus involved in sensory perception; P:positive regulation of transport; P:detection of stimulus involved in sensory perception of pain; P:cellular response to chemical stimulus; P:calcium ion transmembrane import into cytosol; C:plasma membrane bounded cell projection; P:response to oxygen-containing compound","EC:7",NA,"Coil (COILS); IPR002110 (PRINTS); IPR002110 (SMART); IPR020683 (PFAM); IPR002110 (PFAM); IPR036770 (G3DSA:1.25.40.GENE3D); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR020683 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR002110 (PROSITE_PROFILES); IPR036770 (SUPERFAMILY); IPR036770 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",53,42,51,53,97,39,55,50,31,44,32,73,16,3015,48.2898941543525,-1.39212952231016,0.288099100327952,-4.83212033888845,1.35086556008798e-06,0.000555144342216154,"CvsT4"
"412","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0005770",0.0377183773296265,0.993812215624208,3,32,"late endosome","CC",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"413","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0002280",0.045156981046746,0.999480794498421,1,2,"monocyte activation involved in immune response","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"414","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0045444",0.0434945669513915,0.995870774888241,2,14,"fat cell differentiation","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"415","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:1902915",0.0233784021575142,1,1,1,"negative regulation of protein polyubiquitination","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"416","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"417","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0001938",0.0209109479269228,0.99872895331437,2,10,"positive regulation of endothelial cell proliferation","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"418","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:1901842",0.0233784021575142,1,1,1,"negative regulation of high voltage-gated calcium channel activity","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"419","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0005543",0.0011470856433709,0.999912367606281,4,21,"phospholipid binding","MF",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"420","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0045785",0.00737554704068881,0.999774583043782,2,6,"positive regulation of cell adhesion","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"421","Acerv_evm.model.Segkk2585_pilon.5",317,1,"XP_015767006.1",5.9e-161,96.87,NA,NA,NA,NA,NA,5,"MYOF_HUMANMyoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1",0,63.51,38,"P:GO:0001525; P:GO:0001778; P:GO:0001938; P:GO:0002280; P:GO:0002281; F:GO:0005509; F:GO:0005543; C:GO:0005635; C:GO:0005769; C:GO:0005770; C:GO:0005794; C:GO:0005874; C:GO:0005901; P:GO:0006071; P:GO:0006906; P:GO:0006936; P:GO:0008015; F:GO:0008017; P:GO:0010629; P:GO:0019915; C:GO:0030027; C:GO:0030315; C:GO:0030659; P:GO:0030947; P:GO:0033292; C:GO:0034451; P:GO:0034605; P:GO:0042177; F:GO:0043014; P:GO:0043403; P:GO:0045444; P:GO:0045785; P:GO:0050765; P:GO:0071470; P:GO:0090023; P:GO:0090279; P:GO:1901842; P:GO:1902915","P:angiogenesis; P:plasma membrane repair; P:positive regulation of endothelial cell proliferation; P:monocyte activation involved in immune response; P:macrophage activation involved in immune response; F:calcium ion binding; F:phospholipid binding; C:nuclear envelope; C:early endosome; C:late endosome; C:Golgi apparatus; C:microtubule; C:caveola; P:glycerol metabolic process; P:vesicle fusion; P:muscle contraction; P:blood circulation; F:microtubule binding; P:negative regulation of gene expression; P:lipid storage; C:lamellipodium; C:T-tubule; C:cytoplasmic vesicle membrane; P:regulation of vascular endothelial growth factor receptor signaling pathway; P:T-tubule organization; C:centriolar satellite; P:cellular response to heat; P:negative regulation of protein catabolic process; F:alpha-tubulin binding; P:skeletal muscle tissue regeneration; P:fat cell differentiation; P:positive regulation of cell adhesion; P:negative regulation of phagocytosis; P:cellular response to osmotic stress; P:positive regulation of neutrophil chemotaxis; P:regulation of calcium ion import; P:negative regulation of high voltage-gated calcium channel activity; P:negative regulation of protein polyubiquitination",NA,NA,"Coil (COILS); IPR012968 (SMART); IPR006614 (SMART); IPR006614 (SMART); IPR000008 (SMART); IPR012560 (SMART); IPR012561 (SMART); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012561 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR012560 (PFAM); IPR012968 (PFAM); IPR000008 (PFAM); IPR032362 (PFAM); IPR035892 (G3DSA:2.60.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR037725 (CDD); IPR037726 (CDD); IPR037722 (CDD); IPR037720 (CDD); IPR037724 (CDD); IPR037723 (CDD); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF49562 (SUPERFAMILY)","C:GO:0016021","C:integral component of membrane","GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",52,61,96,65,97,30,59,38,24,16,40,65,23,954,48.563080222559,-1.22765305530271,0.354670479151103,-3.46139057933742,0.000537392527535349,0.0371191216695815,"CvsT2"
"422","Acerv_evm.model.Segkk2634_pilon.20",335,1,"XP_029208950.1",1e-142,87.42,NA,NA,NA,NA,NA,5,"MAAI_MOUSEMaleylacetoacetate isomerase OS=Mus musculus OX=10090 GN=Gstz1 PE=1 SV=1",1.82e-97,76.27,9,"F:GO:0004364; F:GO:0004602; C:GO:0005759; C:GO:0005829; P:GO:0006559; P:GO:0006572; P:GO:0006749; F:GO:0016034; F:GO:0042803","F:glutathione transferase activity; F:glutathione peroxidase activity; C:mitochondrial matrix; C:cytosol; P:L-phenylalanine catabolic process; P:tyrosine catabolic process; P:glutathione metabolic process; F:maleylacetoacetate isomerase activity; F:protein homodimerization activity","EC:2.5.1; EC:2.5.1.18; EC:1.11; EC:5.2; EC:1; EC:2; EC:5; EC:1.11.1; EC:5.2.1.2; EC:1.11.1.9","Transferring alkyl or aryl groups, other than methyl groups; Glutathione transferase; Acting on a peroxide as acceptor; Cis-trans-isomerases; Oxidoreductases; Transferases; Isomerases; Acting on a peroxide as acceptor; Maleylacetoacetate isomerase; Glutathione peroxidase","IPR005955 (TIGRFAM); IPR004045 (PFAM); IPR036249 (G3DSA:3.40.30.GENE3D); G3DSA:1.20.1050.10 (GENE3D); IPR004046 (PFAM); IPR004045 (PROSITE_PROFILES); IPR010987 (PROSITE_PROFILES); IPR034330 (CDD); IPR034333 (CDD); IPR036282 (SUPERFAMILY); IPR036249 (SUPERFAMILY)","F:GO:0003824; F:GO:0005515; C:GO:0005737; P:GO:0009072","F:catalytic activity; F:protein binding; C:cytoplasm; P:aromatic amino acid family metabolic process","GO:0016034",0.0229911071967913,1,1,1,"maleylacetoacetate isomerase activity","MF",153,192,159,98,120,134,43,77,40,246,62,144,70,1008,120.204136086316,-1.95008122646433,0.490354971677507,-3.97687662835984,6.98263681701423e-05,0.0119026113318992,"CvsT1"
"423","Acerv_evm.model.Segkk2701_pilon.2",126,1,"XP_029197905.1",7e-57,95.69,NA,NA,NA,NA,NA,5,"TAF5_HUMANTranscription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3",3.06e-09,56.22,11,"C:GO:0000785; F:GO:0003677; C:GO:0005669; P:GO:0006357; P:GO:0006367; C:GO:0015629; F:GO:0016251; C:GO:0033276; F:GO:0042802; P:GO:0045014; F:GO:1990841","C:chromatin; F:DNA binding; C:transcription factor TFIID complex; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; C:actin cytoskeleton; F:RNA polymerase II general transcription initiation factor activity; C:transcription factor TFTC complex; F:identical protein binding; P:carbon catabolite repression of transcription by glucose; F:promoter-specific chromatin binding",NA,NA,"IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0006367",0.0114777293647707,0.999533681149219,2,7,"transcription initiation from RNA polymerase II promoter","BP",108,110,135,100,164,77,176,161,74,37,101,186,29,381,107.723289795647,-1.34404101882597,0.334610814813518,-4.01672916511984,5.90114773891237e-05,0.00741003843159816,"CvsT2"
"424","Acerv_evm.model.Segkk2701_pilon.2",126,1,"XP_029197905.1",7e-57,95.69,NA,NA,NA,NA,NA,5,"TAF5_HUMANTranscription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3",3.06e-09,56.22,11,"C:GO:0000785; F:GO:0003677; C:GO:0005669; P:GO:0006357; P:GO:0006367; C:GO:0015629; F:GO:0016251; C:GO:0033276; F:GO:0042802; P:GO:0045014; F:GO:1990841","C:chromatin; F:DNA binding; C:transcription factor TFIID complex; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; C:actin cytoskeleton; F:RNA polymerase II general transcription initiation factor activity; C:transcription factor TFTC complex; F:identical protein binding; P:carbon catabolite repression of transcription by glucose; F:promoter-specific chromatin binding",NA,NA,"IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0016251",0.0143903496749027,0.999316462477845,2,8,"RNA polymerase II general transcription initiation factor activity","MF",108,110,135,100,164,77,176,161,74,37,101,186,29,381,107.723289795647,-1.34404101882597,0.334610814813518,-4.01672916511984,5.90114773891237e-05,0.00741003843159816,"CvsT2"
"425","Acerv_evm.model.Segkk2701_pilon.2",126,1,"XP_029197905.1",7e-57,95.69,NA,NA,NA,NA,NA,5,"TAF5_HUMANTranscription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3",3.06e-09,56.22,11,"C:GO:0000785; F:GO:0003677; C:GO:0005669; P:GO:0006357; P:GO:0006367; C:GO:0015629; F:GO:0016251; C:GO:0033276; F:GO:0042802; P:GO:0045014; F:GO:1990841","C:chromatin; F:DNA binding; C:transcription factor TFIID complex; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; C:actin cytoskeleton; F:RNA polymerase II general transcription initiation factor activity; C:transcription factor TFTC complex; F:identical protein binding; P:carbon catabolite repression of transcription by glucose; F:promoter-specific chromatin binding",NA,NA,"IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0045014",0.0310287440179269,1,1,1,"carbon catabolite repression of transcription by glucose","BP",108,110,135,100,164,77,176,161,74,37,101,186,29,381,107.723289795647,-1.34404101882597,0.334610814813518,-4.01672916511984,5.90114773891237e-05,0.00741003843159816,"CvsT2"
"426","Acerv_evm.model.Segkk2701_pilon.2",126,1,"XP_029197905.1",7e-57,95.69,NA,NA,NA,NA,NA,5,"TAF5_HUMANTranscription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3",3.06e-09,56.22,11,"C:GO:0000785; F:GO:0003677; C:GO:0005669; P:GO:0006357; P:GO:0006367; C:GO:0015629; F:GO:0016251; C:GO:0033276; F:GO:0042802; P:GO:0045014; F:GO:1990841","C:chromatin; F:DNA binding; C:transcription factor TFIID complex; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; C:actin cytoskeleton; F:RNA polymerase II general transcription initiation factor activity; C:transcription factor TFTC complex; F:identical protein binding; P:carbon catabolite repression of transcription by glucose; F:promoter-specific chromatin binding",NA,NA,"IPR001680 (SMART); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0005669",0.00618987698345828,0.99984106715638,2,5,"transcription factor TFIID complex","CC",108,110,135,100,164,77,176,161,74,37,101,186,29,381,107.723289795647,-1.34404101882597,0.334610814813518,-4.01672916511984,5.90114773891237e-05,0.00741003843159816,"CvsT2"
"427","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010951",0.00318712881833351,0.99994991757276,2,4,"negative regulation of endopeptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.09188725974504,0.524058750036471,-3.99170371566062,6.56003009843338e-05,0.0116292611999875,"CvsT1"
"428","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010466",0.045201482671903,0.999479758613775,1,2,"negative regulation of peptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.09188725974504,0.524058750036471,-3.99170371566062,6.56003009843338e-05,0.0116292611999875,"CvsT1"
"429","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010466",0.045201482671903,0.999479758613775,1,2,"negative regulation of peptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.08183291774043,0.508348423217914,-4.09528744982063,4.21644909131901e-05,0.0079659298725118,"CvsT4"
"430","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010466",0.045201482671903,0.999479758613775,1,2,"negative regulation of peptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.16486911605682,0.470308141852638,-4.60308662216428,4.16274987567054e-06,0.000940885540648433,"CvsT2"
"431","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010951",0.00318712881833351,0.99994991757276,2,4,"negative regulation of endopeptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.08183291774043,0.508348423217914,-4.09528744982063,4.21644909131901e-05,0.0079659298725118,"CvsT4"
"432","Acerv_evm.model.Segkk2725_pilon.8",1102,1,"XP_029213732.1",1.6e-245,90.79,NA,NA,NA,NA,NA,5,"ICI1_PHAANSubtilisin inhibitor 1 OS=Phaseolus angularis OX=3914 PE=1 SV=1",2.03e-14,65.19,6,"F:GO:0004867; C:GO:0005576; P:GO:0009611; P:GO:0010466; P:GO:0010951; F:GO:0030414","F:serine-type endopeptidase inhibitor activity; C:extracellular region; P:response to wounding; P:negative regulation of peptidase activity; P:negative regulation of endopeptidase activity; F:peptidase inhibitor activity",NA,NA,"IPR000864 (PRINTS); G3DSA:3.30.10.10 (GENE3D); IPR000864 (PFAM); IPR000864 (PROSITE_PATTERNS); IPR036354 (SUPERFAMILY)","F:GO:0004867; P:GO:0009611","F:serine-type endopeptidase inhibitor activity; P:response to wounding","GO:0010951",0.00318712881833351,0.99994991757276,2,4,"negative regulation of endopeptidase activity","BP",37,14,35,26,52,23,42,11,26,37,28,62,9,3309,32.4055895391004,-2.16486911605682,0.470308141852638,-4.60308662216428,4.16274987567054e-06,0.000940885540648433,"CvsT2"
"433","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0001784",0.0113616432706379,0.999540856540644,2,7,"phosphotyrosine residue binding","MF",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"434","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0001953",0.0280532528447103,1,1,1,"negative regulation of cell-matrix adhesion","BP",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"435","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0036120",0.00532967948588206,0.999873381679328,2,5,"cellular response to platelet-derived growth factor stimulus","BP",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"436","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0005161",0.0489396593328636,0.99938896378961,1,2,"platelet-derived growth factor receptor binding","MF",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"437","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0043422",0.00310527971656312,0.999951853238082,2,4,"protein kinase B binding","MF",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"438","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0050731",0.0156051601582592,0.999226306257086,2,8,"positive regulation of peptidyl-tyrosine phosphorylation","BP",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"439","Acerv_evm.model.Segkk2763_pilon.1",186,1,"XP_015770357.1",2e-68,97.89,NA,NA,NA,NA,NA,5,"RASA1_RATRas GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1",0,61.65,28,"F:GO:0001784; P:GO:0001953; F:GO:0003924; F:GO:0005096; F:GO:0005161; C:GO:0005829; P:GO:0007613; P:GO:0030539; P:GO:0030833; F:GO:0030971; C:GO:0031256; C:GO:0031965; P:GO:0032868; P:GO:0036120; P:GO:0043066; F:GO:0043422; F:GO:0044325; P:GO:0044344; F:GO:0044877; P:GO:0046326; P:GO:0046580; P:GO:0048013; P:GO:0048146; P:GO:0048514; P:GO:0050731; F:GO:0051020; P:GO:0071364; P:GO:0090630","F:phosphotyrosine residue binding; P:negative regulation of cell-matrix adhesion; F:GTPase activity; F:GTPase activator activity; F:platelet-derived growth factor receptor binding; C:cytosol; P:memory; P:male genitalia development; P:regulation of actin filament polymerization; F:receptor tyrosine kinase binding; C:leading edge membrane; C:nuclear membrane; P:response to insulin; P:cellular response to platelet-derived growth factor stimulus; P:negative regulation of apoptotic process; F:protein kinase B binding; F:transmembrane transporter binding; P:cellular response to fibroblast growth factor stimulus; F:protein-containing complex binding; P:positive regulation of glucose import; P:negative regulation of Ras protein signal transduction; P:ephrin receptor signaling pathway; P:positive regulation of fibroblast proliferation; P:blood vessel morphogenesis; P:positive regulation of peptidyl-tyrosine phosphorylation; F:GTPase binding; P:cellular response to epidermal growth factor stimulus; P:activation of GTPase activity","EC:3.6.1; EC:3.6; EC:3","Acting on acid anhydrides; Acting on acid anhydrides; Hydrolases","IPR000980 (PRINTS); IPR001849 (SMART); IPR001936 (SMART); IPR000980 (SMART); IPR000008 (SMART); IPR001452 (SMART); IPR000008 (PFAM); IPR001849 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); G3DSA:1.10.506.10 (GENE3D); IPR001936 (PFAM); IPR036860 (G3DSA:3.30.505.GENE3D); IPR001452 (PFAM); IPR000980 (PFAM); G3DSA:1.10.506.10 (GENE3D); IPR035892 (G3DSA:2.60.40.GENE3D); IPR011993 (G3DSA:2.30.29.GENE3D); G3DSA:2.30.30.40 (GENE3D); IPR023152 (PROSITE_PATTERNS); IPR000980 (PROSITE_PROFILES); IPR000008 (PROSITE_PROFILES); IPR001849 (PROSITE_PROFILES); IPR000980 (PROSITE_PROFILES); IPR001936 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); cd13260 (CDD); IPR036860 (SUPERFAMILY); IPR036028 (SUPERFAMILY); IPR036860 (SUPERFAMILY); IPR008936 (SUPERFAMILY); SSF49562 (SUPERFAMILY); SSF50729 (SUPERFAMILY)","F:GO:0005515; P:GO:0007165; P:GO:0043087","F:protein binding; P:signal transduction; P:regulation of GTPase activity","GO:0044344",0.00362480518981677,0.999939132095904,2,4,"cellular response to fibroblast growth factor stimulus","BP",32,34,29,17,31,22,18,23,11,38,13,30,19,561,24.8161342335489,-1.57571071364469,0.41877445903962,-3.76267148015256,0.000168107965895872,0.0245139374139449,"CvsT1"
"440","Acerv_evm.model.Segkk2788_pilon.3",1046,1,"XP_029199094.1",0,91.48,NA,NA,NA,NA,NA,5,"ULP1_SCHPOUbiquitin-like-specific protease 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ulp1 PE=3 SV=1",1.46e-15,50.35,9,"F:GO:0004175; C:GO:0005737; P:GO:0006508; P:GO:0010557; F:GO:0016929; P:GO:0031328; C:GO:0031981; P:GO:0045935; P:GO:2000112","F:endopeptidase activity; C:cytoplasm; P:proteolysis; P:positive regulation of macromolecule biosynthetic process; F:SUMO-specific protease activity; P:positive regulation of cellular biosynthetic process; C:nuclear lumen; P:positive regulation of nucleobase-containing compound metabolic process; P:regulation of cellular macromolecule biosynthetic process","EC:3.4; EC:3","Acting on peptide bonds (peptidases); Hydrolases","IPR003653 (PFAM); G3DSA:3.40.395.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR003653 (PROSITE_PROFILES); IPR038765 (SUPERFAMILY)","P:GO:0006508; F:GO:0008234","P:proteolysis; F:cysteine-type peptidase activity","GO:0016929",0.0421045038636204,0.999549330651911,1,2,"SUMO-specific protease activity","MF",191,316,228,147,294,118,146,167,88,110,84,272,62,3141,155.159302637646,-0.839564993698912,0.224688591560273,-3.73657152714715,0.000186546401363418,0.0267708891226454,"CvsT4"
"441","Acerv_evm.model.Segkk2838_pilon.7",369,1,"XP_029186365.1",1.5e-195,93.77,NA,NA,NA,NA,NA,5,"RL15_RAT60S ribosomal protein L15 OS=Rattus norvegicus OX=10116 GN=Rpl15 PE=1 SV=2",2.32e-117,89.22,8,"P:GO:0002181; F:GO:0003723; F:GO:0003735; C:GO:0005634; C:GO:0016020; C:GO:0022625; C:GO:0031672; P:GO:0045471","P:cytoplasmic translation; F:RNA binding; F:structural constituent of ribosome; C:nucleus; C:membrane; C:cytosolic large ribosomal subunit; C:A band; P:response to ethanol",NA,NA,"IPR000439 (SMART); IPR024794 (G3DSA:3.40.1120.GENE3D); IPR000439 (PFAM); IPR020925 (PROSITE_PATTERNS); IPR012678 (SUPERFAMILY)","F:GO:0003735; C:GO:0005840; P:GO:0006412","F:structural constituent of ribosome; C:ribosome; P:translation","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",38,97,69,15,40,15,13,161,20,11,10,37,8,1110,30.0130379401957,1.66127665555708,0.456047498051947,3.64277112066922,0.000269718649223958,0.0224425690980117,"CvsT2"
"442","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0033554",0.00793136978860907,0.999313252323009,3,18,"cellular response to stress","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"443","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0098588",0.0256404082656132,0.996418532001015,3,27,"bounding membrane of organelle","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"444","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"445","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0032386",0.00461202251534642,0.999898335802903,2,5,"regulation of intracellular transport","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"446","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0032555",0.00456640473149219,0.999899857364956,2,5,"purine ribonucleotide binding","MF",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"447","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0071944",0.0149057401211656,0.997494650624873,4,41,"cell periphery","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"448","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0033365",0.0176198370567096,0.999042541857937,2,9,"protein localization to organelle","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"449","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0030234",0.0341028059132467,0.9971907430988,2,13,"enzyme regulator activity","MF",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"450","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0018193",0.0140251627040135,0.999342787695732,2,8,"peptidyl-amino acid modification","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"451","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0032269",0.00484221644192873,0.999890538113711,2,5,"negative regulation of cellular protein metabolic process","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"452","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0021537",0.0281707255552014,0.997957626615179,2,11,"telencephalon development","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"453","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0006996",0.00399445560224313,0.999554020421145,4,28,"organelle organization","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"454","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0030162",0.0165395238029839,0.999130898390482,2,9,"regulation of proteolysis","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"455","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0022603",0.0302989396181243,0.997684567652949,2,12,"regulation of anatomical structure morphogenesis","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"456","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0009967",0.0232132695160049,0.996878338512387,3,27,"positive regulation of signal transduction","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"457","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0001934",0.00824320520368596,0.99884951183754,4,34,"positive regulation of protein phosphorylation","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"458","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"459","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:1902531",0.00116104356819137,0.999911652546393,4,20,"regulation of intracellular signal transduction","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"460","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0010506",0.00576474779983078,0.999567152866091,3,15,"regulation of autophagy","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"461","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0060627",0.0030127162805093,0.999825416102579,3,13,"regulation of vesicle-mediated transport","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"462","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0044092",0.0193172428352737,0.998897710747696,2,9,"negative regulation of molecular function","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"463","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"464","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0080134",0.0409068362710942,0.996244729053058,2,14,"regulation of response to stress","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"465","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0048585",0.0292781079694456,0.995674372847706,3,29,"negative regulation of response to stimulus","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"466","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"467","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0031966",0.0113946667293086,0.998858582605281,3,20,"mitochondrial membrane","CC",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"468","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0120036",0.0479233552627526,0.995163445987144,2,15,"plasma membrane bounded cell projection organization","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"469","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0060548",0.0392308035817381,0.996479950101756,2,14,"negative regulation of cell death","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"470","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0050804",0.0452808168995192,0.991976702887256,3,35,"modulation of chemical synaptic transmission","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"471","Acerv_evm.model.Segkk2909_pilon.1",519,1,"XP_029191351.1",9e-284,97.88,NA,NA,NA,NA,NA,5,"GBPC_DICDICyclic GMP-binding protein C OS=Dictyostelium discoideum OX=44689 GN=gbpC PE=1 SV=1",2.7e-16,47.36,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","Coil (COILS); IPR000906 (SMART); IPR020635 (SMART); IPR000488 (SMART); IPR001296 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:1.10.533.10 (GENE3D); G3DSA:2.60.220.30 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.300 (GENE3D); G3DSA:2.60.220.30 (GENE3D); IPR001245 (PFAM); IPR028098 (PFAM); PF08477 (PFAM); IPR032171 (PFAM); G3DSA:3.40.50.2000 (GENE3D); IPR000906 (PFAM); IPR000488 (PFAM); IPR001452 (PFAM); G3DSA:3.40.50.2000 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR001452 (PROSITE_PROFILES); IPR000906 (PROSITE_PROFILES); IPR000488 (PROSITE_PROFILES); cd01670 (CDD); cd00174 (CDD); cd03801 (CDD); IPR011009 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY); IPR027417 (SUPERFAMILY); IPR036028 (SUPERFAMILY)","F:GO:0004672; F:GO:0004713; F:GO:0005515; P:GO:0006468; P:GO:0007165","F:protein kinase activity; F:protein tyrosine kinase activity; F:protein binding; P:protein phosphorylation; P:signal transduction","GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",199,528,590,131,237,142,138,525,123,189,97,256,95,1560,208.023736204274,0.696595103154785,0.186555834674042,3.73397650291617,0.000188480086212909,0.017750504785947,"CvsT2"
"472","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0005658",0.0444974932456842,0.999496021891244,1,2,"alpha DNA polymerase:primase complex","CC",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.32416008104688,0.599807063664114,-3.87484613276977,0.000106692092400377,0.0178630223591075,"CvsT4"
"473","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006269",0.0444974932456842,0.999496021891244,1,2,"DNA replication, synthesis of RNA primer","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.67779784400671,0.551471818682448,-4.85572925630976,1.19944492746231e-06,0.000338880674662086,"CvsT2"
"474","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0005658",0.0444974932456842,0.999496021891244,1,2,"alpha DNA polymerase:primase complex","CC",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.27462413136072,0.561088427924305,-4.05394946350166,5.03601002071577e-05,0.0111050162432418,"CvsT3"
"475","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0005658",0.0444974932456842,0.999496021891244,1,2,"alpha DNA polymerase:primase complex","CC",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.67779784400671,0.551471818682448,-4.85572925630976,1.19944492746231e-06,0.000338880674662086,"CvsT2"
"476","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006269",0.0444974932456842,0.999496021891244,1,2,"DNA replication, synthesis of RNA primer","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.32416008104688,0.599807063664114,-3.87484613276977,0.000106692092400377,0.0178630223591075,"CvsT4"
"477","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006269",0.0444974932456842,0.999496021891244,1,2,"DNA replication, synthesis of RNA primer","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.27462413136072,0.561088427924305,-4.05394946350166,5.03601002071577e-05,0.0111050162432418,"CvsT3"
"478","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.67779784400671,0.551471818682448,-4.85572925630976,1.19944492746231e-06,0.000338880674662086,"CvsT2"
"479","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.32416008104688,0.599807063664114,-3.87484613276977,0.000106692092400377,0.0178630223591075,"CvsT4"
"480","Acerv_evm.model.Segkk2935_pilon.2",278,1,"XP_029185379.1",8e-138,84.84,NA,NA,NA,NA,NA,5,"DPOA2_MOUSEDNA polymerase alpha subunit B OS=Mus musculus OX=10090 GN=Pola2 PE=1 SV=2",2.1e-147,57.44,7,"F:GO:0003887; F:GO:0005515; C:GO:0005654; C:GO:0005658; C:GO:0005829; P:GO:0006269; P:GO:0006606","F:DNA-directed DNA polymerase activity; F:protein binding; C:nucleoplasm; C:alpha DNA polymerase:primase complex; C:cytosol; P:DNA replication, synthesis of RNA primer; P:protein import into nucleus","EC:2.7; EC:2; EC:2.7.7.7; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; DNA-directed DNA polymerase; Transferring phosphorus-containing groups","IPR043034 (G3DSA:1.10.8.GENE3D); G3DSA:3.60.21.60 (GENE3D); IPR007185 (PFAM); IPR013627 (PFAM); IPR016722 (PIRSF); mobidb-lite (MOBIDB_LITE)","F:GO:0003677; P:GO:0006260","F:DNA binding; P:DNA replication","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",22,12,12,22,57,21,58,13,26,15,11,27,13,837,25.6008276429965,-2.27462413136072,0.561088427924305,-4.05394946350166,5.03601002071577e-05,0.0111050162432418,"CvsT3"
"481","Acerv_evm.model.Segkk30_pilon.11",147,1,"XP_022791124.1",1.3e-14,53.13,NA,NA,NA,NA,NA,5,"TIM14_BOVINMitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3",2.63e-46,76.02,12,"C:GO:0001405; F:GO:0001671; F:GO:0005515; P:GO:0006457; P:GO:0007601; P:GO:0009267; C:GO:0016021; P:GO:0030150; P:GO:0048806; C:GO:0099617; P:GO:1900208; P:GO:1902957","C:PAM complex, Tim23 associated import motor; F:ATPase activator activity; F:protein binding; P:protein folding; P:visual perception; P:cellular response to starvation; C:integral component of membrane; P:protein import into mitochondrial matrix; P:genitalia development; C:matrix side of mitochondrial inner membrane; P:regulation of cardiolipin metabolic process; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone",NA,NA,"IPR001623 (SMART); IPR036869 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (CDD); IPR036869 (SUPERFAMILY)",NA,NA,"GO:1900208",0.0299491028669805,1,1,1,"regulation of cardiolipin metabolic process","BP",136,210,290,59,98,70,70,281,93,69,37,82,56,444,101.709822578524,0.982072087853018,0.267764082235965,3.66767670873637,0.00024476438729107,0.0330285794850531,"CvsT4"
"482","Acerv_evm.model.Segkk30_pilon.11",147,1,"XP_022791124.1",1.3e-14,53.13,NA,NA,NA,NA,NA,5,"TIM14_BOVINMitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3",2.63e-46,76.02,12,"C:GO:0001405; F:GO:0001671; F:GO:0005515; P:GO:0006457; P:GO:0007601; P:GO:0009267; C:GO:0016021; P:GO:0030150; P:GO:0048806; C:GO:0099617; P:GO:1900208; P:GO:1902957","C:PAM complex, Tim23 associated import motor; F:ATPase activator activity; F:protein binding; P:protein folding; P:visual perception; P:cellular response to starvation; C:integral component of membrane; P:protein import into mitochondrial matrix; P:genitalia development; C:matrix side of mitochondrial inner membrane; P:regulation of cardiolipin metabolic process; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone",NA,NA,"IPR001623 (SMART); IPR036869 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (CDD); IPR036869 (SUPERFAMILY)",NA,NA,"GO:1902957",0.0299491028669805,1,1,1,"negative regulation of mitochondrial electron transport, NADH to ubiquinone","BP",136,210,290,59,98,70,70,281,93,69,37,82,56,444,101.709822578524,0.982072087853018,0.267764082235965,3.66767670873637,0.00024476438729107,0.0330285794850531,"CvsT4"
"483","Acerv_evm.model.Segkk30_pilon.11",147,1,"XP_022791124.1",1.3e-14,53.13,NA,NA,NA,NA,NA,5,"TIM14_BOVINMitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3",2.63e-46,76.02,12,"C:GO:0001405; F:GO:0001671; F:GO:0005515; P:GO:0006457; P:GO:0007601; P:GO:0009267; C:GO:0016021; P:GO:0030150; P:GO:0048806; C:GO:0099617; P:GO:1900208; P:GO:1902957","C:PAM complex, Tim23 associated import motor; F:ATPase activator activity; F:protein binding; P:protein folding; P:visual perception; P:cellular response to starvation; C:integral component of membrane; P:protein import into mitochondrial matrix; P:genitalia development; C:matrix side of mitochondrial inner membrane; P:regulation of cardiolipin metabolic process; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone",NA,NA,"IPR001623 (SMART); IPR036869 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (CDD); IPR036869 (SUPERFAMILY)",NA,NA,"GO:0048806",0.0299491028669805,1,1,1,"genitalia development","BP",136,210,290,59,98,70,70,281,93,69,37,82,56,444,101.709822578524,0.982072087853018,0.267764082235965,3.66767670873637,0.00024476438729107,0.0330285794850531,"CvsT4"
"484","Acerv_evm.model.Segkk30_pilon.11",147,1,"XP_022791124.1",1.3e-14,53.13,NA,NA,NA,NA,NA,5,"TIM14_BOVINMitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3",2.63e-46,76.02,12,"C:GO:0001405; F:GO:0001671; F:GO:0005515; P:GO:0006457; P:GO:0007601; P:GO:0009267; C:GO:0016021; P:GO:0030150; P:GO:0048806; C:GO:0099617; P:GO:1900208; P:GO:1902957","C:PAM complex, Tim23 associated import motor; F:ATPase activator activity; F:protein binding; P:protein folding; P:visual perception; P:cellular response to starvation; C:integral component of membrane; P:protein import into mitochondrial matrix; P:genitalia development; C:matrix side of mitochondrial inner membrane; P:regulation of cardiolipin metabolic process; P:negative regulation of mitochondrial electron transport, NADH to ubiquinone",NA,NA,"IPR001623 (SMART); IPR036869 (G3DSA:1.10.287.GENE3D); IPR001623 (PROSITE_PROFILES); IPR001623 (CDD); IPR036869 (SUPERFAMILY)",NA,NA,"GO:0009267",0.0455878192712209,0.995523913081974,2,15,"cellular response to starvation","BP",136,210,290,59,98,70,70,281,93,69,37,82,56,444,101.709822578524,0.982072087853018,0.267764082235965,3.66767670873637,0.00024476438729107,0.0330285794850531,"CvsT4"
"485","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0006367",0.0114777293647707,0.999533681149219,2,7,"transcription initiation from RNA polymerase II promoter","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"486","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:1905776",0.0253413517007199,1,1,1,"positive regulation of DNA helicase activity","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"487","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"488","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000439",0.0462107206129309,0.99945598227306,1,2,"transcription factor TFIIH core complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"489","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:1905776",0.0253413517007199,1,1,1,"positive regulation of DNA helicase activity","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"490","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"491","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000439",0.0462107206129309,0.99945598227306,1,2,"transcription factor TFIIH core complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"492","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000438",0.0253413517007199,1,1,1,"core TFIIH complex portion of holo TFIIH complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"493","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000438",0.0253413517007199,1,1,1,"core TFIIH complex portion of holo TFIIH complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"494","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000438",0.0253413517007199,1,1,1,"core TFIIH complex portion of holo TFIIH complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"495","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:1905776",0.0253413517007199,1,1,1,"positive regulation of DNA helicase activity","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"496","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:1905776",0.0253413517007199,1,1,1,"positive regulation of DNA helicase activity","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"497","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"498","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0016251",0.0143903496749027,0.999316462477845,2,8,"RNA polymerase II general transcription initiation factor activity","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"499","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0016251",0.0143903496749027,0.999316462477845,2,8,"RNA polymerase II general transcription initiation factor activity","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"500","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0016251",0.0143903496749027,0.999316462477845,2,8,"RNA polymerase II general transcription initiation factor activity","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"501","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0005669",0.00618987698345828,0.99984106715638,2,5,"transcription factor TFIID complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"502","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000439",0.0462107206129309,0.99945598227306,1,2,"transcription factor TFIIH core complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"503","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000439",0.0462107206129309,0.99945598227306,1,2,"transcription factor TFIIH core complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"504","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0006367",0.0114777293647707,0.999533681149219,2,7,"transcription initiation from RNA polymerase II promoter","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"505","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0006367",0.0114777293647707,0.999533681149219,2,7,"transcription initiation from RNA polymerase II promoter","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"506","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0006367",0.0114777293647707,0.999533681149219,2,7,"transcription initiation from RNA polymerase II promoter","BP",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"507","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0005669",0.00618987698345828,0.99984106715638,2,5,"transcription factor TFIID complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.81832232812897,0.419772663014313,-6.71392536114927,1.89457246394286e-11,1.71288296465074e-08,"CvsT3"
"508","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0000438",0.0253413517007199,1,1,1,"core TFIIH complex portion of holo TFIIH complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"509","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"510","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0016251",0.0143903496749027,0.999316462477845,2,8,"RNA polymerase II general transcription initiation factor activity","MF",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-3.30114616048314,0.409618370154479,-8.05907742672327,7.68723985997629e-16,1.15833892623409e-12,"CvsT2"
"511","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0005669",0.00618987698345828,0.99984106715638,2,5,"transcription factor TFIID complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.85672963009014,0.437745652695158,-6.52600342802156,6.75477746459949e-11,6.78554922860489e-08,"CvsT4"
"512","Acerv_evm.model.Segkk3047_pilon.5",251,1,"XP_015750061.1",2e-124,97.74,NA,NA,NA,NA,NA,5,"TF2H2_RATGeneral transcription factor IIH subunit 2 OS=Rattus norvegicus OX=10116 GN=Gtf2h2 PE=1 SV=1",8.49e-145,73.83,12,"C:GO:0000438; P:GO:0002031; C:GO:0005669; P:GO:0006289; P:GO:0006357; P:GO:0006367; P:GO:0009411; F:GO:0016251; C:GO:0016607; F:GO:0046872; F:GO:0047485; P:GO:1905776","C:core TFIIH complex portion of holo TFIIH complex; P:G protein-coupled receptor internalization; C:transcription factor TFIID complex; P:nucleotide-excision repair; P:regulation of transcription by RNA polymerase II; P:transcription initiation from RNA polymerase II promoter; P:response to UV; F:RNA polymerase II general transcription initiation factor activity; C:nuclear speck; F:metal ion binding; F:protein N-terminus binding; P:positive regulation of DNA helicase activity",NA,NA,"IPR002035 (SMART); IPR007198 (PFAM); IPR012170 (TIGRFAM); IPR036465 (G3DSA:3.40.50.GENE3D); IPR002035 (PROSITE_PROFILES); IPR007198 (CDD); IPR036465 (SUPERFAMILY)","C:GO:0000439; P:GO:0006289; P:GO:0006351","C:transcription factor TFIIH core complex; P:nucleotide-excision repair; P:transcription, DNA-templated","GO:0005669",0.00618987698345828,0.99984106715638,2,5,"transcription factor TFIID complex","CC",33,11,16,51,67,33,38,8,27,22,34,47,24,756,36.1003524326306,-2.72769415484527,0.459738148048264,-5.93314730662488,2.97181990537559e-09,2.06678644342313e-06,"CvsT1"
"513","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0030687",0.00689983613811048,0.999796314242108,2,6,"preribosome, large subunit precursor","CC",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.16803246780738,0.429007392222717,-7.38456382160127,1.52953974676175e-13,2.7657137700946e-10,"CvsT1"
"514","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:1902570",0.0205146226585087,1,1,1,"protein localization to nucleolus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.1905391438898,0.410823387553705,-7.76620621062553,8.08718508696499e-15,1.3456898770951e-11,"CvsT4"
"515","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:1902570",0.0205146226585087,1,1,1,"protein localization to nucleolus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.16803246780738,0.429007392222717,-7.38456382160127,1.52953974676175e-13,2.7657137700946e-10,"CvsT1"
"516","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:1902570",0.0205146226585087,1,1,1,"protein localization to nucleolus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.08881107955924,0.397207295633342,-7.77632010669434,7.46646331310124e-15,8.43803685171854e-12,"CvsT2"
"517","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:1902570",0.0205146226585087,1,1,1,"protein localization to nucleolus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.01121685231925,0.40057957585612,-7.51715023384222,5.59830752350106e-14,8.43571638666217e-11,"CvsT3"
"518","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0000055",0.0205146226585087,1,1,1,"ribosomal large subunit export from nucleus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.01121685231925,0.40057957585612,-7.51715023384222,5.59830752350106e-14,8.43571638666217e-11,"CvsT3"
"519","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0000055",0.0205146226585087,1,1,1,"ribosomal large subunit export from nucleus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.1905391438898,0.410823387553705,-7.76620621062553,8.08718508696499e-15,1.3456898770951e-11,"CvsT4"
"520","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0030687",0.00689983613811048,0.999796314242108,2,6,"preribosome, large subunit precursor","CC",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.01121685231925,0.40057957585612,-7.51715023384222,5.59830752350106e-14,8.43571638666217e-11,"CvsT3"
"521","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0030687",0.00689983613811048,0.999796314242108,2,6,"preribosome, large subunit precursor","CC",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.1905391438898,0.410823387553705,-7.76620621062553,8.08718508696499e-15,1.3456898770951e-11,"CvsT4"
"522","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0030687",0.00689983613811048,0.999796314242108,2,6,"preribosome, large subunit precursor","CC",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.08881107955924,0.397207295633342,-7.77632010669434,7.46646331310124e-15,8.43803685171854e-12,"CvsT2"
"523","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0000055",0.0205146226585087,1,1,1,"ribosomal large subunit export from nucleus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.16803246780738,0.429007392222717,-7.38456382160127,1.52953974676175e-13,2.7657137700946e-10,"CvsT1"
"524","Acerv_evm.model.Segkk3087_pilon.2",1490,1,"XP_029181611.1",1.2e-227,84.68,NA,NA,NA,NA,NA,5,"RRS1_BOVINRibosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1",6.13e-98,68.18,14,"P:GO:0000027; P:GO:0000055; P:GO:0000447; C:GO:0000794; P:GO:0002244; F:GO:0005515; C:GO:0005654; C:GO:0005730; C:GO:0005783; P:GO:0007080; F:GO:0008097; C:GO:0030687; P:GO:1901796; P:GO:1902570","P:ribosomal large subunit assembly; P:ribosomal large subunit export from nucleus; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); C:condensed nuclear chromosome; P:hematopoietic progenitor cell differentiation; F:protein binding; C:nucleoplasm; C:nucleolus; C:endoplasmic reticulum; P:mitotic metaphase plate congression; F:5S rRNA binding; C:preribosome, large subunit precursor; P:regulation of signal transduction by p53 class mediator; P:protein localization to nucleolus",NA,NA,"IPR007023 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0005634; P:GO:0042254","C:nucleus; P:ribosome biogenesis","GO:0000055",0.0205146226585087,1,1,1,"ribosomal large subunit export from nucleus","BP",50,10,15,33,65,39,38,6,31,27,24,62,12,4472,34.3138867237994,-3.08881107955924,0.397207295633342,-7.77632010669434,7.46646331310124e-15,8.43803685171854e-12,"CvsT2"
"525","Acerv_evm.model.Segkk3091_pilon.8",305,1,"XP_029191096.1",2.2e-144,85.57,NA,NA,NA,NA,NA,5,"ABCA3_RATPhospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1",0,59.92,22,"C:GO:0005770; C:GO:0005783; C:GO:0005886; P:GO:0006638; P:GO:0006855; F:GO:0008559; P:GO:0010875; P:GO:0030324; P:GO:0032464; P:GO:0043129; P:GO:0044267; P:GO:0046471; P:GO:0046618; P:GO:0046890; P:GO:0051384; P:GO:0055091; P:GO:0070925; C:GO:0097233; F:GO:0120019; F:GO:0140345; P:GO:0150172; P:GO:1902995","C:late endosome; C:endoplasmic reticulum; C:plasma membrane; P:neutral lipid metabolic process; P:xenobiotic transmembrane transport; F:ABC-type xenobiotic transporter activity; P:positive regulation of cholesterol efflux; P:lung development; P:positive regulation of protein homooligomerization; P:surfactant homeostasis; P:cellular protein metabolic process; P:phosphatidylglycerol metabolic process; P:xenobiotic export; P:regulation of lipid biosynthetic process; P:response to glucocorticoid; P:phospholipid homeostasis; P:organelle assembly; C:alveolar lamellar body membrane; F:phosphatidylcholine transfer activity; F:phosphatidylcholine flippase activity; P:regulation of phosphatidylcholine metabolic process; P:positive regulation of phospholipid efflux","EC:7.6.2.1; EC:7.6.2.2; EC:7","n/a; n/a; n/a","IPR003593 (SMART); IPR003439 (PFAM); PF12698 (PFAM); IPR003439 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); cd03263 (CDD); cd03263 (CDD); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005524; F:GO:0016887","F:ATP binding; F:ATP hydrolysis activity","GO:0010875",0.00181223944525586,0.999984883484968,2,3,"positive regulation of cholesterol efflux","BP",3386,5867,7599,3683,5847,2287,11822,4923,2069,858,2456,4235,892,918,3969.37392059197,-1.83125611522843,0.511817678907757,-3.57794619196511,0.000346304719199128,0.0436191040736736,"T1vsT2"
"526","Acerv_evm.model.Segkk3091_pilon.8",305,1,"XP_029191096.1",2.2e-144,85.57,NA,NA,NA,NA,NA,5,"ABCA3_RATPhospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1",0,59.92,22,"C:GO:0005770; C:GO:0005783; C:GO:0005886; P:GO:0006638; P:GO:0006855; F:GO:0008559; P:GO:0010875; P:GO:0030324; P:GO:0032464; P:GO:0043129; P:GO:0044267; P:GO:0046471; P:GO:0046618; P:GO:0046890; P:GO:0051384; P:GO:0055091; P:GO:0070925; C:GO:0097233; F:GO:0120019; F:GO:0140345; P:GO:0150172; P:GO:1902995","C:late endosome; C:endoplasmic reticulum; C:plasma membrane; P:neutral lipid metabolic process; P:xenobiotic transmembrane transport; F:ABC-type xenobiotic transporter activity; P:positive regulation of cholesterol efflux; P:lung development; P:positive regulation of protein homooligomerization; P:surfactant homeostasis; P:cellular protein metabolic process; P:phosphatidylglycerol metabolic process; P:xenobiotic export; P:regulation of lipid biosynthetic process; P:response to glucocorticoid; P:phospholipid homeostasis; P:organelle assembly; C:alveolar lamellar body membrane; F:phosphatidylcholine transfer activity; F:phosphatidylcholine flippase activity; P:regulation of phosphatidylcholine metabolic process; P:positive regulation of phospholipid efflux","EC:7.6.2.1; EC:7.6.2.2; EC:7","n/a; n/a; n/a","IPR003593 (SMART); IPR003439 (PFAM); PF12698 (PFAM); IPR003439 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); cd03263 (CDD); cd03263 (CDD); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005524; F:GO:0016887","F:ATP binding; F:ATP hydrolysis activity","GO:0005770",0.0377183773296265,0.993812215624208,3,32,"late endosome","CC",3386,5867,7599,3683,5847,2287,11822,4923,2069,858,2456,4235,892,918,3969.37392059197,-1.83125611522843,0.511817678907757,-3.57794619196511,0.000346304719199128,0.0436191040736736,"T1vsT2"
"527","Acerv_evm.model.Segkk3091_pilon.8",305,1,"XP_029191096.1",2.2e-144,85.57,NA,NA,NA,NA,NA,5,"ABCA3_RATPhospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1",0,59.92,22,"C:GO:0005770; C:GO:0005783; C:GO:0005886; P:GO:0006638; P:GO:0006855; F:GO:0008559; P:GO:0010875; P:GO:0030324; P:GO:0032464; P:GO:0043129; P:GO:0044267; P:GO:0046471; P:GO:0046618; P:GO:0046890; P:GO:0051384; P:GO:0055091; P:GO:0070925; C:GO:0097233; F:GO:0120019; F:GO:0140345; P:GO:0150172; P:GO:1902995","C:late endosome; C:endoplasmic reticulum; C:plasma membrane; P:neutral lipid metabolic process; P:xenobiotic transmembrane transport; F:ABC-type xenobiotic transporter activity; P:positive regulation of cholesterol efflux; P:lung development; P:positive regulation of protein homooligomerization; P:surfactant homeostasis; P:cellular protein metabolic process; P:phosphatidylglycerol metabolic process; P:xenobiotic export; P:regulation of lipid biosynthetic process; P:response to glucocorticoid; P:phospholipid homeostasis; P:organelle assembly; C:alveolar lamellar body membrane; F:phosphatidylcholine transfer activity; F:phosphatidylcholine flippase activity; P:regulation of phosphatidylcholine metabolic process; P:positive regulation of phospholipid efflux","EC:7.6.2.1; EC:7.6.2.2; EC:7","n/a; n/a; n/a","IPR003593 (SMART); IPR003439 (PFAM); PF12698 (PFAM); IPR003439 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); cd03263 (CDD); cd03263 (CDD); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005524; F:GO:0016887","F:ATP binding; F:ATP hydrolysis activity","GO:0070925",0.0138722716888619,0.999353700690453,2,8,"organelle assembly","BP",3386,5867,7599,3683,5847,2287,11822,4923,2069,858,2456,4235,892,918,3969.37392059197,-1.83125611522843,0.511817678907757,-3.57794619196511,0.000346304719199128,0.0436191040736736,"T1vsT2"
"528","Acerv_evm.model.Segkk3091_pilon.8",305,1,"XP_029191096.1",2.2e-144,85.57,NA,NA,NA,NA,NA,5,"ABCA3_RATPhospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1",0,59.92,22,"C:GO:0005770; C:GO:0005783; C:GO:0005886; P:GO:0006638; P:GO:0006855; F:GO:0008559; P:GO:0010875; P:GO:0030324; P:GO:0032464; P:GO:0043129; P:GO:0044267; P:GO:0046471; P:GO:0046618; P:GO:0046890; P:GO:0051384; P:GO:0055091; P:GO:0070925; C:GO:0097233; F:GO:0120019; F:GO:0140345; P:GO:0150172; P:GO:1902995","C:late endosome; C:endoplasmic reticulum; C:plasma membrane; P:neutral lipid metabolic process; P:xenobiotic transmembrane transport; F:ABC-type xenobiotic transporter activity; P:positive regulation of cholesterol efflux; P:lung development; P:positive regulation of protein homooligomerization; P:surfactant homeostasis; P:cellular protein metabolic process; P:phosphatidylglycerol metabolic process; P:xenobiotic export; P:regulation of lipid biosynthetic process; P:response to glucocorticoid; P:phospholipid homeostasis; P:organelle assembly; C:alveolar lamellar body membrane; F:phosphatidylcholine transfer activity; F:phosphatidylcholine flippase activity; P:regulation of phosphatidylcholine metabolic process; P:positive regulation of phospholipid efflux","EC:7.6.2.1; EC:7.6.2.2; EC:7","n/a; n/a; n/a","IPR003593 (SMART); IPR003439 (PFAM); PF12698 (PFAM); IPR003439 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR017871 (PROSITE_PATTERNS); IPR003439 (PROSITE_PROFILES); IPR003439 (PROSITE_PROFILES); cd03263 (CDD); cd03263 (CDD); IPR027417 (SUPERFAMILY); IPR027417 (SUPERFAMILY)","F:GO:0005524; F:GO:0016887","F:ATP binding; F:ATP hydrolysis activity","GO:0006638",0.0236698876556084,1,1,1,"neutral lipid metabolic process","BP",3386,5867,7599,3683,5847,2287,11822,4923,2069,858,2456,4235,892,918,3969.37392059197,-1.83125611522843,0.511817678907757,-3.57794619196511,0.000346304719199128,0.0436191040736736,"T1vsT2"
"529","Acerv_evm.model.Segkk3095_pilon.35",608,1,"XP_029189908.1",0,93.59,NA,NA,NA,NA,NA,5,"NAL12_HUMANNACHT, LRR and PYD domains-containing protein 12 OS=Homo sapiens OX=9606 GN=NLRP12 PE=1 SV=2",2.37e-37,41.01,17,"P:GO:0001818; P:GO:0002376; F:GO:0005488; C:GO:0005737; P:GO:0006952; P:GO:0009968; P:GO:0010033; P:GO:0010556; P:GO:0010604; P:GO:0031323; C:GO:0043231; P:GO:0048522; P:GO:0048584; P:GO:0051240; P:GO:0051246; P:GO:0065009; P:GO:1902531","P:negative regulation of cytokine production; P:immune system process; F:binding; C:cytoplasm; P:defense response; P:negative regulation of signal transduction; P:response to organic substance; P:regulation of macromolecule biosynthetic process; P:positive regulation of macromolecule metabolic process; P:regulation of cellular metabolic process; C:intracellular membrane-bounded organelle; P:positive regulation of cellular process; P:positive regulation of response to stimulus; P:positive regulation of multicellular organismal process; P:regulation of protein metabolic process; P:regulation of molecular function; P:regulation of intracellular signal transduction",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0001818",0.0452184006112893,0.992004936238108,3,34,"negative regulation of cytokine production","BP",172,302,382,244,388,92,183,344,99,45,134,167,45,1827,174.064534461941,-1.43701783621767,0.406844500537394,-3.53210583974843,0.000412264314924727,0.0495221991356519,"T1vsT2"
"530","Acerv_evm.model.Segkk3095_pilon.35",608,1,"XP_029189908.1",0,93.59,NA,NA,NA,NA,NA,5,"NAL12_HUMANNACHT, LRR and PYD domains-containing protein 12 OS=Homo sapiens OX=9606 GN=NLRP12 PE=1 SV=2",2.37e-37,41.01,17,"P:GO:0001818; P:GO:0002376; F:GO:0005488; C:GO:0005737; P:GO:0006952; P:GO:0009968; P:GO:0010033; P:GO:0010556; P:GO:0010604; P:GO:0031323; C:GO:0043231; P:GO:0048522; P:GO:0048584; P:GO:0051240; P:GO:0051246; P:GO:0065009; P:GO:1902531","P:negative regulation of cytokine production; P:immune system process; F:binding; C:cytoplasm; P:defense response; P:negative regulation of signal transduction; P:response to organic substance; P:regulation of macromolecule biosynthetic process; P:positive regulation of macromolecule metabolic process; P:regulation of cellular metabolic process; C:intracellular membrane-bounded organelle; P:positive regulation of cellular process; P:positive regulation of response to stimulus; P:positive regulation of multicellular organismal process; P:regulation of protein metabolic process; P:regulation of molecular function; P:regulation of intracellular signal transduction",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0006952",0.034325644656632,0.997162377795806,2,13,"defense response","BP",172,302,382,244,388,92,183,344,99,45,134,167,45,1827,174.064534461941,-1.43701783621767,0.406844500537394,-3.53210583974843,0.000412264314924727,0.0495221991356519,"T1vsT2"
"531","Acerv_evm.model.Segkk3095_pilon.35",608,1,"XP_029189908.1",0,93.59,NA,NA,NA,NA,NA,5,"NAL12_HUMANNACHT, LRR and PYD domains-containing protein 12 OS=Homo sapiens OX=9606 GN=NLRP12 PE=1 SV=2",2.37e-37,41.01,17,"P:GO:0001818; P:GO:0002376; F:GO:0005488; C:GO:0005737; P:GO:0006952; P:GO:0009968; P:GO:0010033; P:GO:0010556; P:GO:0010604; P:GO:0031323; C:GO:0043231; P:GO:0048522; P:GO:0048584; P:GO:0051240; P:GO:0051246; P:GO:0065009; P:GO:1902531","P:negative regulation of cytokine production; P:immune system process; F:binding; C:cytoplasm; P:defense response; P:negative regulation of signal transduction; P:response to organic substance; P:regulation of macromolecule biosynthetic process; P:positive regulation of macromolecule metabolic process; P:regulation of cellular metabolic process; C:intracellular membrane-bounded organelle; P:positive regulation of cellular process; P:positive regulation of response to stimulus; P:positive regulation of multicellular organismal process; P:regulation of protein metabolic process; P:regulation of molecular function; P:regulation of intracellular signal transduction",NA,NA,"SM00368 (SMART); IPR001611 (PFAM); IPR032675 (G3DSA:3.80.10.GENE3D); SSF52047 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:1902531",0.00116104356819137,0.999911652546393,4,20,"regulation of intracellular signal transduction","BP",172,302,382,244,388,92,183,344,99,45,134,167,45,1827,174.064534461941,-1.43701783621767,0.406844500537394,-3.53210583974843,0.000412264314924727,0.0495221991356519,"T1vsT2"
"532","Acerv_evm.model.Segkk3096_pilon.7",671,1,"XP_029209573.1",6.1e-240,89.83,NA,NA,NA,NA,NA,5,"DVE1_CAEELHomeobox protein dve-1 OS=Caenorhabditis elegans OX=6239 GN=dve-1 PE=1 SV=1",2.99e-10,47.84,8,"F:GO:0003690; F:GO:0003700; F:GO:0005515; C:GO:0005654; P:GO:0006355; P:GO:0007275; P:GO:0042110; F:GO:0043565","F:double-stranded DNA binding; F:DNA-binding transcription factor activity; F:protein binding; C:nucleoplasm; P:regulation of transcription, DNA-templated; P:multicellular organism development; P:T cell activation; F:sequence-specific DNA binding",NA,NA,"IPR001356 (SMART); IPR032355 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR038216 (G3DSA:1.10.260.GENE3D); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0003677","F:DNA binding","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",25,9,16,11,19,13,17,8,8,21,11,15,9,2016,15.0654175528371,-1.7164905355831,0.493872111979779,-3.47557696404891,0.000509755698630054,0.0362889863883017,"CvsT2"
"533","Acerv_evm.model.Segkk3096_pilon.7",671,1,"XP_029209573.1",6.1e-240,89.83,NA,NA,NA,NA,NA,5,"DVE1_CAEELHomeobox protein dve-1 OS=Caenorhabditis elegans OX=6239 GN=dve-1 PE=1 SV=1",2.99e-10,47.84,8,"F:GO:0003690; F:GO:0003700; F:GO:0005515; C:GO:0005654; P:GO:0006355; P:GO:0007275; P:GO:0042110; F:GO:0043565","F:double-stranded DNA binding; F:DNA-binding transcription factor activity; F:protein binding; C:nucleoplasm; P:regulation of transcription, DNA-templated; P:multicellular organism development; P:T cell activation; F:sequence-specific DNA binding",NA,NA,"IPR001356 (SMART); IPR032355 (PFAM); G3DSA:1.10.10.60 (GENE3D); IPR038216 (G3DSA:1.10.260.GENE3D); IPR001356 (PROSITE_PROFILES); IPR001356 (CDD); IPR009057 (SUPERFAMILY)","F:GO:0003677","F:DNA binding","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",25,9,16,11,19,13,17,8,8,21,11,15,9,2016,15.0654175528371,-2.12969452162364,0.531344362762396,-4.00812480733137,6.12027755579259e-05,0.0115277977879002,"CvsT1"
"534","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.84357048310773,0.480869160819452,-3.83382972608618,0.000126163490688082,0.0200113003387886,"CvsT1"
"535","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78254356129735,0.45122239688234,-3.95047669090362,7.79956939543978e-05,0.0133048880951266,"CvsT4"
"536","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0043657",0.0422911832363749,0.999545281473942,1,2,"host cell","CC",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78254356129735,0.45122239688234,-3.95047669090362,7.79956939543978e-05,0.0133048880951266,"CvsT4"
"537","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0043657",0.0422911832363749,0.999545281473942,1,2,"host cell","CC",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.84357048310773,0.480869160819452,-3.83382972608618,0.000126163490688082,0.0200113003387886,"CvsT1"
"538","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78228960219861,0.434795732164726,-4.09914235663053,4.14683926510021e-05,0.00543356141967696,"CvsT2"
"539","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78228960219861,0.434795732164726,-4.09914235663053,4.14683926510021e-05,0.00543356141967696,"CvsT2"
"540","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0048477",0.0289018395428741,0.997910127128071,2,10,"oogenesis","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.84357048310773,0.480869160819452,-3.83382972608618,0.000126163490688082,0.0200113003387886,"CvsT1"
"541","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0048477",0.0289018395428741,0.997910127128071,2,10,"oogenesis","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78228960219861,0.434795732164726,-4.09914235663053,4.14683926510021e-05,0.00543356141967696,"CvsT2"
"542","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0043657",0.0422911832363749,0.999545281473942,1,2,"host cell","CC",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78228960219861,0.434795732164726,-4.09914235663053,4.14683926510021e-05,0.00543356141967696,"CvsT2"
"543","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0048477",0.0289018395428741,0.997910127128071,2,10,"oogenesis","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78254356129735,0.45122239688234,-3.95047669090362,7.79956939543978e-05,0.0133048880951266,"CvsT4"
"544","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0075732",0.0493418145100379,0.999378749993334,1,2,"viral penetration into host nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.84357048310773,0.480869160819452,-3.83382972608618,0.000126163490688082,0.0200113003387886,"CvsT1"
"545","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78254356129735,0.45122239688234,-3.95047669090362,7.79956939543978e-05,0.0133048880951266,"CvsT4"
"546","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0006606",0.0104830728920493,0.998987737650034,3,19,"protein import into nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.84357048310773,0.480869160819452,-3.83382972608618,0.000126163490688082,0.0200113003387886,"CvsT1"
"547","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0075732",0.0493418145100379,0.999378749993334,1,2,"viral penetration into host nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78254356129735,0.45122239688234,-3.95047669090362,7.79956939543978e-05,0.0133048880951266,"CvsT4"
"548","Acerv_evm.model.Segkk3158_pilon.3",284,1,"XP_029184658.1",1.3e-159,93.66,NA,NA,NA,NA,NA,5,"IMA3_MOUSEImportin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1",0,79.39,18,"P:GO:0002119; C:GO:0005643; C:GO:0005654; C:GO:0005829; P:GO:0006607; P:GO:0006999; P:GO:0007127; F:GO:0008022; F:GO:0008139; P:GO:0009792; C:GO:0031965; P:GO:0042542; C:GO:0043657; P:GO:0046718; P:GO:0048477; F:GO:0061608; P:GO:0065003; P:GO:0075732","P:nematode larval development; C:nuclear pore; C:nucleoplasm; C:cytosol; P:NLS-bearing protein import into nucleus; P:nuclear pore organization; P:meiosis I; F:protein C-terminus binding; F:nuclear localization sequence binding; P:embryo development ending in birth or egg hatching; C:nuclear membrane; P:response to hydrogen peroxide; C:host cell; P:viral entry into host cell; P:oogenesis; F:nuclear import signal receptor activity; P:protein-containing complex assembly; P:viral penetration into host nucleus",NA,NA,"Coil (COILS); IPR000225 (SMART); IPR024931 (PIRSF); IPR011989 (G3DSA:1.25.10.GENE3D); IPR032413 (PFAM); IPR002652 (PFAM); IPR036975 (G3DSA:1.20.5.GENE3D); IPR000225 (PFAM); IPR002652 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR000225 (PROSITE_PROFILES); IPR016024 (SUPERFAMILY)","F:GO:0005515; C:GO:0005737; P:GO:0006606; F:GO:0061608","F:protein binding; C:cytoplasm; P:protein import into nucleus; F:nuclear import signal receptor activity","GO:0075732",0.0493418145100379,0.999378749993334,1,2,"viral penetration into host nucleus","BP",14,13,15,21,33,17,18,12,16,17,11,29,11,855,18.5150051134661,-1.78228960219861,0.434795732164726,-4.09914235663053,4.14683926510021e-05,0.00543356141967696,"CvsT2"
"549","Acerv_evm.model.Segkk3192_pilon.40",205,1,"XP_029193867.1",2.1e-79,100,NA,NA,NA,NA,NA,5,"OAS1A_RAT2'-5'-oligoadenylate synthase 1A OS=Rattus norvegicus OX=10116 GN=Oas1a PE=2 SV=1",8.01e-39,52.09,15,"P:GO:0001819; P:GO:0002224; F:GO:0003723; C:GO:0005634; C:GO:0005737; F:GO:0016779; P:GO:0019221; P:GO:0031323; P:GO:0032682; P:GO:0044238; P:GO:0044281; P:GO:0045087; P:GO:0048525; P:GO:0048878; P:GO:0051607","P:positive regulation of cytokine production; P:toll-like receptor signaling pathway; F:RNA binding; C:nucleus; C:cytoplasm; F:nucleotidyltransferase activity; P:cytokine-mediated signaling pathway; P:regulation of cellular metabolic process; P:negative regulation of chemokine production; P:primary metabolic process; P:small molecule metabolic process; P:innate immune response; P:negative regulation of viral process; P:chemical homeostasis; P:defense response to virus","EC:2.7; EC:2; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; Transferring phosphorus-containing groups","IPR018952 (PFAM); IPR043519 (G3DSA:3.30.460.GENE3D); IPR038121 (G3DSA:1.10.1410.GENE3D); IPR002934 (PFAM); PS50152 (PROSITE_PROFILES); IPR006116 (CDD); IPR043519 (SUPERFAMILY); SSF81631 (SUPERFAMILY)","F:GO:0016779","F:nucleotidyltransferase activity","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",281,354,466,255,491,119,244,316,71,55,238,444,72,618,232.361517061136,-1.53321616455527,0.378587940601857,-4.04982832289337,5.12552206534937e-05,0.0174525790656564,"T1vsT2"
"550","Acerv_evm.model.Segkk3192_pilon.40",205,1,"XP_029193867.1",2.1e-79,100,NA,NA,NA,NA,NA,5,"OAS1A_RAT2'-5'-oligoadenylate synthase 1A OS=Rattus norvegicus OX=10116 GN=Oas1a PE=2 SV=1",8.01e-39,52.09,15,"P:GO:0001819; P:GO:0002224; F:GO:0003723; C:GO:0005634; C:GO:0005737; F:GO:0016779; P:GO:0019221; P:GO:0031323; P:GO:0032682; P:GO:0044238; P:GO:0044281; P:GO:0045087; P:GO:0048525; P:GO:0048878; P:GO:0051607","P:positive regulation of cytokine production; P:toll-like receptor signaling pathway; F:RNA binding; C:nucleus; C:cytoplasm; F:nucleotidyltransferase activity; P:cytokine-mediated signaling pathway; P:regulation of cellular metabolic process; P:negative regulation of chemokine production; P:primary metabolic process; P:small molecule metabolic process; P:innate immune response; P:negative regulation of viral process; P:chemical homeostasis; P:defense response to virus","EC:2.7; EC:2; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; Transferring phosphorus-containing groups","IPR018952 (PFAM); IPR043519 (G3DSA:3.30.460.GENE3D); IPR038121 (G3DSA:1.10.1410.GENE3D); IPR002934 (PFAM); PS50152 (PROSITE_PROFILES); IPR006116 (CDD); IPR043519 (SUPERFAMILY); SSF81631 (SUPERFAMILY)","F:GO:0016779","F:nucleotidyltransferase activity","GO:0051607",0.0103456307275163,0.999005857260926,3,19,"defense response to virus","BP",281,354,466,255,491,119,244,316,71,55,238,444,72,618,232.361517061136,-1.53321616455527,0.378587940601857,-4.04982832289337,5.12552206534937e-05,0.0174525790656564,"T1vsT2"
"551","Acerv_evm.model.Segkk3192_pilon.40",205,1,"XP_029193867.1",2.1e-79,100,NA,NA,NA,NA,NA,5,"OAS1A_RAT2'-5'-oligoadenylate synthase 1A OS=Rattus norvegicus OX=10116 GN=Oas1a PE=2 SV=1",8.01e-39,52.09,15,"P:GO:0001819; P:GO:0002224; F:GO:0003723; C:GO:0005634; C:GO:0005737; F:GO:0016779; P:GO:0019221; P:GO:0031323; P:GO:0032682; P:GO:0044238; P:GO:0044281; P:GO:0045087; P:GO:0048525; P:GO:0048878; P:GO:0051607","P:positive regulation of cytokine production; P:toll-like receptor signaling pathway; F:RNA binding; C:nucleus; C:cytoplasm; F:nucleotidyltransferase activity; P:cytokine-mediated signaling pathway; P:regulation of cellular metabolic process; P:negative regulation of chemokine production; P:primary metabolic process; P:small molecule metabolic process; P:innate immune response; P:negative regulation of viral process; P:chemical homeostasis; P:defense response to virus","EC:2.7; EC:2; EC:2.7.7","Transferring phosphorus-containing groups; Transferases; Transferring phosphorus-containing groups","IPR018952 (PFAM); IPR043519 (G3DSA:3.30.460.GENE3D); IPR038121 (G3DSA:1.10.1410.GENE3D); IPR002934 (PFAM); PS50152 (PROSITE_PROFILES); IPR006116 (CDD); IPR043519 (SUPERFAMILY); SSF81631 (SUPERFAMILY)","F:GO:0016779","F:nucleotidyltransferase activity","GO:0045087",0.0477206217885634,0.991366612507763,3,35,"innate immune response","BP",281,354,466,255,491,119,244,316,71,55,238,444,72,618,232.361517061136,-1.53321616455527,0.378587940601857,-4.04982832289337,5.12552206534937e-05,0.0174525790656564,"T1vsT2"
"552","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0035098",0.00798405368936271,0.99974569015649,2,6,"ESC/E(Z) complex","CC",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"553","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0035358",0.0231990754089256,1,1,1,"regulation of peroxisome proliferator activated receptor signaling pathway","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"554","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1904644",0.0231990754089256,1,1,1,"cellular response to curcumin","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"555","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1901416",0.0231990754089256,1,1,1,"regulation of response to ethanol","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"556","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0001938",0.0209109479269228,0.99872895331437,2,10,"positive regulation of endothelial cell proliferation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"557","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1904179",0.0231990754089256,1,1,1,"positive regulation of adipose tissue development","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"558","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0010875",0.00181223944525586,0.999984883484968,2,3,"positive regulation of cholesterol efflux","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"559","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0032071",0.0231990754089256,1,1,1,"regulation of endodeoxyribonuclease activity","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"560","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0061051",0.0468586755200729,0.9994404304357,1,2,"positive regulation of cell growth involved in cardiac muscle cell development","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"561","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0051574",0.0231990754089256,1,1,1,"positive regulation of histone H3-K9 methylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"562","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0034391",0.0231990754089256,1,1,1,"regulation of smooth muscle cell apoptotic process","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"563","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"564","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1904648",0.0231990754089256,1,1,1,"cellular response to rotenone","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"565","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0070857",0.0433179518027505,0.999522679297232,1,2,"regulation of bile acid biosynthetic process","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"566","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000111",0.0231990754089256,1,1,1,"positive regulation of macrophage apoptotic process","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"567","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1904373",0.0231990754089256,1,1,1,"response to kainic acid","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"568","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0042595",0.0231990754089256,1,1,1,"behavioral response to starvation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"569","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0010046",0.0231990754089256,1,1,1,"response to mycotoxin","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"570","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000614",0.0231990754089256,1,1,1,"positive regulation of thyroid-stimulating hormone secretion","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"571","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0071356",0.00572553304945496,0.999562969298826,3,17,"cellular response to tumor necrosis factor","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"572","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0000720",0.0231990754089256,1,1,1,"pyrimidine dimer repair by nucleotide-excision repair","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"573","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0035356",0.0231990754089256,1,1,1,"cellular triglyceride homeostasis","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"574","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1902166",0.0231990754089256,1,1,1,"negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"575","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0009267",0.0455878192712209,0.995523913081974,2,15,"cellular response to starvation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"576","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0051152",0.0231990754089256,1,1,1,"positive regulation of smooth muscle cell differentiation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"577","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0050872",0.0231990754089256,1,1,1,"white fat cell differentiation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"578","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1900113",0.0427552693636298,0.999535134980391,1,2,"negative regulation of histone H3-K9 trimethylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"579","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0060907",0.0231990754089256,1,1,1,"positive regulation of macrophage cytokine production","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"580","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0071441",0.0231990754089256,1,1,1,"negative regulation of histone H3-K14 acetylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"581","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0051097",0.0231990754089256,1,1,1,"negative regulation of helicase activity","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"582","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1902176",0.0441086616176062,0.999504891271106,1,2,"negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"583","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000655",0.0231990754089256,1,1,1,"negative regulation of cellular response to testosterone stimulus","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"584","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0014858",0.0231990754089256,1,1,1,"positive regulation of skeletal muscle cell proliferation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"585","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0010883",0.0452081600792692,0.99947960308955,1,2,"regulation of lipid storage","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"586","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1904638",0.0231990754089256,1,1,1,"response to resveratrol","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"587","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000774",0.0231990754089256,1,1,1,"positive regulation of cellular senescence","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"588","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0090312",0.0231990754089256,1,1,1,"positive regulation of protein deacetylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"589","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0006642",0.0231990754089256,1,1,1,"triglyceride mobilization","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"590","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0060125",0.0487787348772993,0.999393026573106,1,2,"negative regulation of growth hormone secretion","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"591","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0033553",0.0441140029175421,0.999504769979872,1,2,"rDNA heterochromatin","CC",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"592","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000619",0.04517781431286,0.999480309684511,1,2,"negative regulation of histone H4-K16 acetylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"593","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0002821",0.0231990754089256,1,1,1,"positive regulation of adaptive immune response","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"594","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0045348",0.0452866535215028,0.999477773106655,1,2,"positive regulation of MHC class II biosynthetic process","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"595","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:1990254",0.0231990754089256,1,1,1,"keratin filament binding","MF",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"596","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0006346",0.0441137170791731,0.999504776471128,1,2,"DNA methylation-dependent heterochromatin assembly","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"597","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0031393",0.0231990754089256,1,1,1,"negative regulation of prostaglandin biosynthetic process","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"598","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0030308",0.0234186793835969,0.99684013225846,3,27,"negative regulation of cell growth","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"599","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0043518",0.0472194707380602,0.999431673506648,1,2,"negative regulation of DNA damage response, signal transduction by p53 class mediator","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"600","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0000183",0.0440792087876677,0.999505559818545,1,2,"rDNA heterochromatin assembly","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"601","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0043422",0.00310527971656312,0.999951853238082,2,4,"protein kinase B binding","MF",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"602","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0090400",0.0231990754089256,1,1,1,"stress-induced premature senescence","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"603","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0034983",0.0441167839668029,0.999504706821272,1,2,"peptidyl-lysine deacetylation","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"604","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0071303",0.0231990754089256,1,1,1,"cellular response to vitamin B3","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"605","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:2000481",0.0231990754089256,1,1,1,"positive regulation of cAMP-dependent protein kinase activity","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"606","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"607","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0070403",0.00470461115789769,0.999895223321753,2,5,"NAD+ binding","MF",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"608","Acerv_evm.model.Segkk3209_pilon.11",325,1,"XP_029196653.1",1.8e-176,98.46,NA,NA,NA,NA,NA,5,"SIR1_MOUSENAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2",5.47e-157,68.21,138,"P:GO:0000012; P:GO:0000122; P:GO:0000183; P:GO:0000720; P:GO:0000731; C:GO:0000791; F:GO:0000978; P:GO:0001542; C:GO:0001650; P:GO:0001938; F:GO:0002039; P:GO:0002821; F:GO:0003713; F:GO:0003714; C:GO:0005637; C:GO:0005677; C:GO:0005739; C:GO:0005829; P:GO:0006346; P:GO:0006642; P:GO:0007283; P:GO:0007346; F:GO:0008022; P:GO:0008340; P:GO:0009267; P:GO:0010046; P:GO:0010460; P:GO:0010667; P:GO:0010824; P:GO:0010875; P:GO:0010883; P:GO:0010976; P:GO:0014068; P:GO:0014858; P:GO:0016239; P:GO:0016567; C:GO:0016605; F:GO:0016922; P:GO:0030225; P:GO:0030308; C:GO:0030426; P:GO:0030512; P:GO:0031393; P:GO:0031648; P:GO:0032007; P:GO:0032071; P:GO:0032088; P:GO:0032720; P:GO:0032922; P:GO:0033210; C:GO:0033553; P:GO:0034391; P:GO:0034983; C:GO:0035098; P:GO:0035356; P:GO:0035358; P:GO:0035774; P:GO:0042311; F:GO:0042393; P:GO:0042595; P:GO:0042632; F:GO:0042802; P:GO:0043124; P:GO:0043161; P:GO:0043280; P:GO:0043392; F:GO:0043398; F:GO:0043422; F:GO:0043425; P:GO:0043518; P:GO:0043524; P:GO:0043536; P:GO:0045348; P:GO:0045599; P:GO:0045722; P:GO:0045739; P:GO:0045747; P:GO:0045766; P:GO:0045944; P:GO:0046331; P:GO:0046628; F:GO:0046969; P:GO:0048149; P:GO:0050872; F:GO:0051019; P:GO:0051097; P:GO:0051152; P:GO:0051574; P:GO:0051898; P:GO:0055089; P:GO:0060125; P:GO:0060766; P:GO:0060907; P:GO:0061051; P:GO:0070301; F:GO:0070403; P:GO:0070857; P:GO:0070914; P:GO:0070932; P:GO:0071236; P:GO:0071303; P:GO:0071356; P:GO:0071441; P:GO:0071456; P:GO:0071479; P:GO:0090312; P:GO:0090335; P:GO:0090400; P:GO:0106230; F:GO:0106231; P:GO:1900034; P:GO:1900113; P:GO:1900181; P:GO:1901416; P:GO:1902166; P:GO:1902176; P:GO:1902237; P:GO:1902617; P:GO:1903427; P:GO:1904179; P:GO:1904373; P:GO:1904638; P:GO:1904644; P:GO:1904646; P:GO:1904648; F:GO:1990254; P:GO:1990830; F:GO:1990841; P:GO:2000111; P:GO:2000253; P:GO:2000270; P:GO:2000480; P:GO:2000481; P:GO:2000614; P:GO:2000619; P:GO:2000655; P:GO:2000773; P:GO:2000774","P:single strand break repair; P:negative regulation of transcription by RNA polymerase II; P:rDNA heterochromatin assembly; P:pyrimidine dimer repair by nucleotide-excision repair; P:DNA synthesis involved in DNA repair; C:euchromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; P:ovulation from ovarian follicle; C:fibrillar center; P:positive regulation of endothelial cell proliferation; F:p53 binding; P:positive regulation of adaptive immune response; F:transcription coactivator activity; F:transcription corepressor activity; C:nuclear inner membrane; C:chromatin silencing complex; C:mitochondrion; C:cytosol; P:DNA methylation-dependent heterochromatin assembly; P:triglyceride mobilization; P:spermatogenesis; P:regulation of mitotic cell cycle; F:protein C-terminus binding; P:determination of adult lifespan; P:cellular response to starvation; P:response to mycotoxin; P:positive regulation of heart rate; P:negative regulation of cardiac muscle cell apoptotic process; P:regulation of centrosome duplication; P:positive regulation of cholesterol efflux; P:regulation of lipid storage; P:positive regulation of neuron projection development; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle cell proliferation; P:positive regulation of macroautophagy; P:protein ubiquitination; C:PML body; F:nuclear receptor binding; P:macrophage differentiation; P:negative regulation of cell growth; C:growth cone; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:negative regulation of prostaglandin biosynthetic process; P:protein destabilization; P:negative regulation of TOR signaling; P:regulation of endodeoxyribonuclease activity; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of tumor necrosis factor production; P:circadian regulation of gene expression; P:leptin-mediated signaling pathway; C:rDNA heterochromatin; P:regulation of smooth muscle cell apoptotic process; P:peptidyl-lysine deacetylation; C:ESC/E(Z) complex; P:cellular triglyceride homeostasis; P:regulation of peroxisome proliferator activated receptor signaling pathway; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:vasodilation; F:histone binding; P:behavioral response to starvation; P:cholesterol homeostasis; F:identical protein binding; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of DNA binding; F:HLH domain binding; F:protein kinase B binding; F:bHLH transcription factor binding; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; P:negative regulation of neuron apoptotic process; P:positive regulation of blood vessel endothelial cell migration; P:positive regulation of MHC class II biosynthetic process; P:negative regulation of fat cell differentiation; P:positive regulation of gluconeogenesis; P:positive regulation of DNA repair; P:positive regulation of Notch signaling pathway; P:positive regulation of angiogenesis; P:positive regulation of transcription by RNA polymerase II; P:lateral inhibition; P:positive regulation of insulin receptor signaling pathway; F:NAD-dependent histone deacetylase activity (H3-K9 specific); P:behavioral response to ethanol; P:white fat cell differentiation; F:mitogen-activated protein kinase binding; P:negative regulation of helicase activity; P:positive regulation of smooth muscle cell differentiation; P:positive regulation of histone H3-K9 methylation; P:negative regulation of protein kinase B signaling; P:fatty acid homeostasis; P:negative regulation of growth hormone secretion; P:negative regulation of androgen receptor signaling pathway; P:positive regulation of macrophage cytokine production; P:positive regulation of cell growth involved in cardiac muscle cell development; P:cellular response to hydrogen peroxide; F:NAD+ binding; P:regulation of bile acid biosynthetic process; P:UV-damage excision repair; P:histone H3 deacetylation; P:cellular response to antibiotic; P:cellular response to vitamin B3; P:cellular response to tumor necrosis factor; P:negative regulation of histone H3-K14 acetylation; P:cellular response to hypoxia; P:cellular response to ionizing radiation; P:positive regulation of protein deacetylation; P:regulation of brown fat cell differentiation; P:stress-induced premature senescence; P:protein depropionylation; F:protein-propionyllysine depropionylase activity; P:regulation of cellular response to heat; P:negative regulation of histone H3-K9 trimethylation; P:negative regulation of protein localization to nucleus; P:regulation of response to ethanol; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; P:response to fluoride; P:negative regulation of reactive oxygen species biosynthetic process; P:positive regulation of adipose tissue development; P:response to kainic acid; P:response to resveratrol; P:cellular response to curcumin; P:cellular response to amyloid-beta; P:cellular response to rotenone; F:keratin filament binding; P:cellular response to leukemia inhibitory factor; F:promoter-specific chromatin binding; P:positive regulation of macrophage apoptotic process; P:positive regulation of feeding behavior; P:negative regulation of fibroblast apoptotic process; P:negative regulation of cAMP-dependent protein kinase activity; P:positive regulation of cAMP-dependent protein kinase activity; P:positive regulation of thyroid-stimulating hormone secretion; P:negative regulation of histone H4-K16 acetylation; P:negative regulation of cellular response to testosterone stimulus; P:negative regulation of cellular senescence; P:positive regulation of cellular senescence","EC:3.5.1; EC:2.3; EC:3.5.1.98; EC:2; EC:3.5; EC:3; EC:2.3.1","Acting on carbon-nitrogen bonds, other than peptide bonds; Acyltransferases; Histone deacetylase; Transferases; Acting on carbon-nitrogen bonds, other than peptide bonds; Hydrolases; Acyltransferases","Coil (COILS); G3DSA:3.40.50.1220 (GENE3D); IPR026591 (G3DSA:3.30.1600.GENE3D); IPR003000 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR026590 (PROSITE_PROFILES); cd01408 (CDD); IPR029035 (SUPERFAMILY)","F:GO:0070403","F:NAD+ binding","GO:0046969",0.0231990754089256,1,1,1,"NAD-dependent histone deacetylase activity (H3-K9 specific)","MF",95,227,141,37,80,49,26,197,34,59,22,90,41,978,68.7266743645705,1.25819184374286,0.306334265403312,4.10725141076319,4.0039533665823e-05,0.0053234915275398,"CvsT2"
"609","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0051607",0.0103456307275163,0.999005857260926,3,19,"defense response to virus","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"610","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"611","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045590",0.0234487053760925,1,1,1,"negative regulation of regulatory T cell differentiation","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"612","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0051607",0.0103456307275163,0.999005857260926,3,19,"defense response to virus","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"613","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045590",0.0234487053760925,1,1,1,"negative regulation of regulatory T cell differentiation","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"614","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045590",0.0234487053760925,1,1,1,"negative regulation of regulatory T cell differentiation","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"615","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0034124",0.0234487053760925,1,1,1,"regulation of MyD88-dependent toll-like receptor signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"616","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0034124",0.0234487053760925,1,1,1,"regulation of MyD88-dependent toll-like receptor signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"617","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0034124",0.0234487053760925,1,1,1,"regulation of MyD88-dependent toll-like receptor signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"618","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"619","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0051607",0.0103456307275163,0.999005857260926,3,19,"defense response to virus","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"620","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"621","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0032728",0.00746608462180307,0.999788633063835,2,5,"positive regulation of interferon-beta production","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"622","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0032728",0.00746608462180307,0.999788633063835,2,5,"positive regulation of interferon-beta production","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"623","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0032728",0.00746608462180307,0.999788633063835,2,5,"positive regulation of interferon-beta production","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"624","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0060333",0.0234487053760925,1,1,1,"interferon-gamma-mediated signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"625","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0060333",0.0234487053760925,1,1,1,"interferon-gamma-mediated signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"626","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0060333",0.0234487053760925,1,1,1,"interferon-gamma-mediated signaling pathway","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.90771372881486,0.362800963525735,-5.25829289502299,1.45398811009973e-07,6.91868763337455e-05,"CvsT3"
"627","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"628","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.55740694807541,0.38772370767138,-4.01679576786522,5.89948089114437e-05,0.0108628384998645,"CvsT4"
"629","Acerv_evm.model.Segkk3209_pilon.7",314,1,"XP_029209711.1",4.4e-124,81.08,NA,NA,NA,NA,NA,5,"IRF2_CHICKInterferon regulatory factor 2 OS=Gallus gallus OX=9031 GN=IRF2 PE=2 SV=1",2.69e-28,80.33,18,"P:GO:0000122; C:GO:0000785; F:GO:0000978; F:GO:0001228; F:GO:0005515; C:GO:0005654; C:GO:0005829; C:GO:0005925; P:GO:0006915; P:GO:0008285; P:GO:0032728; P:GO:0034124; P:GO:0045590; P:GO:0045944; P:GO:0051607; P:GO:0051726; P:GO:0060333; P:GO:2000564","P:negative regulation of transcription by RNA polymerase II; C:chromatin; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:protein binding; C:nucleoplasm; C:cytosol; C:focal adhesion; P:apoptotic process; P:negative regulation of cell population proliferation; P:positive regulation of interferon-beta production; P:regulation of MyD88-dependent toll-like receptor signaling pathway; P:negative regulation of regulatory T cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:defense response to virus; P:regulation of cell cycle; P:interferon-gamma-mediated signaling pathway; P:regulation of CD8-positive, alpha-beta T cell proliferation",NA,NA,"IPR001346 (PRINTS); IPR001346 (SMART); IPR001346 (PFAM); IPR036388 (G3DSA:1.10.10.GENE3D); IPR001346 (PROSITE_PROFILES); IPR036390 (SUPERFAMILY)","F:GO:0000976","F:transcription cis-regulatory region binding","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",58,21,34,32,45,28,31,19,29,13,26,53,17,945,32.3507213606654,-1.75159610461603,0.364078911408928,-4.81103422836998,1.50151297783239e-06,0.000399269965664194,"CvsT2"
"630","Acerv_evm.model.Segkk3327_pilon.18",309,1,"XP_029187588.1",1.1e-172,89.54,NA,NA,NA,NA,NA,5,"NAGAB_CHICKAlpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1",1.06e-150,68.88,8,"F:GO:0004557; C:GO:0005737; F:GO:0008456; P:GO:0009311; P:GO:0016052; P:GO:0016139; F:GO:0042803; P:GO:0046477","F:alpha-galactosidase activity; C:cytoplasm; F:alpha-N-acetylgalactosaminidase activity; P:oligosaccharide metabolic process; P:carbohydrate catabolic process; P:glycoside catabolic process; F:protein homodimerization activity; P:glycosylceramide catabolic process","EC:3.2; EC:3; EC:3.2.1.22; EC:3.2.1; EC:3.2.1.49","Glycosylases; Hydrolases; Alpha-galactosidase; Glycosylases; Alpha-N-acetylgalactosaminidase","IPR002241 (PRINTS); IPR035373 (PFAM); IPR013780 (G3DSA:2.60.40.GENE3D); IPR002241 (PFAM); IPR013785 (G3DSA:3.20.20.GENE3D); IPR002241 (CDD); IPR017853 (SUPERFAMILY); SSF51011 (SUPERFAMILY)","F:GO:0003824; F:GO:0004553; P:GO:0005975","F:catalytic activity; F:hydrolase activity, hydrolyzing O-glycosyl compounds; P:carbohydrate metabolic process","GO:0046477",0.0444506458588097,0.999497094764091,1,2,"glycosylceramide catabolic process","BP",117,257,131,62,57,100,51,171,60,201,30,114,85,930,107.126578643125,1.71840811827634,0.465459286647518,3.69185483579716,0.000222624525749635,0.0354153502314148,"T1vsT2"
"631","Acerv_evm.model.Segkk3377_pilon.3",65,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"CPSF2_MOUSECleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1",0,74.08,7,"F:GO:0003723; F:GO:0005515; C:GO:0005654; C:GO:0005847; P:GO:0006378; P:GO:0006398; P:GO:0098789","F:RNA binding; F:protein binding; C:nucleoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; P:mRNA polyadenylation; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:pre-mRNA cleavage required for polyadenylation",NA,NA,"Coil (COILS); IPR022712 (SMART); IPR022712 (PFAM); IPR025069 (PFAM); IPR001279 (PFAM); IPR011108 (PFAM); IPR036866 (G3DSA:3.60.15.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR035639 (CDD); IPR036866 (SUPERFAMILY)",NA,NA,"GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",992,1267,1655,115,292,258,311,2214,258,244,71,197,92,197,440.330484410113,2.01562513737583,0.512075925288754,3.93618414347294,8.27874579827249e-05,0.0093560175952727,"CvsT2"
"632","Acerv_evm.model.Segkk3377_pilon.3",65,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"CPSF2_MOUSECleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1",0,74.08,7,"F:GO:0003723; F:GO:0005515; C:GO:0005654; C:GO:0005847; P:GO:0006378; P:GO:0006398; P:GO:0098789","F:RNA binding; F:protein binding; C:nucleoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; P:mRNA polyadenylation; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:pre-mRNA cleavage required for polyadenylation",NA,NA,"Coil (COILS); IPR022712 (SMART); IPR022712 (PFAM); IPR025069 (PFAM); IPR001279 (PFAM); IPR011108 (PFAM); IPR036866 (G3DSA:3.60.15.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR035639 (CDD); IPR036866 (SUPERFAMILY)",NA,NA,"GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",992,1267,1655,115,292,258,311,2214,258,244,71,197,92,197,440.330484410113,2.27360570926044,0.571128225951174,3.98090237174656,6.86541442851622e-05,0.0121197327706629,"CvsT4"
"633","Acerv_evm.model.Segkk3377_pilon.3",65,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"CPSF2_MOUSECleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1",0,74.08,7,"F:GO:0003723; F:GO:0005515; C:GO:0005654; C:GO:0005847; P:GO:0006378; P:GO:0006398; P:GO:0098789","F:RNA binding; F:protein binding; C:nucleoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; P:mRNA polyadenylation; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:pre-mRNA cleavage required for polyadenylation",NA,NA,"Coil (COILS); IPR022712 (SMART); IPR022712 (PFAM); IPR025069 (PFAM); IPR001279 (PFAM); IPR011108 (PFAM); IPR036866 (G3DSA:3.60.15.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR035639 (CDD); IPR036866 (SUPERFAMILY)",NA,NA,"GO:0006398",0.0343223895881153,1,1,1,"mRNA 3'-end processing by stem-loop binding and cleavage","BP",992,1267,1655,115,292,258,311,2214,258,244,71,197,92,197,440.330484410113,2.27360570926044,0.571128225951174,3.98090237174656,6.86541442851622e-05,0.0121197327706629,"CvsT4"
"634","Acerv_evm.model.Segkk3377_pilon.3",65,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"CPSF2_MOUSECleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1",0,74.08,7,"F:GO:0003723; F:GO:0005515; C:GO:0005654; C:GO:0005847; P:GO:0006378; P:GO:0006398; P:GO:0098789","F:RNA binding; F:protein binding; C:nucleoplasm; C:mRNA cleavage and polyadenylation specificity factor complex; P:mRNA polyadenylation; P:mRNA 3'-end processing by stem-loop binding and cleavage; P:pre-mRNA cleavage required for polyadenylation",NA,NA,"Coil (COILS); IPR022712 (SMART); IPR022712 (PFAM); IPR025069 (PFAM); IPR001279 (PFAM); IPR011108 (PFAM); IPR036866 (G3DSA:3.60.15.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR035639 (CDD); IPR036866 (SUPERFAMILY)",NA,NA,"GO:0006398",0.0343223895881153,1,1,1,"mRNA 3'-end processing by stem-loop binding and cleavage","BP",992,1267,1655,115,292,258,311,2214,258,244,71,197,92,197,440.330484410113,2.01562513737583,0.512075925288754,3.93618414347294,8.27874579827249e-05,0.0093560175952727,"CvsT2"
"635","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0070776",0.0438770150378614,0.999510136926687,1,2,"MOZ/MORF histone acetyltransferase complex","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"636","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0043972",0.0214146650641262,1,1,1,"histone H3-K23 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"637","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0070776",0.0438770150378614,0.999510136926687,1,2,"MOZ/MORF histone acetyltransferase complex","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"638","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0070776",0.0438770150378614,0.999510136926687,1,2,"MOZ/MORF histone acetyltransferase complex","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"639","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"640","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"641","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"642","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0000793",0.0145986544537164,0.999301284027216,2,8,"condensed chromosome","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"643","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0043972",0.0214146650641262,1,1,1,"histone H3-K23 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"644","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0043972",0.0214146650641262,1,1,1,"histone H3-K23 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"645","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0036359",0.0214146650641262,1,1,1,"renal potassium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"646","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0036359",0.0214146650641262,1,1,1,"renal potassium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"647","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0036359",0.0214146650641262,1,1,1,"renal potassium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"648","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0036359",0.0214146650641262,1,1,1,"renal potassium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"649","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035064",0.0491687102047344,0.994967071115346,2,15,"methylated histone binding","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"650","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035064",0.0491687102047344,0.994967071115346,2,15,"methylated histone binding","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"651","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035812",0.0214146650641262,1,1,1,"renal sodium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"652","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035812",0.0214146650641262,1,1,1,"renal sodium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"653","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035812",0.0214146650641262,1,1,1,"renal sodium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"654","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035812",0.0214146650641262,1,1,1,"renal sodium excretion","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"655","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0043972",0.0214146650641262,1,1,1,"histone H3-K23 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"656","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0010698",0.0214146650641262,1,1,1,"acetyltransferase activator activity","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"657","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"658","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"659","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"660","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"661","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0070776",0.0438770150378614,0.999510136926687,1,2,"MOZ/MORF histone acetyltransferase complex","CC",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"662","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0044154",0.0438770150378614,0.999510136926687,1,2,"histone H3-K14 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"663","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0044154",0.0438770150378614,0.999510136926687,1,2,"histone H3-K14 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"664","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035064",0.0491687102047344,0.994967071115346,2,15,"methylated histone binding","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"665","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035064",0.0491687102047344,0.994967071115346,2,15,"methylated histone binding","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"666","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0010698",0.0214146650641262,1,1,1,"acetyltransferase activator activity","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"667","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0010698",0.0214146650641262,1,1,1,"acetyltransferase activator activity","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"668","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0010698",0.0214146650641262,1,1,1,"acetyltransferase activator activity","MF",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"669","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035811",0.0214146650641262,1,1,1,"negative regulation of urine volume","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"670","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035811",0.0214146650641262,1,1,1,"negative regulation of urine volume","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"671","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035811",0.0214146650641262,1,1,1,"negative regulation of urine volume","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"672","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:2001161",0.0214146650641262,1,1,1,"negative regulation of histone H3-K79 methylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.21903368974746,0.397631609728434,-13.125298799338,2.35850657107763e-39,1.06616289545564e-35,"CvsT1"
"673","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0044154",0.0438770150378614,0.999510136926687,1,2,"histone H3-K14 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"674","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:2001161",0.0214146650641262,1,1,1,"negative regulation of histone H3-K79 methylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"675","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:2001161",0.0214146650641262,1,1,1,"negative regulation of histone H3-K79 methylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.36757671541,0.367063505779908,-14.6230192620358,2.00316192433335e-48,9.05529347894889e-45,"CvsT2"
"676","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0044154",0.0438770150378614,0.999510136926687,1,2,"histone H3-K14 acetylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"677","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:0035811",0.0214146650641262,1,1,1,"negative regulation of urine volume","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.66864598388488,0.393565824556362,-14.4032983307805,4.93318988769762e-47,2.23004848873371e-43,"CvsT4"
"678","Acerv_evm.model.Segkk3394_pilon.16",617,1,"XP_015753975.1",0,95.79,NA,NA,NA,NA,NA,5,"AF10_HUMANProtein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2",1.15e-107,78.53,18,"C:GO:0000793; F:GO:0003677; C:GO:0005829; C:GO:0005886; F:GO:0010698; P:GO:0010765; P:GO:0016246; F:GO:0031491; F:GO:0035064; P:GO:0035811; P:GO:0035812; P:GO:0036359; P:GO:0043972; P:GO:0044154; P:GO:0045944; F:GO:0046872; C:GO:0070776; P:GO:2001161","C:condensed chromosome; F:DNA binding; C:cytosol; C:plasma membrane; F:acetyltransferase activator activity; P:positive regulation of sodium ion transport; P:RNA interference; F:nucleosome binding; F:methylated histone binding; P:negative regulation of urine volume; P:renal sodium excretion; P:renal potassium excretion; P:histone H3-K23 acetylation; P:histone H3-K14 acetylation; P:positive regulation of transcription by RNA polymerase II; F:metal ion binding; C:MOZ/MORF histone acetyltransferase complex; P:negative regulation of histone H3-K79 methylation",NA,NA,"Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR013083 (G3DSA:3.30.40.GENE3D); PF13832 (PFAM); PF13831 (PFAM); IPR013083 (G3DSA:3.30.40.GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR019787 (PROSITE_PROFILES); IPR034732 (PROSITE_PROFILES); cd15672 (CDD); cd15574 (CDD); IPR011011 (SUPERFAMILY)",NA,NA,"GO:2001161",0.0214146650641262,1,1,1,"negative regulation of histone H3-K79 methylation","BP",311,28,12,288,513,246,188,6,152,155,186,521,123,1854,232.324672539613,-5.14601062654285,0.368281641584695,-13.9730305436889,2.27726371386063e-44,1.0294370618507e-40,"CvsT3"
"679","Acerv_evm.model.Segkk3395_pilon.4",1191,1,"XP_029206259.1",2.1e-09,87.5,NA,NA,NA,NA,NA,5,"TSN_MOUSETranslin OS=Mus musculus OX=10090 GN=Tsn PE=1 SV=1",2.09e-91,74.17,8,"F:GO:0003677; F:GO:0003729; F:GO:0004518; C:GO:0005654; C:GO:0005783; C:GO:0005829; P:GO:0006310; F:GO:0042802","F:DNA binding; F:mRNA binding; F:nuclease activity; C:nucleoplasm; C:endoplasmic reticulum; C:cytosol; P:DNA recombination; F:identical protein binding","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","IPR016069 (G3DSA:1.20.58.GENE3D); IPR016068 (G3DSA:1.20.58.GENE3D); IPR002848 (PFAM); IPR033956 (CDD); IPR036081 (SUPERFAMILY)","F:GO:0003697; F:GO:0003723; P:GO:0016070; F:GO:0043565","F:single-stranded DNA binding; F:RNA binding; P:RNA metabolic process; F:sequence-specific DNA binding","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",74,63,50,79,161,76,112,91,73,99,43,163,29,3576,87.0602308492711,-1.79762624052207,0.3893701946256,-4.61675358138439,3.8978965137107e-06,0.0013052178659429,"CvsT4"
"680","Acerv_evm.model.Segkk3395_pilon.4",1191,1,"XP_029206259.1",2.1e-09,87.5,NA,NA,NA,NA,NA,5,"TSN_MOUSETranslin OS=Mus musculus OX=10090 GN=Tsn PE=1 SV=1",2.09e-91,74.17,8,"F:GO:0003677; F:GO:0003729; F:GO:0004518; C:GO:0005654; C:GO:0005783; C:GO:0005829; P:GO:0006310; F:GO:0042802","F:DNA binding; F:mRNA binding; F:nuclease activity; C:nucleoplasm; C:endoplasmic reticulum; C:cytosol; P:DNA recombination; F:identical protein binding","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","IPR016069 (G3DSA:1.20.58.GENE3D); IPR016068 (G3DSA:1.20.58.GENE3D); IPR002848 (PFAM); IPR033956 (CDD); IPR036081 (SUPERFAMILY)","F:GO:0003697; F:GO:0003723; P:GO:0016070; F:GO:0043565","F:single-stranded DNA binding; F:RNA binding; P:RNA metabolic process; F:sequence-specific DNA binding","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",74,63,50,79,161,76,112,91,73,99,43,163,29,3576,87.0602308492711,-1.60423426896623,0.357217757129067,-4.49091411876985,7.09181442748492e-06,0.00149109521485793,"CvsT2"
"681","Acerv_evm.model.Segkk3395_pilon.4",1191,1,"XP_029206259.1",2.1e-09,87.5,NA,NA,NA,NA,NA,5,"TSN_MOUSETranslin OS=Mus musculus OX=10090 GN=Tsn PE=1 SV=1",2.09e-91,74.17,8,"F:GO:0003677; F:GO:0003729; F:GO:0004518; C:GO:0005654; C:GO:0005783; C:GO:0005829; P:GO:0006310; F:GO:0042802","F:DNA binding; F:mRNA binding; F:nuclease activity; C:nucleoplasm; C:endoplasmic reticulum; C:cytosol; P:DNA recombination; F:identical protein binding","EC:3.1; EC:3","Acting on ester bonds; Hydrolases","IPR016069 (G3DSA:1.20.58.GENE3D); IPR016068 (G3DSA:1.20.58.GENE3D); IPR002848 (PFAM); IPR033956 (CDD); IPR036081 (SUPERFAMILY)","F:GO:0003697; F:GO:0003723; P:GO:0016070; F:GO:0043565","F:single-stranded DNA binding; F:RNA binding; P:RNA metabolic process; F:sequence-specific DNA binding","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",74,63,50,79,161,76,112,91,73,99,43,163,29,3576,87.0602308492711,-1.84261873668471,0.396270742130755,-4.6498985183133,3.32098395746331e-06,0.00125104233164274,"CvsT1"
"682","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.27750297286288,0.669656668419502,-3.40100096104196,0.000671395917842947,0.0439861629943339,"CvsT2"
"683","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.43161074244555,0.668589700027745,-3.63692522087111,0.000275911989343991,0.0455815873666253,"CvsT3"
"684","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005381",0.0299491028669805,1,1,1,"iron ion transmembrane transporter activity","MF",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.27750297286288,0.669656668419502,-3.40100096104196,0.000671395917842947,0.0439861629943339,"CvsT2"
"685","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005381",0.0299491028669805,1,1,1,"iron ion transmembrane transporter activity","MF",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.51737087379388,0.712232307788823,-3.53448003729182,0.000408578297329322,0.049918329542627,"CvsT4"
"686","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.51737087379388,0.712232307788823,-3.53448003729182,0.000408578297329322,0.049918329542627,"CvsT4"
"687","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005381",0.0299491028669805,1,1,1,"iron ion transmembrane transporter activity","MF",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.43161074244555,0.668589700027745,-3.63692522087111,0.000275911989343991,0.0455815873666253,"CvsT3"
"688","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.87586561522411,0.723924944271256,-3.97260190850188,7.10918053227026e-05,0.0119026113318992,"CvsT1"
"689","Acerv_evm.model.Segkk3419_pilon.10",147,1,"XP_015764269.1",2.2e-65,99.25,NA,NA,NA,NA,NA,5,"S39AD_CHICKZinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1",1.35e-88,55.69,12,"F:GO:0005381; F:GO:0005506; F:GO:0005515; C:GO:0005783; C:GO:0005794; P:GO:0006826; P:GO:0006829; P:GO:0010312; C:GO:0016021; C:GO:0016323; P:GO:0060586; P:GO:0098662","F:iron ion transmembrane transporter activity; F:iron ion binding; F:protein binding; C:endoplasmic reticulum; C:Golgi apparatus; P:iron ion transport; P:zinc ion transport; P:detoxification of zinc ion; C:integral component of membrane; C:basolateral plasma membrane; P:multicellular organismal iron ion homeostasis; P:inorganic cation transmembrane transport","EC:7",NA,"IPR003689 (PFAM); mobidb-lite (MOBIDB_LITE)","C:GO:0016020; P:GO:0030001; F:GO:0046873; P:GO:0055085","C:membrane; P:metal ion transport; F:metal ion transmembrane transporter activity; P:transmembrane transport","GO:0005381",0.0299491028669805,1,1,1,"iron ion transmembrane transporter activity","MF",24,14,10,16,33,13,12,0,8,27,12,27,13,444,17.5759453097951,-2.87586561522411,0.723924944271256,-3.97260190850188,7.10918053227026e-05,0.0119026113318992,"CvsT1"
"690","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0005834",0.0223108908079585,1,1,1,"heterotrimeric G-protein complex","CC",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.43331787598888,0.3366521665906,-19.1096880235213,2.09718861480924e-81,1.89606822664903e-77,"CvsT4"
"691","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:1902624",0.0432303548629445,0.999524629430881,1,2,"positive regulation of neutrophil migration","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.43331787598888,0.3366521665906,-19.1096880235213,2.09718861480924e-81,1.89606822664903e-77,"CvsT4"
"692","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.31229011800149,0.317141513687842,-19.9037018036516,3.77956845189301e-88,3.41710783735647e-84,"CvsT2"
"693","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:1902624",0.0432303548629445,0.999524629430881,1,2,"positive regulation of neutrophil migration","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.57140927343474,0.316934901700728,-20.7342556410525,1.70065606168771e-95,1.53756314537186e-91,"CvsT3"
"694","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:1902624",0.0432303548629445,0.999524629430881,1,2,"positive regulation of neutrophil migration","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.31229011800149,0.317141513687842,-19.9037018036516,3.77956845189301e-88,3.41710783735647e-84,"CvsT2"
"695","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0005834",0.0223108908079585,1,1,1,"heterotrimeric G-protein complex","CC",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.50048591445517,0.338080461226406,-19.2276296916843,2.17337089471544e-82,1.96494462591223e-78,"CvsT1"
"696","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0040013",0.0223108908079585,1,1,1,"negative regulation of locomotion","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.57140927343474,0.316934901700728,-20.7342556410525,1.70065606168771e-95,1.53756314537186e-91,"CvsT3"
"697","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0040013",0.0223108908079585,1,1,1,"negative regulation of locomotion","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.50048591445517,0.338080461226406,-19.2276296916843,2.17337089471544e-82,1.96494462591223e-78,"CvsT1"
"698","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:1902624",0.0432303548629445,0.999524629430881,1,2,"positive regulation of neutrophil migration","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.50048591445517,0.338080461226406,-19.2276296916843,2.17337089471544e-82,1.96494462591223e-78,"CvsT1"
"699","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0005834",0.0223108908079585,1,1,1,"heterotrimeric G-protein complex","CC",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.57140927343474,0.316934901700728,-20.7342556410525,1.70065606168771e-95,1.53756314537186e-91,"CvsT3"
"700","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.57140927343474,0.316934901700728,-20.7342556410525,1.70065606168771e-95,1.53756314537186e-91,"CvsT3"
"701","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.50048591445517,0.338080461226406,-19.2276296916843,2.17337089471544e-82,1.96494462591223e-78,"CvsT1"
"702","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0040013",0.0223108908079585,1,1,1,"negative regulation of locomotion","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.43331787598888,0.3366521665906,-19.1096880235213,2.09718861480924e-81,1.89606822664903e-77,"CvsT4"
"703","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0005834",0.0223108908079585,1,1,1,"heterotrimeric G-protein complex","CC",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.31229011800149,0.317141513687842,-19.9037018036516,3.77956845189301e-88,3.41710783735647e-84,"CvsT2"
"704","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0040013",0.0223108908079585,1,1,1,"negative regulation of locomotion","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.31229011800149,0.317141513687842,-19.9037018036516,3.77956845189301e-88,3.41710783735647e-84,"CvsT2"
"705","Acerv_evm.model.Segkk3422_pilon.23",376,1,"XP_015753792.1",4.5e-216,100,NA,NA,NA,NA,NA,5,"GBB1_DANREGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1",0,89.03,12,"P:GO:0000132; F:GO:0005516; C:GO:0005737; C:GO:0005834; P:GO:0007186; P:GO:0009792; F:GO:0030159; P:GO:0040013; P:GO:0046662; P:GO:0048920; P:GO:0051301; P:GO:1902624","P:establishment of mitotic spindle orientation; F:calmodulin binding; C:cytoplasm; C:heterotrimeric G-protein complex; P:G protein-coupled receptor signaling pathway; P:embryo development ending in birth or egg hatching; F:signaling receptor complex adaptor activity; P:negative regulation of locomotion; P:regulation of oviposition; P:posterior lateral line neuromast primordium migration; P:cell division; P:positive regulation of neutrophil migration",NA,NA,"Coil (COILS); IPR001632 (PRINTS); IPR020472 (PRINTS); IPR001680 (SMART); PIRSF002394 (PIRSF); IPR001680 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR019775 (PROSITE_PATTERNS); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR017986 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); IPR001680 (PROSITE_PROFILES); cd00200 (CDD); IPR036322 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0009792",0.0293889329909476,0.99779076867125,2,12,"embryo development ending in birth or egg hatching","BP",799,15,8,471,680,524,537,22,402,449,304,1079,353,1131,501.414761403948,-6.43331787598888,0.3366521665906,-19.1096880235213,2.09718861480924e-81,1.89606822664903e-77,"CvsT4"
"706","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050731",0.0156051601582592,0.999226306257086,2,8,"positive regulation of peptidyl-tyrosine phosphorylation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"707","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"708","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050731",0.0156051601582592,0.999226306257086,2,8,"positive regulation of peptidyl-tyrosine phosphorylation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"709","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071639",0.0423863760111512,0.99954320956549,1,2,"positive regulation of monocyte chemotactic protein-1 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"710","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:2000110",0.0214089201446791,1,1,1,"negative regulation of macrophage apoptotic process","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"711","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006954",0.045397274700207,0.991960755408372,3,34,"inflammatory response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"712","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006965",0.0214089201446791,1,1,1,"positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"713","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"714","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006965",0.0214089201446791,1,1,1,"positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"715","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071639",0.0423863760111512,0.99954320956549,1,2,"positive regulation of monocyte chemotactic protein-1 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"716","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032701",0.0214089201446791,1,1,1,"negative regulation of interleukin-18 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"717","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0043330",0.00343041765546804,0.999944011394379,2,4,"response to exogenous dsRNA","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"718","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032500",0.0214089201446791,1,1,1,"muramyl dipeptide binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"719","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032500",0.0214089201446791,1,1,1,"muramyl dipeptide binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"720","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:2000110",0.0214089201446791,1,1,1,"negative regulation of macrophage apoptotic process","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"721","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0045087",0.0477206217885634,0.991366612507763,3,35,"innate immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"722","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0045087",0.0477206217885634,0.991366612507763,3,35,"innate immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"723","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006954",0.045397274700207,0.991960755408372,3,34,"inflammatory response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"724","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002830",0.0214089201446791,1,1,1,"positive regulation of type 2 immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"725","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0031398",0.0366095586990858,0.996865760844341,2,13,"positive regulation of protein ubiquitination","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"726","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0070431",0.0214089201446791,1,1,1,"nucleotide-binding oligomerization domain containing 2 signaling pathway","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"727","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0070431",0.0214089201446791,1,1,1,"nucleotide-binding oligomerization domain containing 2 signaling pathway","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"728","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0042834",0.0214089201446791,1,1,1,"peptidoglycan binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"729","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0016045",0.0214089201446791,1,1,1,"detection of bacterium","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"730","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0043330",0.00343041765546804,0.999944011394379,2,4,"response to exogenous dsRNA","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"731","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0010951",0.00318712881833351,0.99994991757276,2,4,"negative regulation of endopeptidase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"732","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032740",0.0214089201446791,1,1,1,"positive regulation of interleukin-17 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"733","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032740",0.0214089201446791,1,1,1,"positive regulation of interleukin-17 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"734","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002606",0.0214089201446791,1,1,1,"positive regulation of dendritic cell antigen processing and presentation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"735","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002606",0.0214089201446791,1,1,1,"positive regulation of dendritic cell antigen processing and presentation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"736","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002830",0.0214089201446791,1,1,1,"positive regulation of type 2 immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"737","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"738","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032498",0.0214089201446791,1,1,1,"detection of muramyl dipeptide","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"739","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032498",0.0214089201446791,1,1,1,"detection of muramyl dipeptide","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"740","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:1905246",0.0214089201446791,1,1,1,"negative regulation of aspartic-type peptidase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"741","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:1905246",0.0214089201446791,1,1,1,"negative regulation of aspartic-type peptidase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"742","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0042834",0.0214089201446791,1,1,1,"peptidoglycan binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"743","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0010951",0.00318712881833351,0.99994991757276,2,4,"negative regulation of endopeptidase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"744","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"745","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002253",0.047518818356573,0.99942435510003,1,2,"activation of immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"746","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002253",0.047518818356573,0.99942435510003,1,2,"activation of immune response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"747","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:2000363",0.0214089201446791,1,1,1,"positive regulation of prostaglandin-E synthase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"748","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:2000363",0.0214089201446791,1,1,1,"positive regulation of prostaglandin-E synthase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"749","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"750","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050679",0.0403604788707613,0.99632201577817,2,14,"positive regulation of epithelial cell proliferation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"751","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0090022",0.0214089201446791,1,1,1,"regulation of neutrophil chemotaxis","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"752","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0090022",0.0214089201446791,1,1,1,"regulation of neutrophil chemotaxis","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"753","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032701",0.0214089201446791,1,1,1,"negative regulation of interleukin-18 production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"754","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002925",0.0214089201446791,1,1,1,"positive regulation of humoral immune response mediated by circulating immunoglobulin","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"755","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0016045",0.0214089201446791,1,1,1,"detection of bacterium","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"756","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006915",0.0326768522250439,0.994962807215015,3,29,"apoptotic process","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"757","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0051879",0.0396283256766858,0.996424662695642,2,14,"Hsp90 protein binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"758","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0043552",0.0423619239645238,0.999543742233349,1,2,"positive regulation of phosphatidylinositol 3-kinase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"759","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0043552",0.0423619239645238,0.999543742233349,1,2,"positive regulation of phosphatidylinositol 3-kinase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"760","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071224",0.0214089201446791,1,1,1,"cellular response to peptidoglycan","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"761","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071224",0.0214089201446791,1,1,1,"cellular response to peptidoglycan","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"762","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050679",0.0403604788707613,0.99632201577817,2,14,"positive regulation of epithelial cell proliferation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"763","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002227",0.0214089201446791,1,1,1,"innate immune response in mucosa","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"764","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0031398",0.0366095586990858,0.996865760844341,2,13,"positive regulation of protein ubiquitination","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"765","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0030277",0.0423628399092541,0.999543722285967,1,2,"maintenance of gastrointestinal epithelium","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"766","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0030277",0.0423628399092541,0.999543722285967,1,2,"maintenance of gastrointestinal epithelium","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"767","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002732",0.0214089201446791,1,1,1,"positive regulation of dendritic cell cytokine production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"768","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002732",0.0214089201446791,1,1,1,"positive regulation of dendritic cell cytokine production","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"769","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071225",0.0214089201446791,1,1,1,"cellular response to muramyl dipeptide","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"770","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0030544",0.00186451154599067,0.999912263942145,3,11,"Hsp70 protein binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"771","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0051879",0.0396283256766858,0.996424662695642,2,14,"Hsp90 protein binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"772","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006952",0.034325644656632,0.997162377795806,2,13,"defense response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"773","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0006952",0.034325644656632,0.997162377795806,2,13,"defense response","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"774","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0060585",0.0214089201446791,1,1,1,"positive regulation of prostaglandin-endoperoxide synthase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"775","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0019966",0.0214089201446791,1,1,1,"interleukin-1 binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"776","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0019966",0.0214089201446791,1,1,1,"interleukin-1 binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"777","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0010955",0.042535073510181,0.999539963473382,1,2,"negative regulation of protein processing","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"778","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0010955",0.042535073510181,0.999539963473382,1,2,"negative regulation of protein processing","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"779","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050871",0.0423738382341399,0.999543482730392,1,2,"positive regulation of B cell activation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"780","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050871",0.0423738382341399,0.999543482730392,1,2,"positive regulation of B cell activation","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"781","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071225",0.0214089201446791,1,1,1,"cellular response to muramyl dipeptide","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"782","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002925",0.0214089201446791,1,1,1,"positive regulation of humoral immune response mediated by circulating immunoglobulin","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"783","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050700",0.0214089201446791,1,1,1,"CARD domain binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"784","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0089720",0.042535073510181,0.999539963473382,1,2,"caspase binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"785","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0089720",0.042535073510181,0.999539963473382,1,2,"caspase binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"786","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0050700",0.0214089201446791,1,1,1,"CARD domain binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"787","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"788","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0060585",0.0214089201446791,1,1,1,"positive regulation of prostaglandin-endoperoxide synthase activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"789","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0002227",0.0214089201446791,1,1,1,"innate immune response in mucosa","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"790","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:1902523",0.0443812035900513,0.999498682940667,1,2,"positive regulation of protein K63-linked ubiquitination","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"791","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:1902523",0.0443812035900513,0.999498682940667,1,2,"positive regulation of protein K63-linked ubiquitination","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"792","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"793","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071347",0.0333645161209214,0.997283981097769,2,13,"cellular response to interleukin-1","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"794","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0030544",0.00186451154599067,0.999912263942145,3,11,"Hsp70 protein binding","MF",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.87286817257862,0.230211512875559,-3.79159218266572,0.000149684568296631,0.0148714085930752,"CvsT2"
"795","Acerv_evm.model.Segkk3450_pilon.3",753,1,"XP_029212513.1",0,89.64,NA,NA,NA,NA,NA,4,"NLRC4_XENTRNLR family CARD domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=nlrc4 PE=2 SV=2",1.48e-11,41.33,115,"F:GO:0000166; P:GO:0002221; P:GO:0002227; P:GO:0002253; P:GO:0002376; P:GO:0002606; P:GO:0002710; P:GO:0002720; P:GO:0002732; P:GO:0002830; P:GO:0002862; P:GO:0002925; F:GO:0003779; F:GO:0005515; F:GO:0005524; C:GO:0005575; C:GO:0005737; C:GO:0005794; C:GO:0005829; C:GO:0005856; C:GO:0005886; P:GO:0006915; P:GO:0006952; P:GO:0006954; P:GO:0006963; P:GO:0006965; P:GO:0007165; P:GO:0007584; P:GO:0008284; P:GO:0009595; C:GO:0009986; P:GO:0010951; P:GO:0010955; C:GO:0016020; P:GO:0016045; C:GO:0016323; F:GO:0019828; F:GO:0019899; F:GO:0019901; F:GO:0019966; P:GO:0030277; F:GO:0030544; P:GO:0031398; C:GO:0031982; P:GO:0032088; P:GO:0032494; P:GO:0032495; P:GO:0032496; P:GO:0032498; F:GO:0032500; P:GO:0032689; P:GO:0032691; P:GO:0032695; P:GO:0032701; P:GO:0032703; P:GO:0032720; P:GO:0032731; P:GO:0032733; P:GO:0032735; P:GO:0032740; P:GO:0032755; P:GO:0032757; P:GO:0032760; P:GO:0032874; C:GO:0032991; P:GO:0034136; P:GO:0035556; F:GO:0038187; P:GO:0042742; F:GO:0042802; F:GO:0042834; P:GO:0042981; P:GO:0043123; P:GO:0043330; P:GO:0043406; P:GO:0043410; P:GO:0043552; F:GO:0044877; P:GO:0045087; P:GO:0045089; C:GO:0045335; P:GO:0045747; P:GO:0045944; P:GO:0046330; C:GO:0046658; P:GO:0050679; F:GO:0050700; P:GO:0050727; P:GO:0050731; P:GO:0050766; P:GO:0050830; P:GO:0050871; P:GO:0051092; P:GO:0051353; P:GO:0051770; F:GO:0051879; P:GO:0060585; P:GO:0070374; P:GO:0070431; P:GO:0071222; P:GO:0071224; P:GO:0071225; P:GO:0071347; P:GO:0071407; P:GO:0071639; F:GO:0089720; P:GO:0090022; P:GO:1900016; P:GO:1900017; P:GO:1901224; P:GO:1902523; P:GO:1904417; P:GO:1905246; P:GO:2000110; P:GO:2000363","F:nucleotide binding; P:pattern recognition receptor signaling pathway; P:innate immune response in mucosa; P:activation of immune response; P:immune system process; P:positive regulation of dendritic cell antigen processing and presentation; P:negative regulation of T cell mediated immunity; P:positive regulation of cytokine production involved in immune response; P:positive regulation of dendritic cell cytokine production; P:positive regulation of type 2 immune response; P:negative regulation of inflammatory response to antigenic stimulus; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; F:actin binding; F:protein binding; F:ATP binding; C:cellular_component; C:cytoplasm; C:Golgi apparatus; C:cytosol; C:cytoskeleton; C:plasma membrane; P:apoptotic process; P:defense response; P:inflammatory response; P:positive regulation of antibacterial peptide biosynthetic process; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; P:signal transduction; P:response to nutrient; P:positive regulation of cell population proliferation; P:detection of biotic stimulus; C:cell surface; P:negative regulation of endopeptidase activity; P:negative regulation of protein processing; C:membrane; P:detection of bacterium; C:basolateral plasma membrane; F:aspartic-type endopeptidase inhibitor activity; F:enzyme binding; F:protein kinase binding; F:interleukin-1 binding; P:maintenance of gastrointestinal epithelium; F:Hsp70 protein binding; P:positive regulation of protein ubiquitination; C:vesicle; P:negative regulation of NF-kappaB transcription factor activity; P:response to peptidoglycan; P:response to muramyl dipeptide; P:response to lipopolysaccharide; P:detection of muramyl dipeptide; F:muramyl dipeptide binding; P:negative regulation of interferon-gamma production; P:negative regulation of interleukin-1 beta production; P:negative regulation of interleukin-12 production; P:negative regulation of interleukin-18 production; P:negative regulation of interleukin-2 production; P:negative regulation of tumor necrosis factor production; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-12 production; P:positive regulation of interleukin-17 production; P:positive regulation of interleukin-6 production; P:positive regulation of interleukin-8 production; P:positive regulation of tumor necrosis factor production; P:positive regulation of stress-activated MAPK cascade; C:protein-containing complex; P:negative regulation of toll-like receptor 2 signaling pathway; P:intracellular signal transduction; F:pattern recognition receptor activity; P:defense response to bacterium; F:identical protein binding; F:peptidoglycan binding; P:regulation of apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:response to exogenous dsRNA; P:positive regulation of MAP kinase activity; P:positive regulation of MAPK cascade; P:positive regulation of phosphatidylinositol 3-kinase activity; F:protein-containing complex binding; P:innate immune response; P:positive regulation of innate immune response; C:phagocytic vesicle; P:positive regulation of Notch signaling pathway; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of JNK cascade; C:anchored component of plasma membrane; P:positive regulation of epithelial cell proliferation; F:CARD domain binding; P:regulation of inflammatory response; P:positive regulation of peptidyl-tyrosine phosphorylation; P:positive regulation of phagocytosis; P:defense response to Gram-positive bacterium; P:positive regulation of B cell activation; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of oxidoreductase activity; P:positive regulation of nitric-oxide synthase biosynthetic process; F:Hsp90 protein binding; P:positive regulation of prostaglandin-endoperoxide synthase activity; P:positive regulation of ERK1 and ERK2 cascade; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:cellular response to lipopolysaccharide; P:cellular response to peptidoglycan; P:cellular response to muramyl dipeptide; P:cellular response to interleukin-1; P:cellular response to organic cyclic compound; P:positive regulation of monocyte chemotactic protein-1 production; F:caspase binding; P:regulation of neutrophil chemotaxis; P:negative regulation of cytokine production involved in inflammatory response; P:positive regulation of cytokine production involved in inflammatory response; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of protein K63-linked ubiquitination; P:positive regulation of xenophagy; P:negative regulation of aspartic-type peptidase activity; P:negative regulation of macrophage apoptotic process; P:positive regulation of prostaglandin-E synthase activity",NA,NA,"Coil (COILS); G3DSA:3.40.50.300 (GENE3D); IPR007111 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR007111 (PROSITE_PROFILES); IPR027417 (SUPERFAMILY); SSF52047 (SUPERFAMILY)",NA,NA,"GO:0071347",0.0333645161209214,0.997283981097769,2,13,"cellular response to interleukin-1","BP",604,740,852,488,996,368,608,542,226,215,325,838,213,2262,494.415251175838,-0.938500769403817,0.255382348673094,-3.67488502741103,0.000237956546087641,0.0325964414117934,"CvsT4"
"796","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010305",0.030716833111339,1,1,1,"leaf vascular tissue pattern formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"797","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048443",0.030716833111339,1,1,1,"stamen development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"798","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010305",0.030716833111339,1,1,1,"leaf vascular tissue pattern formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"799","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048440",0.030716833111339,1,1,1,"carpel development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"800","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010082",0.030716833111339,1,1,1,"regulation of root meristem growth","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"801","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0009933",0.030716833111339,1,1,1,"meristem structural organization","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"802","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0009933",0.030716833111339,1,1,1,"meristem structural organization","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"803","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010082",0.030716833111339,1,1,1,"regulation of root meristem growth","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"804","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0000398",0.0349575951395509,0.994443688270107,3,31,"mRNA splicing, via spliceosome","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"805","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048443",0.030716833111339,1,1,1,"stamen development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"806","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010338",0.030716833111339,1,1,1,"leaf formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"807","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048453",0.030716833111339,1,1,1,"sepal formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"808","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0000412",0.030716833111339,1,1,1,"histone peptidyl-prolyl isomerization","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"809","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048440",0.030716833111339,1,1,1,"carpel development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"810","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010358",0.030716833111339,1,1,1,"leaf shaping","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"811","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010358",0.030716833111339,1,1,1,"leaf shaping","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"812","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0010338",0.030716833111339,1,1,1,"leaf formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"813","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0000412",0.030716833111339,1,1,1,"histone peptidyl-prolyl isomerization","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"814","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0009909",0.030716833111339,1,1,1,"regulation of flower development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.32569382499383,0.346001737258783,3.83146580562489,0.000127382080280642,0.0199912588510795,"CvsT4"
"815","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0009909",0.030716833111339,1,1,1,"regulation of flower development","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"816","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0048453",0.030716833111339,1,1,1,"sepal formation","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"817","Acerv_evm.model.Segkk3453_pilon.14",132,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PPWD1_HUMANPeptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=PPWD1 PE=1 SV=1",0,78.42,18,"P:GO:0000398; P:GO:0000412; F:GO:0003682; F:GO:0003755; P:GO:0009909; P:GO:0009933; P:GO:0010082; P:GO:0010305; P:GO:0010338; P:GO:0010358; F:GO:0016018; C:GO:0016604; F:GO:0042393; P:GO:0048440; P:GO:0048443; P:GO:0048453; P:GO:0061087; C:GO:0071013","P:mRNA splicing, via spliceosome; P:histone peptidyl-prolyl isomerization; F:chromatin binding; F:peptidyl-prolyl cis-trans isomerase activity; P:regulation of flower development; P:meristem structural organization; P:regulation of root meristem growth; P:leaf vascular tissue pattern formation; P:leaf formation; P:leaf shaping; F:cyclosporin A binding; C:nuclear body; F:histone binding; P:carpel development; P:stamen development; P:sepal formation; P:positive regulation of histone H3-K27 methylation; C:catalytic step 2 spliceosome","EC:5.2.1.8; EC:5.2; EC:5","Peptidylprolyl isomerase; Cis-trans-isomerases; Isomerases","IPR002130 (PRINTS); IPR001680 (SMART); IPR029000 (G3DSA:2.40.100.GENE3D); IPR002130 (PFAM); IPR015943 (G3DSA:2.130.10.GENE3D); IPR015943 (G3DSA:2.130.10.GENE3D); IPR001680 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR017986 (PROSITE_PROFILES); IPR002130 (PROSITE_PROFILES); cd01927 (CDD); IPR029000 (SUPERFAMILY); IPR036322 (SUPERFAMILY)","P:GO:0000413; F:GO:0003755; F:GO:0005515","P:protein peptidyl-prolyl isomerization; F:peptidyl-prolyl cis-trans isomerase activity; F:protein binding","GO:0000398",0.0349575951395509,0.994443688270107,3,31,"mRNA splicing, via spliceosome","BP",96,226,210,37,74,46,34,187,28,35,17,38,26,399,61.4597688273756,1.3733366820236,0.32565277056597,4.21718101656806,2.4737539131828e-05,0.00379071341170944,"CvsT2"
"818","Acerv_evm.model.Segkk3463_pilon.1",363,1,"XP_029207859.1",1e-148,82.87,NA,NA,NA,NA,NA,5,"PEA15_RATAstrocytic phosphoprotein PEA-15 OS=Rattus norvegicus OX=10116 GN=Pea15 PE=1 SV=1",1.73e-11,64.26,8,"F:GO:0005080; C:GO:0005654; C:GO:0005829; P:GO:0035556; P:GO:0043278; P:GO:0046325; P:GO:1902042; P:GO:1902043","F:protein kinase C binding; C:nucleoplasm; C:cytosol; P:intracellular signal transduction; P:response to morphine; P:negative regulation of glucose import; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors",NA,NA,"IPR001875 (SMART); IPR001875 (PFAM); G3DSA:1.10.533.10 (GENE3D); IPR001875 (PROSITE_PROFILES); cd00045 (CDD); IPR011029 (SUPERFAMILY)","F:GO:0005515; P:GO:0042981","F:protein binding; P:regulation of apoptotic process","GO:1902043",0.00215665836141749,0.99998032964564,2,3,"positive regulation of extrinsic apoptotic signaling pathway via death domain receptors","BP",235,525,305,212,363,132,268,316,119,64,152,304,78,1090,209.564895965638,-1.08472132845127,0.301782249982671,-3.59438412469109,0.00032515981758991,0.0433991410550897,"T1vsT2"
"819","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.52539503522904,0.45232449586878,-5.58314895234341,2.36202279446928e-08,1.25617929910569e-05,"CvsT2"
"820","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.55061998035237,0.453977427309738,-5.61838502735101,1.92750590196495e-08,1.025092991745e-05,"CvsT3"
"821","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.52539503522904,0.45232449586878,-5.58314895234341,2.36202279446928e-08,1.25617929910569e-05,"CvsT2"
"822","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.52539503522904,0.45232449586878,-5.58314895234341,2.36202279446928e-08,1.25617929910569e-05,"CvsT2"
"823","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.56554899533705,0.478819718500902,-5.35806880169705,8.41162101728407e-08,4.75309160107908e-05,"CvsT4"
"824","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.55061998035237,0.453977427309738,-5.61838502735101,1.92750590196495e-08,1.025092991745e-05,"CvsT3"
"825","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.72603434565656,0.493419551096705,-5.52477975304689,3.29899190698961e-08,1.65701032394962e-05,"CvsT1"
"826","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.72603434565656,0.493419551096705,-5.52477975304689,3.29899190698961e-08,1.65701032394962e-05,"CvsT1"
"827","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0043204",0.0255005360526249,0.996445518385473,3,27,"perikaryon","CC",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.56554899533705,0.478819718500902,-5.35806880169705,8.41162101728407e-08,4.75309160107908e-05,"CvsT4"
"828","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.56554899533705,0.478819718500902,-5.35806880169705,8.41162101728407e-08,4.75309160107908e-05,"CvsT4"
"829","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.72603434565656,0.493419551096705,-5.52477975304689,3.29899190698961e-08,1.65701032394962e-05,"CvsT1"
"830","Acerv_evm.model.Segkk3525_pilon.1",956,1,"XP_015778593.1",2.5e-223,91.88,NA,NA,NA,NA,NA,1,"CPLX2_NARJAComplexin-2 OS=Narke japonica OX=62965 PE=1 SV=1",4.64e-06,55.7,11,"C:GO:0005634; C:GO:0005737; C:GO:0005829; P:GO:0006836; P:GO:0006887; F:GO:0019905; C:GO:0030054; C:GO:0042995; C:GO:0043204; C:GO:0045202; C:GO:0098793","C:nucleus; C:cytoplasm; C:cytosol; P:neurotransmitter transport; P:exocytosis; F:syntaxin binding; C:cell junction; C:cell projection; C:perikaryon; C:synapse; C:presynapse",NA,NA,"Coil (COILS); IPR008849 (PFAM); G3DSA:1.20.5.580 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); SSF58038 (SUPERFAMILY)","P:GO:0006836; F:GO:0019905","P:neurotransmitter transport; F:syntaxin binding","GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",48,19,11,27,58,21,24,9,28,39,27,45,10,2871,30.4771373417541,-2.55061998035237,0.453977427309738,-5.61838502735101,1.92750590196495e-08,1.025092991745e-05,"CvsT3"
"831","Acerv_evm.model.Segkk3540_pilon.3",244,1,"XP_029198520.1",2.6e-108,78.75,NA,NA,NA,NA,NA,5,"MOD5_HUMANtRNA dimethylallyltransferase OS=Homo sapiens OX=9606 GN=TRIT1 PE=1 SV=1",3.96e-48,71.7,7,"F:GO:0003676; F:GO:0005515; F:GO:0005524; C:GO:0005759; F:GO:0008270; F:GO:0052381; P:GO:0070900","F:nucleic acid binding; F:protein binding; F:ATP binding; C:mitochondrial matrix; F:zinc ion binding; F:tRNA dimethylallyltransferase activity; P:mitochondrial tRNA modification","EC:2.5.1; EC:2; EC:2.5.1.75","Transferring alkyl or aryl groups, other than methyl groups; Transferases; tRNA dimethylallyltransferase","G3DSA:3.40.50.300 (GENE3D); PF01715 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR027417 (SUPERFAMILY)",NA,NA,"GO:0070900",0.0256003117474283,1,1,1,"mitochondrial tRNA modification","BP",13,31,22,16,20,21,189,35,14,28,30,37,10,735,38.7027136382568,-2.76346370727362,0.689335285226612,-4.00888184095373,6.10069307588636e-05,0.00755566658891625,"CvsT2"
"832","Acerv_evm.model.Segkk3540_pilon.3",244,1,"XP_029198520.1",2.6e-108,78.75,NA,NA,NA,NA,NA,5,"MOD5_HUMANtRNA dimethylallyltransferase OS=Homo sapiens OX=9606 GN=TRIT1 PE=1 SV=1",3.96e-48,71.7,7,"F:GO:0003676; F:GO:0005515; F:GO:0005524; C:GO:0005759; F:GO:0008270; F:GO:0052381; P:GO:0070900","F:nucleic acid binding; F:protein binding; F:ATP binding; C:mitochondrial matrix; F:zinc ion binding; F:tRNA dimethylallyltransferase activity; P:mitochondrial tRNA modification","EC:2.5.1; EC:2; EC:2.5.1.75","Transferring alkyl or aryl groups, other than methyl groups; Transferases; tRNA dimethylallyltransferase","G3DSA:3.40.50.300 (GENE3D); PF01715 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR027417 (SUPERFAMILY)",NA,NA,"GO:0052381",0.0256003117474283,1,1,1,"tRNA dimethylallyltransferase activity","MF",13,31,22,16,20,21,189,35,14,28,30,37,10,735,38.7027136382568,-2.76346370727362,0.689335285226612,-4.00888184095373,6.10069307588636e-05,0.00755566658891625,"CvsT2"
"833","Acerv_evm.model.Segkk3644_pilon.3",198,1,"XP_029184336.1",2.1e-71,82.67,NA,NA,NA,NA,NA,5,"CXXC1_BOVINCXXC-type zinc finger protein 1 OS=Bos taurus OX=9913 GN=CXXC1 PE=2 SV=1",1.06e-102,67.55,11,"F:GO:0000987; C:GO:0005829; C:GO:0016363; C:GO:0016607; F:GO:0035064; F:GO:0042800; F:GO:0045322; P:GO:0045893; F:GO:0046872; C:GO:0048188; P:GO:0051568","F:cis-regulatory region sequence-specific DNA binding; C:cytosol; C:nuclear matrix; C:nuclear speck; F:methylated histone binding; F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; P:positive regulation of transcription, DNA-templated; F:metal ion binding; C:Set1C/COMPASS complex; P:histone H3-K4 methylation","EC:2.1; EC:2; EC:2.1.1.354; EC:2.1.1","Transferring one-carbon groups; Transferases; n/a; Transferring one-carbon groups","Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR019787 (PFAM); G3DSA:2.60.120.650 (GENE3D); IPR022056 (PFAM); IPR002857 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR002857 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY)","F:GO:0003677; F:GO:0008270","F:DNA binding; F:zinc ion binding","GO:0045322",0.0483501374213227,0.99940377939282,1,2,"unmethylated CpG binding","MF",1743,4054,3172,1633,2691,1169,1963,2838,903,868,1078,3174,680,597,1745.34052803933,-0.580406605011431,0.164869482512029,-3.52040047780876,0.000430895663261507,0.0498276784087269,"T1vsT2"
"834","Acerv_evm.model.Segkk3644_pilon.3",198,1,"XP_029184336.1",2.1e-71,82.67,NA,NA,NA,NA,NA,5,"CXXC1_BOVINCXXC-type zinc finger protein 1 OS=Bos taurus OX=9913 GN=CXXC1 PE=2 SV=1",1.06e-102,67.55,11,"F:GO:0000987; C:GO:0005829; C:GO:0016363; C:GO:0016607; F:GO:0035064; F:GO:0042800; F:GO:0045322; P:GO:0045893; F:GO:0046872; C:GO:0048188; P:GO:0051568","F:cis-regulatory region sequence-specific DNA binding; C:cytosol; C:nuclear matrix; C:nuclear speck; F:methylated histone binding; F:histone methyltransferase activity (H3-K4 specific); F:unmethylated CpG binding; P:positive regulation of transcription, DNA-templated; F:metal ion binding; C:Set1C/COMPASS complex; P:histone H3-K4 methylation","EC:2.1; EC:2; EC:2.1.1.354; EC:2.1.1","Transferring one-carbon groups; Transferases; n/a; Transferring one-carbon groups","Coil (COILS); Coil (COILS); IPR001965 (SMART); IPR019787 (PFAM); G3DSA:2.60.120.650 (GENE3D); IPR022056 (PFAM); IPR002857 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR019786 (PROSITE_PATTERNS); IPR002857 (PROSITE_PROFILES); IPR019787 (PROSITE_PROFILES); IPR011011 (SUPERFAMILY)","F:GO:0003677; F:GO:0008270","F:DNA binding; F:zinc ion binding","GO:0035064",0.0491687102047344,0.994967071115346,2,15,"methylated histone binding","MF",1743,4054,3172,1633,2691,1169,1963,2838,903,868,1078,3174,680,597,1745.34052803933,-0.580406605011431,0.164869482512029,-3.52040047780876,0.000430895663261507,0.0498276784087269,"T1vsT2"
"835","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"836","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0045087",0.0477206217885634,0.991366612507763,3,35,"innate immune response","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"837","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0045087",0.0477206217885634,0.991366612507763,3,35,"innate immune response","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"838","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0048215",0.0214279527409935,1,1,1,"positive regulation of Golgi vesicle fusion to target membrane","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"839","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"840","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0035147",0.0434767623758957,0.999519133355804,1,2,"branch fusion, open tracheal system","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"841","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0047485",0.0104877852263895,0.998975683136574,3,21,"protein N-terminus binding","MF",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"842","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0006887",0.0377196248260859,0.99671776322395,2,13,"exocytosis","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"843","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0005642",0.04300502472027,0.999529627109784,1,2,"annulate lamellae","CC",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"844","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"845","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0032456",0.0132298136595217,0.999398849854241,2,8,"endocytic recycling","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"846","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0000145",0.0429846265951985,0.999530078194509,1,2,"exocyst","CC",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"847","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0000145",0.0429846265951985,0.999530078194509,1,2,"exocyst","CC",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"848","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0035147",0.0434767623758957,0.999519133355804,1,2,"branch fusion, open tracheal system","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"849","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0060074",0.0214279527409935,1,1,1,"synapse maturation","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"850","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0060074",0.0214279527409935,1,1,1,"synapse maturation","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"851","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0048215",0.0214279527409935,1,1,1,"positive regulation of Golgi vesicle fusion to target membrane","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"852","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0072697",0.0214279527409935,1,1,1,"protein localization to cell cortex","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"853","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0005642",0.04300502472027,0.999529627109784,1,2,"annulate lamellae","CC",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.79328003440253,0.432200041452612,-4.14918987137384,3.33653981683272e-05,0.00701526894976387,"CvsT4"
"854","Acerv_evm.model.Segkk384_pilon.7",567,1,"XP_015765818.1",1.1e-285,73.53,NA,NA,NA,NA,NA,5,"EXOC2_DROMEExocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1",3.42e-11,58.62,25,"C:GO:0000145; C:GO:0005642; P:GO:0006887; P:GO:0007269; P:GO:0007298; P:GO:0007349; C:GO:0016028; F:GO:0019901; C:GO:0030136; F:GO:0031267; C:GO:0031594; P:GO:0032456; C:GO:0035003; P:GO:0035147; P:GO:0043001; P:GO:0045056; P:GO:0045087; F:GO:0047485; P:GO:0048215; P:GO:0048599; C:GO:0055037; P:GO:0060074; P:GO:0071896; P:GO:0072697; P:GO:2000535","C:exocyst; C:annulate lamellae; P:exocytosis; P:neurotransmitter secretion; P:border follicle cell migration; P:cellularization; C:rhabdomere; F:protein kinase binding; C:clathrin-coated vesicle; F:small GTPase binding; C:neuromuscular junction; P:endocytic recycling; C:subapical complex; P:branch fusion, open tracheal system; P:Golgi to plasma membrane protein transport; P:transcytosis; P:innate immune response; F:protein N-terminus binding; P:positive regulation of Golgi vesicle fusion to target membrane; P:oocyte development; C:recycling endosome; P:synapse maturation; P:protein localization to adherens junction; P:protein localization to cell cortex; P:regulation of entry of bacterium into host cell",NA,NA,"Coil (COILS); IPR002909 (SMART); IPR019018 (PFAM); IPR013783 (G3DSA:2.60.40.GENE3D); IPR002909 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR014756 (SUPERFAMILY); IPR037245 (SUPERFAMILY)",NA,NA,"GO:0072697",0.0214279527409935,1,1,1,"protein localization to cell cortex","BP",69,74,66,68,95,70,81,28,49,37,28,162,33,1704,65.739399547516,-1.5177281428251,0.397578006878211,-3.81743485949418,0.000134846374286582,0.0136982704485954,"CvsT2"
"855","Acerv_evm.model.Segkk3903_pilon.2",260,1,"ACJ64663.1",2.3e-150,97.69,2,"F:GO:0004089; F:GO:0008270","F:carbonate dehydratase activity; F:zinc ion binding","EC:4.2.1; EC:4.2.1.1; EC:4.2; EC:4","Carbon-oxygen lyases; Carbonic anhydrase; Carbon-oxygen lyases; Lyases",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GO:0004089",0.0458864583427078,0.999463680778699,1,2,"carbonate dehydratase activity","MF",2554,3990,6951,2964,3310,1557,10419,3243,1586,861,2198,3706,978,783,3234.70959315205,-1.9985397579972,0.492322925874959,-4.0594082724167,4.91972291261793e-05,0.0174525790656564,"T1vsT2"
"856","Acerv_evm.model.Segkk3903_pilon.2",260,1,"ACJ64663.1",2.3e-150,97.69,2,"F:GO:0004089; F:GO:0008270","F:carbonate dehydratase activity; F:zinc ion binding","EC:4.2.1; EC:4.2.1.1; EC:4.2; EC:4","Carbon-oxygen lyases; Carbonic anhydrase; Carbon-oxygen lyases; Lyases",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GO:0004089",0.0458864583427078,0.999463680778699,1,2,"carbonate dehydratase activity","MF",2554,3990,6951,2964,3310,1557,10419,3243,1586,861,2198,3706,978,783,3234.70959315205,-1.51444373420607,0.439757878972878,-3.44381262194389,0.000573573063869508,0.0386990602271957,"CvsT2"
"857","Acerv_evm.model.Segkk3914_pilon.1",709,1,"XP_029181869.1",1.1e-119,83.27,NA,NA,NA,NA,NA,5,"ESYT3_MOUSEExtended synaptotagmin-3 OS=Mus musculus OX=10090 GN=Esyt3 PE=2 SV=2",4.53e-13,56.08,7,"F:GO:0005515; F:GO:0005543; C:GO:0005887; C:GO:0031227; C:GO:0031234; F:GO:0043169; C:GO:0140268","F:protein binding; F:phospholipid binding; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; F:cation binding; C:endoplasmic reticulum-plasma membrane contact site",NA,NA,"Coil (COILS); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0140268",0.00839261548990601,0.99972562062008,2,6,"endoplasmic reticulum-plasma membrane contact site","CC",52,70,62,30,62,37,37,43,27,67,24,70,22,2132,45.1241482110601,-1.34899420732794,0.334040415257076,-4.03841614880572,5.38133227315143e-05,0.010735537785985,"CvsT1"
"858","Acerv_evm.model.Segkk3914_pilon.1",709,1,"XP_029181869.1",1.1e-119,83.27,NA,NA,NA,NA,NA,5,"ESYT3_MOUSEExtended synaptotagmin-3 OS=Mus musculus OX=10090 GN=Esyt3 PE=2 SV=2",4.53e-13,56.08,7,"F:GO:0005515; F:GO:0005543; C:GO:0005887; C:GO:0031227; C:GO:0031234; F:GO:0043169; C:GO:0140268","F:protein binding; F:phospholipid binding; C:integral component of plasma membrane; C:intrinsic component of endoplasmic reticulum membrane; C:extrinsic component of cytoplasmic side of plasma membrane; F:cation binding; C:endoplasmic reticulum-plasma membrane contact site",NA,NA,"Coil (COILS); mobidb-lite (MOBIDB_LITE)",NA,NA,"GO:0005543",0.0011470856433709,0.999912367606281,4,21,"phospholipid binding","MF",52,70,62,30,62,37,37,43,27,67,24,70,22,2132,45.1241482110601,-1.34899420732794,0.334040415257076,-4.03841614880572,5.38133227315143e-05,0.010735537785985,"CvsT1"
"859","Acerv_evm.model.Segkk4025_pilon.2",547,1,"XP_029197368.1",2.7e-302,95.98,NA,NA,NA,NA,NA,5,"ASTRB_MOUSEProtein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2",2.2e-116,52.12,5,"F:GO:0005543; C:GO:0005789; C:GO:0005886; P:GO:0009987; C:GO:0140268","F:phospholipid binding; C:endoplasmic reticulum membrane; C:plasma membrane; P:cellular process; C:endoplasmic reticulum-plasma membrane contact site",NA,NA,"IPR004182 (SMART); IPR004182 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR031968 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR031968 (PROSITE_PROFILES); cd13220 (CDD)",NA,NA,"GO:0005543",0.0011470856433709,0.999912367606281,4,21,"phospholipid binding","MF",342,641,618,275,439,168,267,472,153,100,185,378,103,1644,273.904438482909,-0.842605506883747,0.225219285834645,-3.7412671111229,0.000183094795810908,0.0327378124251447,"T1vsT2"
"860","Acerv_evm.model.Segkk4025_pilon.2",547,1,"XP_029197368.1",2.7e-302,95.98,NA,NA,NA,NA,NA,5,"ASTRB_MOUSEProtein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2",2.2e-116,52.12,5,"F:GO:0005543; C:GO:0005789; C:GO:0005886; P:GO:0009987; C:GO:0140268","F:phospholipid binding; C:endoplasmic reticulum membrane; C:plasma membrane; P:cellular process; C:endoplasmic reticulum-plasma membrane contact site",NA,NA,"IPR004182 (SMART); IPR004182 (PFAM); IPR011993 (G3DSA:2.30.29.GENE3D); IPR031968 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR031968 (PROSITE_PROFILES); cd13220 (CDD)",NA,NA,"GO:0140268",0.00839261548990601,0.99972562062008,2,6,"endoplasmic reticulum-plasma membrane contact site","CC",342,641,618,275,439,168,267,472,153,100,185,378,103,1644,273.904438482909,-0.842605506883747,0.225219285834645,-3.7412671111229,0.000183094795810908,0.0327378124251447,"T1vsT2"
"861","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"862","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0042531",0.042744181183065,0.999535378740031,1,2,"positive regulation of tyrosine phosphorylation of STAT protein","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"863","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"864","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0042531",0.042744181183065,0.999535378740031,1,2,"positive regulation of tyrosine phosphorylation of STAT protein","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"865","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0070403",0.00470461115789769,0.999895223321753,2,5,"NAD+ binding","MF",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"866","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0019985",0.0423648365073404,0.999543678802645,1,2,"translesion synthesis","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"867","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"868","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"869","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0060336",0.0437610921977573,0.999512751282033,1,2,"negative regulation of interferon-gamma-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"870","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"871","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0032088",0.0151817162634037,0.998291079964399,3,22,"negative regulation of NF-kappaB transcription factor activity","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"872","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0060336",0.0437610921977573,0.999512751282033,1,2,"negative regulation of interferon-gamma-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"873","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:1902216",0.0437610921977573,0.999512751282033,1,2,"positive regulation of interleukin-4-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"874","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010847",0.0424060855347008,0.999542779978452,1,2,"regulation of chromatin assembly","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"875","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010847",0.0424060855347008,0.999542779978452,1,2,"regulation of chromatin assembly","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"876","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:1902216",0.0437610921977573,0.999512751282033,1,2,"positive regulation of interleukin-4-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"877","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0070403",0.00470461115789769,0.999895223321753,2,5,"NAD+ binding","MF",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"878","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0019985",0.0423648365073404,0.999543678802645,1,2,"translesion synthesis","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"879","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"880","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"881","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0042531",0.042744181183065,0.999535378740031,1,2,"positive regulation of tyrosine phosphorylation of STAT protein","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"882","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0070403",0.00470461115789769,0.999895223321753,2,5,"NAD+ binding","MF",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,2.50404997439413,0.568759443858028,4.40265212549013,1.06935557816693e-05,0.0278460192554669,"T2vsT3"
"883","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0060336",0.0437610921977573,0.999512751282033,1,2,"negative regulation of interferon-gamma-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"884","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:1902216",0.0437610921977573,0.999512751282033,1,2,"positive regulation of interleukin-4-mediated signaling pathway","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"885","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0010847",0.0424060855347008,0.999542779978452,1,2,"regulation of chromatin assembly","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.78206120380723,0.63666983284462,-4.36970790869276,1.24412838260195e-05,0.00990928733289509,"T1vsT2"
"886","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"887","Acerv_evm.model.Segkk4047_pilon.16",653,1,"PFX29773.1",3.6e-261,69.88,NA,NA,NA,NA,NA,5,"PAR14_MOUSEProtein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3",2.39e-40,54.27,25,"P:GO:0000122; F:GO:0003714; F:GO:0003950; C:GO:0005730; C:GO:0005794; C:GO:0005829; C:GO:0005886; P:GO:0010629; P:GO:0010847; F:GO:0019899; P:GO:0019985; P:GO:0032088; P:GO:0042531; P:GO:0042532; P:GO:0045071; P:GO:0048147; P:GO:0060336; P:GO:0070212; P:GO:0070213; F:GO:0070403; F:GO:0070530; P:GO:0140289; P:GO:1900045; P:GO:1902216; F:GO:1990404","P:negative regulation of transcription by RNA polymerase II; F:transcription corepressor activity; F:NAD+ ADP-ribosyltransferase activity; C:nucleolus; C:Golgi apparatus; C:cytosol; C:plasma membrane; P:negative regulation of gene expression; P:regulation of chromatin assembly; F:enzyme binding; P:translesion synthesis; P:negative regulation of NF-kappaB transcription factor activity; P:positive regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of tyrosine phosphorylation of STAT protein; P:negative regulation of viral genome replication; P:negative regulation of fibroblast proliferation; P:negative regulation of interferon-gamma-mediated signaling pathway; P:protein poly-ADP-ribosylation; P:protein auto-ADP-ribosylation; F:NAD+ binding; F:K63-linked polyubiquitin modification-dependent protein binding; P:protein mono-ADP-ribosylation; P:negative regulation of protein K63-linked ubiquitination; P:positive regulation of interleukin-4-mediated signaling pathway; F:protein ADP-ribosylase activity","EC:2.4.2; EC:2.4; EC:2; EC:2.4.2.30","Glycosyltransferases; Glycosyltransferases; Transferases; NAD(+) ADP-ribosyltransferase","Coil (COILS); IPR037197 (G3DSA:3.30.720.GENE3D); IPR012317 (PFAM); G3DSA:3.90.228.10 (GENE3D); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR012317 (PROSITE_PROFILES); IPR037197 (SUPERFAMILY); SSF56399 (SUPERFAMILY)","F:GO:0003950","F:NAD+ ADP-ribosyltransferase activity","GO:0019985",0.0423648365073404,0.999543678802645,1,2,"translesion synthesis","BP",366,681,959,836,624,223,3601,1127,345,202,446,344,88,1962,752.00053670691,-2.12974089597568,0.566738524952983,-3.75788975374908,0.000171352341581785,0.0166580270993647,"CvsT2"
"888","Acerv_evm.model.Segkk4113_pilon.15",346,1,"XP_029203233.1",2.1e-191,97.04,NA,NA,NA,NA,NA,5,"AGTRB_XENLAType-1 angiotensin II receptor B OS=Xenopus laevis OX=8355 GN=agtr1-b PE=2 SV=1",6.75e-16,47.68,5,"F:GO:0001595; P:GO:0007200; P:GO:0007204; C:GO:0016020; P:GO:0032501","F:angiotensin receptor activity; P:phospholipase C-activating G protein-coupled receptor signaling pathway; P:positive regulation of cytosolic calcium ion concentration; C:membrane; P:multicellular organismal process",NA,NA,"IPR000276 (PRINTS); IPR017452 (PFAM); G3DSA:1.20.1070.10 (GENE3D); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00637 (CDD); SSF81321 (SUPERFAMILY)","F:GO:0004930; P:GO:0007186; C:GO:0016021","F:G protein-coupled receptor activity; P:G protein-coupled receptor signaling pathway; C:integral component of membrane","GO:0001595",0.0227822725079843,1,1,1,"angiotensin receptor activity","MF",227,306,367,298,464,93,276,131,73,47,139,248,54,1041,190.069276739747,-1.72074602774085,0.454814926779105,-3.7833983152813,0.000154701543096924,0.0311013549908585,"T1vsT2"
"889","Acerv_evm.model.Segkk4122_pilon.1",87,1,"XP_029184144.1",1.1e-24,75.31,NA,NA,NA,NA,NA,5,"TAAR6_RATTrace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1",3.51e-20,47.58,10,"F:GO:0004930; C:GO:0005887; P:GO:0007186; P:GO:0007610; P:GO:0044057; C:GO:0045202; P:GO:0048518; P:GO:0050877; P:GO:0051046; P:GO:0065008","F:G protein-coupled receptor activity; C:integral component of plasma membrane; P:G protein-coupled receptor signaling pathway; P:behavior; P:regulation of system process; C:synapse; P:positive regulation of biological process; P:nervous system process; P:regulation of secretion; P:regulation of biological quality",NA,NA,"IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); IPR017452 (PFAM); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00637 (CDD); SSF81321 (SUPERFAMILY)","F:GO:0004930; P:GO:0007186; C:GO:0016021","F:G protein-coupled receptor activity; P:G protein-coupled receptor signaling pathway; C:integral component of membrane","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",61,44,54,33,68,44,40,31,38,42,23,64,23,266,43.9319593397779,-1.38356363134145,0.27637485162786,-5.006112615501,5.55402706187231e-07,0.000226443320172653,"CvsT3"
"890","Acerv_evm.model.Segkk4122_pilon.1",87,1,"XP_029184144.1",1.1e-24,75.31,NA,NA,NA,NA,NA,5,"TAAR6_RATTrace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1",3.51e-20,47.58,10,"F:GO:0004930; C:GO:0005887; P:GO:0007186; P:GO:0007610; P:GO:0044057; C:GO:0045202; P:GO:0048518; P:GO:0050877; P:GO:0051046; P:GO:0065008","F:G protein-coupled receptor activity; C:integral component of plasma membrane; P:G protein-coupled receptor signaling pathway; P:behavior; P:regulation of system process; C:synapse; P:positive regulation of biological process; P:nervous system process; P:regulation of secretion; P:regulation of biological quality",NA,NA,"IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); IPR017452 (PFAM); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00637 (CDD); SSF81321 (SUPERFAMILY)","F:GO:0004930; P:GO:0007186; C:GO:0016021","F:G protein-coupled receptor activity; P:G protein-coupled receptor signaling pathway; C:integral component of membrane","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",61,44,54,33,68,44,40,31,38,42,23,64,23,266,43.9319593397779,-1.18928297013093,0.289963696776307,-4.10148919796813,4.10499673383265e-05,0.0079659298725118,"CvsT4"
"891","Acerv_evm.model.Segkk4122_pilon.1",87,1,"XP_029184144.1",1.1e-24,75.31,NA,NA,NA,NA,NA,5,"TAAR6_RATTrace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1",3.51e-20,47.58,10,"F:GO:0004930; C:GO:0005887; P:GO:0007186; P:GO:0007610; P:GO:0044057; C:GO:0045202; P:GO:0048518; P:GO:0050877; P:GO:0051046; P:GO:0065008","F:G protein-coupled receptor activity; C:integral component of plasma membrane; P:G protein-coupled receptor signaling pathway; P:behavior; P:regulation of system process; C:synapse; P:positive regulation of biological process; P:nervous system process; P:regulation of secretion; P:regulation of biological quality",NA,NA,"IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); IPR017452 (PFAM); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00637 (CDD); SSF81321 (SUPERFAMILY)","F:GO:0004930; P:GO:0007186; C:GO:0016021","F:G protein-coupled receptor activity; P:G protein-coupled receptor signaling pathway; C:integral component of membrane","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",61,44,54,33,68,44,40,31,38,42,23,64,23,266,43.9319593397779,-1.49799454060583,0.304173537343041,-4.92480231413562,8.44456809606654e-07,0.000363558762650179,"CvsT1"
"892","Acerv_evm.model.Segkk4122_pilon.1",87,1,"XP_029184144.1",1.1e-24,75.31,NA,NA,NA,NA,NA,5,"TAAR6_RATTrace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1",3.51e-20,47.58,10,"F:GO:0004930; C:GO:0005887; P:GO:0007186; P:GO:0007610; P:GO:0044057; C:GO:0045202; P:GO:0048518; P:GO:0050877; P:GO:0051046; P:GO:0065008","F:G protein-coupled receptor activity; C:integral component of plasma membrane; P:G protein-coupled receptor signaling pathway; P:behavior; P:regulation of system process; C:synapse; P:positive regulation of biological process; P:nervous system process; P:regulation of secretion; P:regulation of biological quality",NA,NA,"IPR000276 (PRINTS); G3DSA:1.20.1070.10 (GENE3D); IPR017452 (PFAM); IPR000276 (PROSITE_PATTERNS); IPR017452 (PROSITE_PROFILES); cd00637 (CDD); SSF81321 (SUPERFAMILY)","F:GO:0004930; P:GO:0007186; C:GO:0016021","F:G protein-coupled receptor activity; P:G protein-coupled receptor signaling pathway; C:integral component of membrane","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",61,44,54,33,68,44,40,31,38,42,23,64,23,266,43.9319593397779,-1.04263354517972,0.282853462707494,-3.68612614885301,0.000227693518306302,0.02018212842164,"CvsT2"
"893","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:1990712",0.0317126921183667,1,1,1,"HFE-transferrin receptor complex","CC",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"894","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0010629",0.0367267762767562,0.991764584473208,4,54,"negative regulation of gene expression","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"895","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0005025",0.0317126921183667,1,1,1,"transforming growth factor beta receptor activity, type I","MF",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"896","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0001550",0.0317126921183667,1,1,1,"ovarian cumulus expansion","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"897","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0001934",0.00824320520368596,0.99884951183754,4,34,"positive regulation of protein phosphorylation","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"898","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0045944",0.034163324423141,0.987224450876541,8,159,"positive regulation of transcription by RNA polymerase II","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"899","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0048179",0.0317126921183667,1,1,1,"activin receptor complex","CC",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"900","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0006954",0.045397274700207,0.991960755408372,3,34,"inflammatory response","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"901","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:1902731",0.0317126921183667,1,1,1,"negative regulation of chondrocyte proliferation","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"902","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0034711",0.0317126921183667,1,1,1,"inhibin binding","MF",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"903","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:1902043",0.00215665836141749,0.99998032964564,2,3,"positive regulation of extrinsic apoptotic signaling pathway via death domain receptors","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"904","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0002063",0.0174884521003746,0.999053448579429,2,9,"chondrocyte development","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"905","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0016361",0.0317126921183667,1,1,1,"activin receptor activity, type I","MF",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"906","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0098821",0.0317126921183667,1,1,1,"BMP receptor activity","MF",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"907","Acerv_evm.model.Segkk4124_pilon.10",113,1,"XP_029189534.1",1e-38,84.96,NA,NA,NA,NA,NA,5,"BMR1B_MOUSEBone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1",1.28e-33,68.64,51,"P:GO:0000082; P:GO:0001502; P:GO:0001550; P:GO:0001701; P:GO:0001934; P:GO:0001942; P:GO:0002063; F:GO:0005025; F:GO:0005524; C:GO:0005829; P:GO:0006703; P:GO:0006954; P:GO:0007179; P:GO:0009953; C:GO:0009986; P:GO:0010628; P:GO:0010629; F:GO:0016361; P:GO:0018107; F:GO:0019211; F:GO:0019838; P:GO:0030166; P:GO:0030308; C:GO:0030425; P:GO:0030501; P:GO:0030509; P:GO:0031290; P:GO:0032332; P:GO:0032927; F:GO:0034711; P:GO:0035108; F:GO:0036122; P:GO:0038092; C:GO:0043025; F:GO:0043539; C:GO:0044214; P:GO:0045648; P:GO:0045669; P:GO:0045944; F:GO:0046332; P:GO:0046777; C:GO:0048179; F:GO:0048185; P:GO:0060041; P:GO:0060350; F:GO:0098821; F:GO:0140537; P:GO:1901165; P:GO:1902043; P:GO:1902731; C:GO:1990712","P:G1/S transition of mitotic cell cycle; P:cartilage condensation; P:ovarian cumulus expansion; P:in utero embryonic development; P:positive regulation of protein phosphorylation; P:hair follicle development; P:chondrocyte development; F:transforming growth factor beta receptor activity, type I; F:ATP binding; C:cytosol; P:estrogen biosynthetic process; P:inflammatory response; P:transforming growth factor beta receptor signaling pathway; P:dorsal/ventral pattern formation; C:cell surface; P:positive regulation of gene expression; P:negative regulation of gene expression; F:activin receptor activity, type I; P:peptidyl-threonine phosphorylation; F:phosphatase activator activity; F:growth factor binding; P:proteoglycan biosynthetic process; P:negative regulation of cell growth; C:dendrite; P:positive regulation of bone mineralization; P:BMP signaling pathway; P:retinal ganglion cell axon guidance; P:positive regulation of chondrocyte differentiation; P:positive regulation of activin receptor signaling pathway; F:inhibin binding; P:limb morphogenesis; F:BMP binding; P:nodal signaling pathway; C:neuronal cell body; F:protein serine/threonine kinase activator activity; C:spanning component of plasma membrane; P:positive regulation of erythrocyte differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of transcription by RNA polymerase II; F:SMAD binding; P:protein autophosphorylation; C:activin receptor complex; F:activin binding; P:retina development in camera-type eye; P:endochondral bone morphogenesis; F:BMP receptor activity; F:transcription regulator activator activity; P:positive regulation of trophoblast cell migration; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of chondrocyte proliferation; C:HFE-transferrin receptor complex","EC:2.7.1; EC:2.7; EC:2; EC:2.7.11.30","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Receptor protein serine/threonine kinase","IPR001245 (PFAM); G3DSA:1.10.510.10 (GENE3D); G3DSA:3.30.200.20 (GENE3D); IPR017441 (PROSITE_PATTERNS); IPR000719 (PROSITE_PROFILES); IPR011009 (SUPERFAMILY)","F:GO:0004672; F:GO:0005524; P:GO:0006468","F:protein kinase activity; F:ATP binding; P:protein phosphorylation","GO:0030308",0.0234186793835969,0.99684013225846,3,27,"negative regulation of cell growth","BP",84,36,34,59,73,134,65,33,0,199,25,113,63,342,81.1219958015919,-3.77973582656705,0.911097229434392,-4.14855374866358,3.34582297625753e-05,0.0073530919127924,"CvsT1"
"908","Acerv_evm.model.Segkk4124_pilon.2",695,1,"XP_015748382.1",2.6e-254,70.5,NA,NA,NA,NA,NA,5,"GLCE_HUMAND-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3",2e-170,60.25,8,"C:GO:0000139; F:GO:0005509; P:GO:0015012; P:GO:0030210; F:GO:0042803; F:GO:0047464; F:GO:0050379; P:GO:0050789","C:Golgi membrane; F:calcium ion binding; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process; F:protein homodimerization activity; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:UDP-glucuronate 5'-epimerase activity; P:regulation of biological process","EC:5.1; EC:5; EC:5.1.3.17; EC:5.1.3","Racemases and epimerases; Isomerases; Heparosan-N-sulfate-glucuronate 5-epimerase; Racemases and epimerases","IPR010598 (PFAM)",NA,NA,"GO:0047464",0.0214092873098645,1,1,1,"heparosan-N-sulfate-glucuronate 5-epimerase activity","MF",1193,3689,1317,860,971,1557,444,3545,700,2695,294,1522,1031,2088,1423.32223530085,2.06637111331873,0.527747458019971,3.91545441274401,9.02340940136871e-05,0.0230920816245462,"T1vsT2"
"909","Acerv_evm.model.Segkk4124_pilon.2",695,1,"XP_015748382.1",2.6e-254,70.5,NA,NA,NA,NA,NA,5,"GLCE_HUMAND-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3",2e-170,60.25,8,"C:GO:0000139; F:GO:0005509; P:GO:0015012; P:GO:0030210; F:GO:0042803; F:GO:0047464; F:GO:0050379; P:GO:0050789","C:Golgi membrane; F:calcium ion binding; P:heparan sulfate proteoglycan biosynthetic process; P:heparin biosynthetic process; F:protein homodimerization activity; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; F:UDP-glucuronate 5'-epimerase activity; P:regulation of biological process","EC:5.1; EC:5; EC:5.1.3.17; EC:5.1.3","Racemases and epimerases; Isomerases; Heparosan-N-sulfate-glucuronate 5-epimerase; Racemases and epimerases","IPR010598 (PFAM)",NA,NA,"GO:0050379",0.0214092873098645,1,1,1,"UDP-glucuronate 5'-epimerase activity","MF",1193,3689,1317,860,971,1557,444,3545,700,2695,294,1522,1031,2088,1423.32223530085,2.06637111331873,0.527747458019971,3.91545441274401,9.02340940136871e-05,0.0230920816245462,"T1vsT2"
"910","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0045785",0.00737554704068881,0.999774583043782,2,6,"positive regulation of cell adhesion","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"911","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:1900106",0.0211539661125585,1,1,1,"positive regulation of hyaluranon cable assembly","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"912","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0044344",0.00362480518981677,0.999939132095904,2,4,"cellular response to fibroblast growth factor stimulus","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"913","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0006954",0.045397274700207,0.991960755408372,3,34,"inflammatory response","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"914","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0030214",0.0211539661125585,1,1,1,"hyaluronan catabolic process","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"915","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0036117",0.0211539661125585,1,1,1,"hyaluranon cable","CC",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"916","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0004415",0.0480801234315449,0.999410503031134,1,2,"hyalurononglucosaminidase activity","MF",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"917","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0071347",0.0333645161209214,0.997283981097769,2,13,"cellular response to interleukin-1","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"918","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0030207",0.0211539661125585,1,1,1,"chondroitin sulfate catabolic process","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"919","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0071356",0.00572553304945496,0.999562969298826,3,17,"cellular response to tumor necrosis factor","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"920","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0036120",0.00532967948588206,0.999873381679328,2,5,"cellular response to platelet-derived growth factor stimulus","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"921","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0030213",0.0211539661125585,1,1,1,"hyaluronan biosynthetic process","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"922","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0030308",0.0234186793835969,0.99684013225846,3,27,"negative regulation of cell growth","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"923","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0050501",0.0211539661125585,1,1,1,"hyaluronan synthase activity","MF",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"924","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0071493",0.0211539661125585,1,1,1,"cellular response to UV-B","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"925","Acerv_evm.model.Segkk4124_pilon.3",1108,1,"XP_029189533.1",0,58.32,NA,NA,NA,NA,NA,5,"HYAL1_BOVINHyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1",7.59e-82,58.6,29,"P:GO:0000302; F:GO:0004415; C:GO:0005615; C:GO:0005764; P:GO:0006954; P:GO:0009615; C:GO:0009986; P:GO:0010634; P:GO:0030207; P:GO:0030213; P:GO:0030214; P:GO:0030307; P:GO:0030308; C:GO:0031410; C:GO:0036117; P:GO:0036120; P:GO:0044344; P:GO:0045766; P:GO:0045785; P:GO:0046677; F:GO:0050501; P:GO:0050679; P:GO:0051216; P:GO:0071347; P:GO:0071356; P:GO:0071467; P:GO:0071493; P:GO:1900087; P:GO:1900106","P:response to reactive oxygen species; F:hyalurononglucosaminidase activity; C:extracellular space; C:lysosome; P:inflammatory response; P:response to virus; C:cell surface; P:positive regulation of epithelial cell migration; P:chondroitin sulfate catabolic process; P:hyaluronan biosynthetic process; P:hyaluronan catabolic process; P:positive regulation of cell growth; P:negative regulation of cell growth; C:cytoplasmic vesicle; C:hyaluranon cable; P:cellular response to platelet-derived growth factor stimulus; P:cellular response to fibroblast growth factor stimulus; P:positive regulation of angiogenesis; P:positive regulation of cell adhesion; P:response to antibiotic; F:hyaluronan synthase activity; P:positive regulation of epithelial cell proliferation; P:cartilage development; P:cellular response to interleukin-1; P:cellular response to tumor necrosis factor; P:cellular response to pH; P:cellular response to UV-B; P:positive regulation of G1/S transition of mitotic cell cycle; P:positive regulation of hyaluranon cable assembly","EC:3.2; EC:2.4; EC:2; EC:3; EC:3.2.1.35; EC:2.4.1.212; EC:2.4.1; EC:3.2.1","Glycosylases; Glycosyltransferases; Transferases; Hydrolases; Hyaluronoglucosaminidase; Hyaluronan synthase; Glycosyltransferases; Glycosylases","IPR018155 (PRINTS); IPR013785 (G3DSA:3.20.20.GENE3D); IPR018155 (PFAM); IPR017853 (SUPERFAMILY)","F:GO:0003824; F:GO:0004415; P:GO:0005975","F:catalytic activity; F:hyalurononglucosaminidase activity; P:carbohydrate metabolic process","GO:0050679",0.0403604788707613,0.99632201577817,2,14,"positive regulation of epithelial cell proliferation","BP",1799,4846,1605,1047,1350,1804,608,3592,774,3152,354,1716,1127,3327,1690.29097894504,1.96437116005791,0.483641614844303,4.06162559169003,4.87321895872157e-05,0.0174525790656564,"T1vsT2"
"926","Acerv_evm.model.Segkk4302_pilon.1",78,1,"XP_015768955.1",7.2e-36,92.31,NA,NA,NA,NA,NA,5,"CENPX_BOVINCentromere protein X OS=Bos taurus OX=9913 GN=CENPX PE=3 SV=1",7.99e-20,69.04,10,"P:GO:0000712; C:GO:0000775; F:GO:0003690; F:GO:0005515; C:GO:0005654; P:GO:0006974; P:GO:0031297; P:GO:0031398; C:GO:0043240; C:GO:0071821","P:resolution of meiotic recombination intermediates; C:chromosome, centromeric region; F:double-stranded DNA binding; F:protein binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; P:replication fork processing; P:positive regulation of protein ubiquitination; C:Fanconi anaemia nuclear complex; C:FANCM-MHF complex",NA,NA,"IPR018552 (PFAM); G3DSA:1.10.286.100 (GENE3D); IPR009072 (SUPERFAMILY)","P:GO:0006281; F:GO:0046982; P:GO:0051382","P:DNA repair; F:protein heterodimerization activity; P:kinetochore assembly","GO:0031398",0.0366095586990858,0.996865760844341,2,13,"positive regulation of protein ubiquitination","BP",110,269,168,63,76,104,47,351,100,169,27,114,71,239,115.764502155384,1.63882380292666,0.438993379033324,3.73314013649909,0.000189107309285579,0.0327378124251447,"T1vsT2"
"927","Acerv_evm.model.Segkk4302_pilon.1",78,1,"XP_015768955.1",7.2e-36,92.31,NA,NA,NA,NA,NA,5,"CENPX_BOVINCentromere protein X OS=Bos taurus OX=9913 GN=CENPX PE=3 SV=1",7.99e-20,69.04,10,"P:GO:0000712; C:GO:0000775; F:GO:0003690; F:GO:0005515; C:GO:0005654; P:GO:0006974; P:GO:0031297; P:GO:0031398; C:GO:0043240; C:GO:0071821","P:resolution of meiotic recombination intermediates; C:chromosome, centromeric region; F:double-stranded DNA binding; F:protein binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; P:replication fork processing; P:positive regulation of protein ubiquitination; C:Fanconi anaemia nuclear complex; C:FANCM-MHF complex",NA,NA,"IPR018552 (PFAM); G3DSA:1.10.286.100 (GENE3D); IPR009072 (SUPERFAMILY)","P:GO:0006281; F:GO:0046982; P:GO:0051382","P:DNA repair; F:protein heterodimerization activity; P:kinetochore assembly","GO:0003690",0.00415861816436389,0.999722425071719,3,15,"double-stranded DNA binding","MF",110,269,168,63,76,104,47,351,100,169,27,114,71,239,115.764502155384,1.63882380292666,0.438993379033324,3.73314013649909,0.000189107309285579,0.0327378124251447,"T1vsT2"
"928","Acerv_evm.model.Segkk4302_pilon.1",78,1,"XP_015768955.1",7.2e-36,92.31,NA,NA,NA,NA,NA,5,"CENPX_BOVINCentromere protein X OS=Bos taurus OX=9913 GN=CENPX PE=3 SV=1",7.99e-20,69.04,10,"P:GO:0000712; C:GO:0000775; F:GO:0003690; F:GO:0005515; C:GO:0005654; P:GO:0006974; P:GO:0031297; P:GO:0031398; C:GO:0043240; C:GO:0071821","P:resolution of meiotic recombination intermediates; C:chromosome, centromeric region; F:double-stranded DNA binding; F:protein binding; C:nucleoplasm; P:cellular response to DNA damage stimulus; P:replication fork processing; P:positive regulation of protein ubiquitination; C:Fanconi anaemia nuclear complex; C:FANCM-MHF complex",NA,NA,"IPR018552 (PFAM); G3DSA:1.10.286.100 (GENE3D); IPR009072 (SUPERFAMILY)","P:GO:0006281; F:GO:0046982; P:GO:0051382","P:DNA repair; F:protein heterodimerization activity; P:kinetochore assembly","GO:0051382",0.0335591553993246,1,1,1,"kinetochore assembly","BP",110,269,168,63,76,104,47,351,100,169,27,114,71,239,115.764502155384,1.63882380292666,0.438993379033324,3.73314013649909,0.000189107309285579,0.0327378124251447,"T1vsT2"
"929","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0070887",0.00517481574459637,0.999374355980325,4,30,"cellular response to chemical stimulus","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"930","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0033365",0.0176198370567096,0.999042541857937,2,9,"protein localization to organelle","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"931","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0120036",0.0479233552627526,0.995163445987144,2,15,"plasma membrane bounded cell projection organization","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"932","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0010506",0.00576474779983078,0.999567152866091,3,15,"regulation of autophagy","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"933","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0001934",0.00824320520368596,0.99884951183754,4,34,"positive regulation of protein phosphorylation","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"934","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0048585",0.0292781079694456,0.995674372847706,3,29,"negative regulation of response to stimulus","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"935","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0080134",0.0409068362710942,0.996244729053058,2,14,"regulation of response to stress","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"936","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0009967",0.0232132695160049,0.996878338512387,3,27,"positive regulation of signal transduction","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"937","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0030234",0.0341028059132467,0.9971907430988,2,13,"enzyme regulator activity","MF",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"938","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0022603",0.0302989396181243,0.997684567652949,2,12,"regulation of anatomical structure morphogenesis","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"939","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0032555",0.00456640473149219,0.999899857364956,2,5,"purine ribonucleotide binding","MF",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"940","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0060627",0.0030127162805093,0.999825416102579,3,13,"regulation of vesicle-mediated transport","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"941","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:1902531",0.00116104356819137,0.999911652546393,4,20,"regulation of intracellular signal transduction","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"942","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0044092",0.0193172428352737,0.998897710747696,2,9,"negative regulation of molecular function","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"943","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0032386",0.00461202251534642,0.999898335802903,2,5,"regulation of intracellular transport","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"944","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0006996",0.00399445560224313,0.999554020421145,4,28,"organelle organization","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"945","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0042391",0.00361391757658163,0.999457702860776,5,44,"regulation of membrane potential","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"946","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0071944",0.0149057401211656,0.997494650624873,4,41,"cell periphery","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"947","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0021537",0.0281707255552014,0.997957626615179,2,11,"telencephalon development","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"948","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0098793",0.00534615049028164,0.999116134218519,5,47,"presynapse","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"949","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0032269",0.00484221644192873,0.999890538113711,2,5,"negative regulation of cellular protein metabolic process","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"950","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0033554",0.00793136978860907,0.999313252323009,3,18,"cellular response to stress","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"951","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0036477",0.0110941526491426,0.998304929804106,4,36,"somatodendritic compartment","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"952","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0018193",0.0140251627040135,0.999342787695732,2,8,"peptidyl-amino acid modification","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"953","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0031966",0.0113946667293086,0.998858582605281,3,20,"mitochondrial membrane","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"954","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0050804",0.0452808168995192,0.991976702887256,3,35,"modulation of chemical synaptic transmission","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"955","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0098588",0.0256404082656132,0.996418532001015,3,27,"bounding membrane of organelle","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"956","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0060548",0.0392308035817381,0.996479950101756,2,14,"negative regulation of cell death","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"957","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0005794",0.0364795901722606,0.986181141927686,8,161,"Golgi apparatus","CC",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"958","Acerv_evm.model.Segkk4318_pilon.2",336,1,"XP_029195288.1",6.9e-160,90.86,NA,NA,NA,NA,NA,5,"PATS1_DICDIProbable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1",2.48e-14,44.09,43,"P:GO:0001934; F:GO:0004674; C:GO:0005773; C:GO:0005783; C:GO:0005794; P:GO:0006996; F:GO:0008092; P:GO:0009967; P:GO:0010468; P:GO:0010506; F:GO:0016787; P:GO:0018193; P:GO:0021537; P:GO:0022603; P:GO:0030154; P:GO:0030162; F:GO:0030234; C:GO:0030424; C:GO:0031410; C:GO:0031966; P:GO:0032269; P:GO:0032386; F:GO:0032555; P:GO:0033365; P:GO:0033554; C:GO:0036477; P:GO:0042391; P:GO:0043085; F:GO:0043168; P:GO:0044092; P:GO:0048585; P:GO:0050804; P:GO:0051128; P:GO:0051239; P:GO:0060548; P:GO:0060627; P:GO:0070887; C:GO:0071944; P:GO:0080134; C:GO:0098588; C:GO:0098793; P:GO:0120036; P:GO:1902531","P:positive regulation of protein phosphorylation; F:protein serine/threonine kinase activity; C:vacuole; C:endoplasmic reticulum; C:Golgi apparatus; P:organelle organization; F:cytoskeletal protein binding; P:positive regulation of signal transduction; P:regulation of gene expression; P:regulation of autophagy; F:hydrolase activity; P:peptidyl-amino acid modification; P:telencephalon development; P:regulation of anatomical structure morphogenesis; P:cell differentiation; P:regulation of proteolysis; F:enzyme regulator activity; C:axon; C:cytoplasmic vesicle; C:mitochondrial membrane; P:negative regulation of cellular protein metabolic process; P:regulation of intracellular transport; F:purine ribonucleotide binding; P:protein localization to organelle; P:cellular response to stress; C:somatodendritic compartment; P:regulation of membrane potential; P:positive regulation of catalytic activity; F:anion binding; P:negative regulation of molecular function; P:negative regulation of response to stimulus; P:modulation of chemical synaptic transmission; P:regulation of cellular component organization; P:regulation of multicellular organismal process; P:negative regulation of cell death; P:regulation of vesicle-mediated transport; P:cellular response to chemical stimulus; C:cell periphery; P:regulation of response to stress; C:bounding membrane of organelle; C:presynapse; P:plasma membrane bounded cell projection organization; P:regulation of intracellular signal transduction","EC:2.7.1; EC:2.7; EC:2; EC:3","Transferring phosphorus-containing groups; Transferring phosphorus-containing groups; Transferases; Hydrolases","G3DSA:3.40.50.2000 (GENE3D); IPR032171 (PFAM); G3DSA:1.10.533.10 (GENE3D); G3DSA:1.10.10.2190 (GENE3D); G3DSA:3.40.50.2000 (GENE3D); G3DSA:3.40.50.300 (GENE3D); PF13692 (PFAM); PF08477 (PFAM); G3DSA:3.40.50.300 (GENE3D); mobidb-lite (MOBIDB_LITE); IPR020859 (PROSITE_PROFILES); cd01670 (CDD); cd03801 (CDD); IPR027417 (SUPERFAMILY); SSF53756 (SUPERFAMILY); IPR011029 (SUPERFAMILY)",NA,NA,"GO:0030162",0.0165395238029839,0.999130898390482,2,9,"regulation of proteolysis","BP",38,26,39,35,60,23,47,54,20,15,31,39,13,1011,33.2094659588047,-1.37468927353532,0.376087078402534,-3.65524197048844,0.000256939520777674,0.0221237162604853,"CvsT2"
"959","Acerv_evm.model.Segkk4345_pilon.12",583,1,"RUA05461.1",3.8e-238,73.62,2,"P:GO:0006259; P:GO:0051276","P:DNA metabolic process; P:chromosome organization",NA,NA,5,"TCB1_YEASTTricalbin-1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TCB1 PE=1 SV=1",8.63e-18,46.43,4,"C:GO:0005783; F:GO:0008289; C:GO:0016020; C:GO:0071944","C:endoplasmic reticulum; F:lipid binding; C:membrane; C:cell periphery",NA,NA,"IPR031468 (PROSITE_PROFILES)","F:GO:0008289","F:lipid binding","GO:0071944",0.0149057401211656,0.997494650624873,4,41,"cell periphery","CC",64,73,65,46,62,50,49,34,19,75,27,83,30,1752,52.0998325681553,-1.64624927389044,0.389833389281138,-4.22295606060365,2.41118840637058e-05,0.00589177145459363,"CvsT1"
"960","Acerv_evm.model.Segkk451_pilon.2",444,1,"XP_029201636.1",2.4e-232,97.74,NA,NA,NA,NA,NA,5,"PRRT1_RATProline-rich transmembrane protein 1 OS=Rattus norvegicus OX=10116 GN=Prrt1 PE=1 SV=2",8.96e-17,63.13,14,"P:GO:0006468; P:GO:0007611; F:GO:0030545; C:GO:0030672; P:GO:0034394; F:GO:0042802; C:GO:0042995; P:GO:0051965; P:GO:0060291; P:GO:0060292; C:GO:0098839; C:GO:0098978; C:GO:0099055; P:GO:2000311","P:protein phosphorylation; P:learning or memory; F:signaling receptor regulator activity; C:synaptic vesicle membrane; P:protein localization to cell surface; F:identical protein binding; C:cell projection; P:positive regulation of synapse assembly; P:long-term synaptic potentiation; P:long-term synaptic depression; C:postsynaptic density membrane; C:glutamatergic synapse; C:integral component of postsynaptic membrane; P:regulation of AMPA receptor activity",NA,NA,"IPR007593 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0016021","C:integral component of membrane","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",457,739,877,672,925,269,468,513,184,167,403,570,118,1335,444.618313993841,-1.02620193286227,0.287067255317952,-3.57477878041388,0.000350524145822673,0.0271776986700309,"CvsT2"
"961","Acerv_evm.model.Segkk451_pilon.2",444,1,"XP_029201636.1",2.4e-232,97.74,NA,NA,NA,NA,NA,5,"PRRT1_RATProline-rich transmembrane protein 1 OS=Rattus norvegicus OX=10116 GN=Prrt1 PE=1 SV=2",8.96e-17,63.13,14,"P:GO:0006468; P:GO:0007611; F:GO:0030545; C:GO:0030672; P:GO:0034394; F:GO:0042802; C:GO:0042995; P:GO:0051965; P:GO:0060291; P:GO:0060292; C:GO:0098839; C:GO:0098978; C:GO:0099055; P:GO:2000311","P:protein phosphorylation; P:learning or memory; F:signaling receptor regulator activity; C:synaptic vesicle membrane; P:protein localization to cell surface; F:identical protein binding; C:cell projection; P:positive regulation of synapse assembly; P:long-term synaptic potentiation; P:long-term synaptic depression; C:postsynaptic density membrane; C:glutamatergic synapse; C:integral component of postsynaptic membrane; P:regulation of AMPA receptor activity",NA,NA,"IPR007593 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0016021","C:integral component of membrane","GO:0007611",0.0163294007022753,0.998095676484755,3,24,"learning or memory","BP",457,739,877,672,925,269,468,513,184,167,403,570,118,1335,444.618313993841,-1.23714005141144,0.32594411882047,-3.79555874758045,0.000147311305395681,0.0311013549908585,"T1vsT2"
"962","Acerv_evm.model.Segkk451_pilon.2",444,1,"XP_029201636.1",2.4e-232,97.74,NA,NA,NA,NA,NA,5,"PRRT1_RATProline-rich transmembrane protein 1 OS=Rattus norvegicus OX=10116 GN=Prrt1 PE=1 SV=2",8.96e-17,63.13,14,"P:GO:0006468; P:GO:0007611; F:GO:0030545; C:GO:0030672; P:GO:0034394; F:GO:0042802; C:GO:0042995; P:GO:0051965; P:GO:0060291; P:GO:0060292; C:GO:0098839; C:GO:0098978; C:GO:0099055; P:GO:2000311","P:protein phosphorylation; P:learning or memory; F:signaling receptor regulator activity; C:synaptic vesicle membrane; P:protein localization to cell surface; F:identical protein binding; C:cell projection; P:positive regulation of synapse assembly; P:long-term synaptic potentiation; P:long-term synaptic depression; C:postsynaptic density membrane; C:glutamatergic synapse; C:integral component of postsynaptic membrane; P:regulation of AMPA receptor activity",NA,NA,"IPR007593 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0016021","C:integral component of membrane","GO:0060291",0.00967798161593436,0.999640440306866,2,7,"long-term synaptic potentiation","BP",457,739,877,672,925,269,468,513,184,167,403,570,118,1335,444.618313993841,-1.23714005141144,0.32594411882047,-3.79555874758045,0.000147311305395681,0.0311013549908585,"T1vsT2"
"963","Acerv_evm.model.Segkk451_pilon.2",444,1,"XP_029201636.1",2.4e-232,97.74,NA,NA,NA,NA,NA,5,"PRRT1_RATProline-rich transmembrane protein 1 OS=Rattus norvegicus OX=10116 GN=Prrt1 PE=1 SV=2",8.96e-17,63.13,14,"P:GO:0006468; P:GO:0007611; F:GO:0030545; C:GO:0030672; P:GO:0034394; F:GO:0042802; C:GO:0042995; P:GO:0051965; P:GO:0060291; P:GO:0060292; C:GO:0098839; C:GO:0098978; C:GO:0099055; P:GO:2000311","P:protein phosphorylation; P:learning or memory; F:signaling receptor regulator activity; C:synaptic vesicle membrane; P:protein localization to cell surface; F:identical protein binding; C:cell projection; P:positive regulation of synapse assembly; P:long-term synaptic potentiation; P:long-term synaptic depression; C:postsynaptic density membrane; C:glutamatergic synapse; C:integral component of postsynaptic membrane; P:regulation of AMPA receptor activity",NA,NA,"IPR007593 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE)","C:GO:0016021","C:integral component of membrane","GO:0060291",0.00967798161593436,0.999640440306866,2,7,"long-term synaptic potentiation","BP",457,739,877,672,925,269,468,513,184,167,403,570,118,1335,444.618313993841,-1.02620193286227,0.287067255317952,-3.57477878041388,0.000350524145822673,0.0271776986700309,"CvsT2"
"964","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0036261",0.0346685412431733,1,1,1,"7-methylguanosine cap hypermethylation","BP",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,2.29331722006174,0.523932945259204,4.37711970742206,1.20257933546359e-05,0.00990928733289509,"T1vsT2"
"965","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0071164",0.0346685412431733,1,1,1,"RNA trimethylguanosine synthase activity","MF",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,2.29331722006174,0.523932945259204,4.37711970742206,1.20257933546359e-05,0.00990928733289509,"T1vsT2"
"966","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0009452",0.0346685412431733,1,1,1,"7-methylguanosine RNA capping","BP",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,2.29331722006174,0.523932945259204,4.37711970742206,1.20257933546359e-05,0.00990928733289509,"T1vsT2"
"967","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0071164",0.0346685412431733,1,1,1,"RNA trimethylguanosine synthase activity","MF",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,-2.09032509927881,0.520588406037635,-4.01531243307729,5.93670970466532e-05,0.0114199558382722,"CvsT1"
"968","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0009452",0.0346685412431733,1,1,1,"7-methylguanosine RNA capping","BP",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,-2.09032509927881,0.520588406037635,-4.01531243307729,5.93670970466532e-05,0.0114199558382722,"CvsT1"
"969","Acerv_evm.model.Segkk454_pilon.2",58,1,"XP_015750400.1",5.4e-28,96.55,NA,NA,NA,NA,NA,5,"TGS1_HUMANTrimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3",4.21e-98,62.95,9,"F:GO:0005515; C:GO:0005730; C:GO:0005829; P:GO:0009452; C:GO:0015030; P:GO:0016043; P:GO:0022613; P:GO:0036261; F:GO:0071164","F:protein binding; C:nucleolus; C:cytosol; P:7-methylguanosine RNA capping; C:Cajal body; P:cellular component organization; P:ribonucleoprotein complex biogenesis; P:7-methylguanosine cap hypermethylation; F:RNA trimethylguanosine synthase activity","EC:2.1; EC:2; EC:2.1.1","Transferring one-carbon groups; Transferases; Transferring one-carbon groups","Coil (COILS); G3DSA:3.40.50.150 (GENE3D); IPR019012 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); cd02440 (CDD); IPR029063 (SUPERFAMILY)","P:GO:0001510; F:GO:0008168; P:GO:0009452","P:RNA methylation; F:methyltransferase activity; P:7-methylguanosine RNA capping","GO:0036261",0.0346685412431733,1,1,1,"7-methylguanosine cap hypermethylation","BP",297,582,334,231,189,427,94,455,195,933,102,398,267,178,364.692702804814,-2.09032509927881,0.520588406037635,-4.01531243307729,5.93670970466532e-05,0.0114199558382722,"CvsT1"
"970","Acerv_evm.model.Segkk657_pilon.10",483,1,"XP_029192964.1",3.3e-288,97.14,NA,NA,NA,NA,NA,5,"S23IP_MOUSESEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2",5.6e-175,57.06,19,"P:GO:0001675; F:GO:0005515; C:GO:0005774; C:GO:0005793; C:GO:0005801; C:GO:0005829; P:GO:0006886; P:GO:0007030; P:GO:0007338; P:GO:0007610; P:GO:0009605; P:GO:0009629; P:GO:0016042; F:GO:0016298; C:GO:0030134; C:GO:0034451; F:GO:0052689; C:GO:0070971; C:GO:0097038","P:acrosome assembly; F:protein binding; C:vacuolar membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:cis-Golgi network; C:cytosol; P:intracellular protein transport; P:Golgi organization; P:single fertilization; P:behavior; P:response to external stimulus; P:response to gravity; P:lipid catabolic process; F:lipase activity; C:COPII-coated ER to Golgi transport vesicle; C:centriolar satellite; F:carboxylic ester hydrolase activity; C:endoplasmic reticulum exit site; C:perinuclear endoplasmic reticulum","EC:3.1; EC:3; EC:3.1.1; EC:3.1.1.1","Acting on ester bonds; Hydrolases; Acting on ester bonds; Carboxylesterase","Coil (COILS); IPR001660 (SMART); IPR004177 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR004177 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR004177 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY)","F:GO:0005515; F:GO:0046872","F:protein binding; F:metal ion binding","GO:0007610",0.0297898357613848,0.995580193557033,3,28,"behavior","BP",170,353,330,96,183,161,74,264,149,225,58,147,105,1452,166.642444209543,1.37182493659094,0.293233457449968,4.67826880506978,2.89307124245486e-06,0.00567620577769644,"T1vsT2"
"971","Acerv_evm.model.Segkk657_pilon.10",483,1,"XP_029192964.1",3.3e-288,97.14,NA,NA,NA,NA,NA,5,"S23IP_MOUSESEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2",5.6e-175,57.06,19,"P:GO:0001675; F:GO:0005515; C:GO:0005774; C:GO:0005793; C:GO:0005801; C:GO:0005829; P:GO:0006886; P:GO:0007030; P:GO:0007338; P:GO:0007610; P:GO:0009605; P:GO:0009629; P:GO:0016042; F:GO:0016298; C:GO:0030134; C:GO:0034451; F:GO:0052689; C:GO:0070971; C:GO:0097038","P:acrosome assembly; F:protein binding; C:vacuolar membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:cis-Golgi network; C:cytosol; P:intracellular protein transport; P:Golgi organization; P:single fertilization; P:behavior; P:response to external stimulus; P:response to gravity; P:lipid catabolic process; F:lipase activity; C:COPII-coated ER to Golgi transport vesicle; C:centriolar satellite; F:carboxylic ester hydrolase activity; C:endoplasmic reticulum exit site; C:perinuclear endoplasmic reticulum","EC:3.1; EC:3; EC:3.1.1; EC:3.1.1.1","Acting on ester bonds; Hydrolases; Acting on ester bonds; Carboxylesterase","Coil (COILS); IPR001660 (SMART); IPR004177 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR004177 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR004177 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY)","F:GO:0005515; F:GO:0046872","F:protein binding; F:metal ion binding","GO:0007030",0.0169144280635555,0.998017358692076,3,22,"Golgi organization","BP",170,353,330,96,183,161,74,264,149,225,58,147,105,1452,166.642444209543,1.37182493659094,0.293233457449968,4.67826880506978,2.89307124245486e-06,0.00567620577769644,"T1vsT2"
"972","Acerv_evm.model.Segkk657_pilon.10",483,1,"XP_029192964.1",3.3e-288,97.14,NA,NA,NA,NA,NA,5,"S23IP_MOUSESEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2",5.6e-175,57.06,19,"P:GO:0001675; F:GO:0005515; C:GO:0005774; C:GO:0005793; C:GO:0005801; C:GO:0005829; P:GO:0006886; P:GO:0007030; P:GO:0007338; P:GO:0007610; P:GO:0009605; P:GO:0009629; P:GO:0016042; F:GO:0016298; C:GO:0030134; C:GO:0034451; F:GO:0052689; C:GO:0070971; C:GO:0097038","P:acrosome assembly; F:protein binding; C:vacuolar membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:cis-Golgi network; C:cytosol; P:intracellular protein transport; P:Golgi organization; P:single fertilization; P:behavior; P:response to external stimulus; P:response to gravity; P:lipid catabolic process; F:lipase activity; C:COPII-coated ER to Golgi transport vesicle; C:centriolar satellite; F:carboxylic ester hydrolase activity; C:endoplasmic reticulum exit site; C:perinuclear endoplasmic reticulum","EC:3.1; EC:3; EC:3.1.1; EC:3.1.1.1","Acting on ester bonds; Hydrolases; Acting on ester bonds; Carboxylesterase","Coil (COILS); IPR001660 (SMART); IPR004177 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR004177 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR004177 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY)","F:GO:0005515; F:GO:0046872","F:protein binding; F:metal ion binding","GO:0009629",0.0455843242423402,0.999470803382937,1,2,"response to gravity","BP",170,353,330,96,183,161,74,264,149,225,58,147,105,1452,166.642444209543,1.37182493659094,0.293233457449968,4.67826880506978,2.89307124245486e-06,0.00567620577769644,"T1vsT2"
"973","Acerv_evm.model.Segkk657_pilon.10",483,1,"XP_029192964.1",3.3e-288,97.14,NA,NA,NA,NA,NA,5,"S23IP_MOUSESEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2",5.6e-175,57.06,19,"P:GO:0001675; F:GO:0005515; C:GO:0005774; C:GO:0005793; C:GO:0005801; C:GO:0005829; P:GO:0006886; P:GO:0007030; P:GO:0007338; P:GO:0007610; P:GO:0009605; P:GO:0009629; P:GO:0016042; F:GO:0016298; C:GO:0030134; C:GO:0034451; F:GO:0052689; C:GO:0070971; C:GO:0097038","P:acrosome assembly; F:protein binding; C:vacuolar membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:cis-Golgi network; C:cytosol; P:intracellular protein transport; P:Golgi organization; P:single fertilization; P:behavior; P:response to external stimulus; P:response to gravity; P:lipid catabolic process; F:lipase activity; C:COPII-coated ER to Golgi transport vesicle; C:centriolar satellite; F:carboxylic ester hydrolase activity; C:endoplasmic reticulum exit site; C:perinuclear endoplasmic reticulum","EC:3.1; EC:3; EC:3.1.1; EC:3.1.1.1","Acting on ester bonds; Hydrolases; Acting on ester bonds; Carboxylesterase","Coil (COILS); IPR001660 (SMART); IPR004177 (SMART); IPR013761 (G3DSA:1.10.150.GENE3D); IPR001660 (PFAM); IPR004177 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR004177 (PROSITE_PROFILES); IPR013761 (SUPERFAMILY)","F:GO:0005515; F:GO:0046872","F:protein binding; F:metal ion binding","GO:0001675",0.0428468842353726,0.99953311844266,1,2,"acrosome assembly","BP",170,353,330,96,183,161,74,264,149,225,58,147,105,1452,166.642444209543,1.37182493659094,0.293233457449968,4.67826880506978,2.89307124245486e-06,0.00567620577769644,"T1vsT2"
"974","Acerv_evm.model.Segkk68_pilon.68",297,1,"XP_029188136.1",1.5e-153,96.3,NA,NA,NA,NA,NA,5,"MOC2B_BOVINMolybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2",1.9e-64,75.12,7,"C:GO:0005829; P:GO:0006777; C:GO:0016607; C:GO:0019008; F:GO:0030366; P:GO:0032324; F:GO:0042802","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:nuclear speck; C:molybdopterin synthase complex; F:molybdopterin synthase activity; P:molybdopterin cofactor biosynthetic process; F:identical protein binding","EC:2.8.1; EC:2; EC:2.8.1.12; EC:2.8","Transferring sulfur-containing groups; Transferases; Molybdopterin synthase; Transferring sulfur-containing groups","IPR036563 (G3DSA:3.90.1170.GENE3D); IPR003448 (PFAM); IPR028888 (HAMAP); IPR003448 (CDD); IPR036563 (SUPERFAMILY)","C:GO:0005829; P:GO:0006777; C:GO:0019008; F:GO:0030366","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex; F:molybdopterin synthase activity","GO:0030366",0.0238797721885053,1,1,1,"molybdopterin synthase activity","MF",600,1037,623,906,1166,714,1340,862,158,516,858,2114,480,894,875.655446194534,-1.780302178713,0.432965055864829,-4.11188421466698,3.92443112132329e-05,0.00529563906983341,"CvsT2"
"975","Acerv_evm.model.Segkk68_pilon.68",297,1,"XP_029188136.1",1.5e-153,96.3,NA,NA,NA,NA,NA,5,"MOC2B_BOVINMolybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2",1.9e-64,75.12,7,"C:GO:0005829; P:GO:0006777; C:GO:0016607; C:GO:0019008; F:GO:0030366; P:GO:0032324; F:GO:0042802","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:nuclear speck; C:molybdopterin synthase complex; F:molybdopterin synthase activity; P:molybdopterin cofactor biosynthetic process; F:identical protein binding","EC:2.8.1; EC:2; EC:2.8.1.12; EC:2.8","Transferring sulfur-containing groups; Transferases; Molybdopterin synthase; Transferring sulfur-containing groups","IPR036563 (G3DSA:3.90.1170.GENE3D); IPR003448 (PFAM); IPR028888 (HAMAP); IPR003448 (CDD); IPR036563 (SUPERFAMILY)","C:GO:0005829; P:GO:0006777; C:GO:0019008; F:GO:0030366","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex; F:molybdopterin synthase activity","GO:0032324",0.0238797721885053,1,1,1,"molybdopterin cofactor biosynthetic process","BP",600,1037,623,906,1166,714,1340,862,158,516,858,2114,480,894,875.655446194534,-1.780302178713,0.432965055864829,-4.11188421466698,3.92443112132329e-05,0.00529563906983341,"CvsT2"
"976","Acerv_evm.model.Segkk68_pilon.68",297,1,"XP_029188136.1",1.5e-153,96.3,NA,NA,NA,NA,NA,5,"MOC2B_BOVINMolybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2",1.9e-64,75.12,7,"C:GO:0005829; P:GO:0006777; C:GO:0016607; C:GO:0019008; F:GO:0030366; P:GO:0032324; F:GO:0042802","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:nuclear speck; C:molybdopterin synthase complex; F:molybdopterin synthase activity; P:molybdopterin cofactor biosynthetic process; F:identical protein binding","EC:2.8.1; EC:2; EC:2.8.1.12; EC:2.8","Transferring sulfur-containing groups; Transferases; Molybdopterin synthase; Transferring sulfur-containing groups","IPR036563 (G3DSA:3.90.1170.GENE3D); IPR003448 (PFAM); IPR028888 (HAMAP); IPR003448 (CDD); IPR036563 (SUPERFAMILY)","C:GO:0005829; P:GO:0006777; C:GO:0019008; F:GO:0030366","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex; F:molybdopterin synthase activity","GO:0006777",0.0238797721885053,1,1,1,"Mo-molybdopterin cofactor biosynthetic process","BP",600,1037,623,906,1166,714,1340,862,158,516,858,2114,480,894,875.655446194534,-1.780302178713,0.432965055864829,-4.11188421466698,3.92443112132329e-05,0.00529563906983341,"CvsT2"
"977","Acerv_evm.model.Segkk68_pilon.68",297,1,"XP_029188136.1",1.5e-153,96.3,NA,NA,NA,NA,NA,5,"MOC2B_BOVINMolybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2",1.9e-64,75.12,7,"C:GO:0005829; P:GO:0006777; C:GO:0016607; C:GO:0019008; F:GO:0030366; P:GO:0032324; F:GO:0042802","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:nuclear speck; C:molybdopterin synthase complex; F:molybdopterin synthase activity; P:molybdopterin cofactor biosynthetic process; F:identical protein binding","EC:2.8.1; EC:2; EC:2.8.1.12; EC:2.8","Transferring sulfur-containing groups; Transferases; Molybdopterin synthase; Transferring sulfur-containing groups","IPR036563 (G3DSA:3.90.1170.GENE3D); IPR003448 (PFAM); IPR028888 (HAMAP); IPR003448 (CDD); IPR036563 (SUPERFAMILY)","C:GO:0005829; P:GO:0006777; C:GO:0019008; F:GO:0030366","C:cytosol; P:Mo-molybdopterin cofactor biosynthetic process; C:molybdopterin synthase complex; F:molybdopterin synthase activity","GO:0019008",0.0238797721885053,1,1,1,"molybdopterin synthase complex","CC",600,1037,623,906,1166,714,1340,862,158,516,858,2114,480,894,875.655446194534,-1.780302178713,0.432965055864829,-4.11188421466698,3.92443112132329e-05,0.00529563906983341,"CvsT2"
"978","Acerv_evm.model.Segkk893_pilon.2",321,1,"XP_015767423.1",1.2e-161,86.88,NA,NA,NA,NA,NA,5,"DDX18_HUMANATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2",0,82.55,13,"P:GO:0000462; P:GO:0000463; F:GO:0003723; F:GO:0003724; F:GO:0005524; C:GO:0005635; C:GO:0005694; C:GO:0005730; F:GO:0016787; C:GO:0030687; F:GO:0042802; P:GO:0071392; P:GO:1990417","P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; F:RNA helicase activity; F:ATP binding; C:nuclear envelope; C:chromosome; C:nucleolus; F:hydrolase activity; C:preribosome, large subunit precursor; F:identical protein binding; P:cellular response to estradiol stimulus; P:snoRNA release from pre-rRNA","EC:3.6.4.13; EC:3","RNA helicase; Hydrolases","Coil (COILS); IPR001650 (SMART); IPR025313 (SMART); IPR014001 (SMART); IPR011545 (PFAM); G3DSA:3.40.50.300 (GENE3D); G3DSA:3.40.50.300 (GENE3D); IPR001650 (PFAM); IPR025313 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000629 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); cd18787 (CDD); cd17942 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003676; F:GO:0004386; F:GO:0005524","F:nucleic acid binding; F:helicase activity; F:ATP binding","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",265,423,381,227,444,235,281,380,180,143,208,431,132,966,271.500713463636,-0.760589572213085,0.198439990004669,-3.832844237672,0.000126670163595522,0.013316569175199,"CvsT2"
"979","Acerv_evm.model.Segkk893_pilon.2",321,1,"XP_015767423.1",1.2e-161,86.88,NA,NA,NA,NA,NA,5,"DDX18_HUMANATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2",0,82.55,13,"P:GO:0000462; P:GO:0000463; F:GO:0003723; F:GO:0003724; F:GO:0005524; C:GO:0005635; C:GO:0005694; C:GO:0005730; F:GO:0016787; C:GO:0030687; F:GO:0042802; P:GO:0071392; P:GO:1990417","P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; F:RNA helicase activity; F:ATP binding; C:nuclear envelope; C:chromosome; C:nucleolus; F:hydrolase activity; C:preribosome, large subunit precursor; F:identical protein binding; P:cellular response to estradiol stimulus; P:snoRNA release from pre-rRNA","EC:3.6.4.13; EC:3","RNA helicase; Hydrolases","Coil (COILS); IPR001650 (SMART); IPR025313 (SMART); IPR014001 (SMART); IPR011545 (PFAM); G3DSA:3.40.50.300 (GENE3D); G3DSA:3.40.50.300 (GENE3D); IPR001650 (PFAM); IPR025313 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000629 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); cd18787 (CDD); cd17942 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003676; F:GO:0004386; F:GO:0005524","F:nucleic acid binding; F:helicase activity; F:ATP binding","GO:0030687",0.00689983613811048,0.999796314242108,2,6,"preribosome, large subunit precursor","CC",265,423,381,227,444,235,281,380,180,143,208,431,132,966,271.500713463636,-0.760589572213085,0.198439990004669,-3.832844237672,0.000126670163595522,0.013316569175199,"CvsT2"
"980","Acerv_evm.model.Segkk893_pilon.2",321,1,"XP_015767423.1",1.2e-161,86.88,NA,NA,NA,NA,NA,5,"DDX18_HUMANATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2",0,82.55,13,"P:GO:0000462; P:GO:0000463; F:GO:0003723; F:GO:0003724; F:GO:0005524; C:GO:0005635; C:GO:0005694; C:GO:0005730; F:GO:0016787; C:GO:0030687; F:GO:0042802; P:GO:0071392; P:GO:1990417","P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; F:RNA helicase activity; F:ATP binding; C:nuclear envelope; C:chromosome; C:nucleolus; F:hydrolase activity; C:preribosome, large subunit precursor; F:identical protein binding; P:cellular response to estradiol stimulus; P:snoRNA release from pre-rRNA","EC:3.6.4.13; EC:3","RNA helicase; Hydrolases","Coil (COILS); IPR001650 (SMART); IPR025313 (SMART); IPR014001 (SMART); IPR011545 (PFAM); G3DSA:3.40.50.300 (GENE3D); G3DSA:3.40.50.300 (GENE3D); IPR001650 (PFAM); IPR025313 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000629 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); cd18787 (CDD); cd17942 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003676; F:GO:0004386; F:GO:0005524","F:nucleic acid binding; F:helicase activity; F:ATP binding","GO:0000463",0.0481846474445031,0.999407904907446,1,2,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)","BP",265,423,381,227,444,235,281,380,180,143,208,431,132,966,271.500713463636,-0.760589572213085,0.198439990004669,-3.832844237672,0.000126670163595522,0.013316569175199,"CvsT2"
"981","Acerv_evm.model.Segkk893_pilon.2",321,1,"XP_015767423.1",1.2e-161,86.88,NA,NA,NA,NA,NA,5,"DDX18_HUMANATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2",0,82.55,13,"P:GO:0000462; P:GO:0000463; F:GO:0003723; F:GO:0003724; F:GO:0005524; C:GO:0005635; C:GO:0005694; C:GO:0005730; F:GO:0016787; C:GO:0030687; F:GO:0042802; P:GO:0071392; P:GO:1990417","P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); F:RNA binding; F:RNA helicase activity; F:ATP binding; C:nuclear envelope; C:chromosome; C:nucleolus; F:hydrolase activity; C:preribosome, large subunit precursor; F:identical protein binding; P:cellular response to estradiol stimulus; P:snoRNA release from pre-rRNA","EC:3.6.4.13; EC:3","RNA helicase; Hydrolases","Coil (COILS); IPR001650 (SMART); IPR025313 (SMART); IPR014001 (SMART); IPR011545 (PFAM); G3DSA:3.40.50.300 (GENE3D); G3DSA:3.40.50.300 (GENE3D); IPR001650 (PFAM); IPR025313 (PFAM); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); mobidb-lite (MOBIDB_LITE); IPR000629 (PROSITE_PATTERNS); IPR014001 (PROSITE_PROFILES); IPR014014 (PROSITE_PROFILES); IPR001650 (PROSITE_PROFILES); cd18787 (CDD); cd17942 (CDD); IPR027417 (SUPERFAMILY)","F:GO:0003676; F:GO:0004386; F:GO:0005524","F:nucleic acid binding; F:helicase activity; F:ATP binding","GO:1990417",0.0232872713646177,1,1,1,"snoRNA release from pre-rRNA","BP",265,423,381,227,444,235,281,380,180,143,208,431,132,966,271.500713463636,-0.760589572213085,0.198439990004669,-3.832844237672,0.000126670163595522,0.013316569175199,"CvsT2"
"982","Acerv_evm.model.Segkk905_pilon.19",616,1,"XP_029189720.1",0,91.24,NA,NA,NA,NA,NA,5,"GORS2_HUMANGolgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3",7.39e-126,81.42,14,"C:GO:0000139; F:GO:0005515; C:GO:0005789; C:GO:0005797; P:GO:0006487; P:GO:0007030; P:GO:0007283; P:GO:0015031; C:GO:0033116; P:GO:0034976; F:GO:0046872; P:GO:0050774; P:GO:0061951; P:GO:0070925","C:Golgi membrane; F:protein binding; C:endoplasmic reticulum membrane; C:Golgi medial cisterna; P:protein N-linked glycosylation; P:Golgi organization; P:spermatogenesis; P:protein transport; C:endoplasmic reticulum-Golgi intermediate compartment membrane; P:response to endoplasmic reticulum stress; F:metal ion binding; P:negative regulation of dendrite morphogenesis; P:establishment of protein localization to plasma membrane; P:organelle assembly",NA,NA,"IPR036034 (G3DSA:2.30.42.GENE3D); IPR024958 (PFAM); IPR036034 (G3DSA:2.30.42.GENE3D); IPR024958 (PROSITE_PROFILES); IPR024958 (PROSITE_PROFILES); IPR036034 (SUPERFAMILY); IPR036034 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0007030",0.0169144280635555,0.998017358692076,3,22,"Golgi organization","BP",202,429,349,184,312,109,176,307,93,80,128,350,73,1851,186.159216006429,-0.769307136265855,0.203092689942547,-3.78796074089857,0.000151888842298714,0.0311013549908585,"T1vsT2"
"983","Acerv_evm.model.Segkk905_pilon.19",616,1,"XP_029189720.1",0,91.24,NA,NA,NA,NA,NA,5,"GORS2_HUMANGolgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3",7.39e-126,81.42,14,"C:GO:0000139; F:GO:0005515; C:GO:0005789; C:GO:0005797; P:GO:0006487; P:GO:0007030; P:GO:0007283; P:GO:0015031; C:GO:0033116; P:GO:0034976; F:GO:0046872; P:GO:0050774; P:GO:0061951; P:GO:0070925","C:Golgi membrane; F:protein binding; C:endoplasmic reticulum membrane; C:Golgi medial cisterna; P:protein N-linked glycosylation; P:Golgi organization; P:spermatogenesis; P:protein transport; C:endoplasmic reticulum-Golgi intermediate compartment membrane; P:response to endoplasmic reticulum stress; F:metal ion binding; P:negative regulation of dendrite morphogenesis; P:establishment of protein localization to plasma membrane; P:organelle assembly",NA,NA,"IPR036034 (G3DSA:2.30.42.GENE3D); IPR024958 (PFAM); IPR036034 (G3DSA:2.30.42.GENE3D); IPR024958 (PROSITE_PROFILES); IPR024958 (PROSITE_PROFILES); IPR036034 (SUPERFAMILY); IPR036034 (SUPERFAMILY)","F:GO:0005515","F:protein binding","GO:0070925",0.0138722716888619,0.999353700690453,2,8,"organelle assembly","BP",202,429,349,184,312,109,176,307,93,80,128,350,73,1851,186.159216006429,-0.769307136265855,0.203092689942547,-3.78796074089857,0.000151888842298714,0.0311013549908585,"T1vsT2"
"984","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0005001",0.0261977708110464,1,1,1,"transmembrane receptor protein tyrosine phosphatase activity","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,0.941687850940453,0.266052673053667,3.53947900666459,0.000400917656744912,0.0297106273330389,"CvsT2"
"985","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0070097",0.0261977708110464,1,1,1,"delta-catenin binding","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,0.941687850940453,0.266052673053667,3.53947900666459,0.000400917656744912,0.0297106273330389,"CvsT2"
"986","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0070097",0.0261977708110464,1,1,1,"delta-catenin binding","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,1.21725619198378,0.290528783792692,4.18979550354073,2.79205963374165e-05,0.00631075278716456,"CvsT4"
"987","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0045294",0.0487087525796024,0.999394789047504,1,2,"alpha-catenin binding","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,0.941687850940453,0.266052673053667,3.53947900666459,0.000400917656744912,0.0297106273330389,"CvsT2"
"988","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0005001",0.0261977708110464,1,1,1,"transmembrane receptor protein tyrosine phosphatase activity","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,1.21725619198378,0.290528783792692,4.18979550354073,2.79205963374165e-05,0.00631075278716456,"CvsT4"
"989","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:1904893",0.0261977708110464,1,1,1,"negative regulation of receptor signaling pathway via STAT","BP",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,0.941687850940453,0.266052673053667,3.53947900666459,0.000400917656744912,0.0297106273330389,"CvsT2"
"990","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:0045294",0.0487087525796024,0.999394789047504,1,2,"alpha-catenin binding","MF",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,1.21725619198378,0.290528783792692,4.18979550354073,2.79205963374165e-05,0.00631075278716456,"CvsT4"
"991","Acerv_evm.model.Segkk984_pilon.10",228,1,"XP_029207174.1",3.2e-100,77.97,NA,NA,NA,NA,NA,5,"PTN9_RATTyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1",9.45e-159,58.74,24,"F:GO:0005001; C:GO:0005737; C:GO:0005887; P:GO:0007156; P:GO:0007169; F:GO:0008013; C:GO:0009986; P:GO:0010977; F:GO:0016790; F:GO:0019903; P:GO:0030336; F:GO:0042803; C:GO:0043226; C:GO:0044306; F:GO:0045294; F:GO:0045295; F:GO:0045296; F:GO:0051393; F:GO:0070097; P:GO:0071354; F:GO:0097677; P:GO:1903078; P:GO:1904893; P:GO:1990264","F:transmembrane receptor protein tyrosine phosphatase activity; C:cytoplasm; C:integral component of plasma membrane; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:beta-catenin binding; C:cell surface; P:negative regulation of neuron projection development; F:thiolester hydrolase activity; F:protein phosphatase binding; P:negative regulation of cell migration; F:protein homodimerization activity; C:organelle; C:neuron projection terminus; F:alpha-catenin binding; F:gamma-catenin binding; F:cadherin binding; F:alpha-actinin binding; F:delta-catenin binding; P:cellular response to interleukin-6; F:STAT family protein binding; P:positive regulation of protein localization to plasma membrane; P:negative regulation of receptor signaling pathway via STAT; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity","EC:3.1; EC:3.1.3.48; EC:3; EC:3.1.2; EC:3.1.3","Acting on ester bonds; Protein-tyrosine-phosphatase; Hydrolases; Acting on ester bonds; Acting on ester bonds","IPR000242 (PRINTS); IPR000242 (SMART); IPR003595 (SMART); IPR001251 (SMART); IPR000242 (PFAM); IPR036865 (G3DSA:3.40.525.GENE3D); IPR001251 (PFAM); IPR029021 (G3DSA:3.90.190.GENE3D); IPR016130 (PROSITE_PATTERNS); IPR000387 (PROSITE_PROFILES); IPR001251 (PROSITE_PROFILES); IPR000242 (PROSITE_PROFILES); cd14543 (CDD); IPR001251 (CDD); IPR029021 (SUPERFAMILY); IPR036865 (SUPERFAMILY)","F:GO:0004725; P:GO:0006470; P:GO:0016311; F:GO:0016791","F:protein tyrosine phosphatase activity; P:protein dephosphorylation; P:dephosphorylation; F:phosphatase activity","GO:1904893",0.0261977708110464,1,1,1,"negative regulation of receptor signaling pathway via STAT","BP",124,327,254,73,90,104,81,381,63,129,33,98,51,689,115.514816285691,1.21725619198378,0.290528783792692,4.18979550354073,2.79205963374165e-05,0.00631075278716456,"CvsT4"
"992","Acerv_evm.model.Segkk999_pilon.5",280,1,"XP_015747683.1",8.1e-154,98.93,NA,NA,NA,NA,NA,5,"RBM19_HUMANProbable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3",1.25e-63,70.18,7,"P:GO:0000398; F:GO:0003723; C:GO:0005694; C:GO:0005730; C:GO:0005737; C:GO:0016607; P:GO:0040019","P:mRNA splicing, via spliceosome; F:RNA binding; C:chromosome; C:nucleolus; C:cytoplasm; C:nuclear speck; P:positive regulation of embryonic development",NA,NA,"IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR034421 (CDD); IPR035979 (SUPERFAMILY); IPR035979 (SUPERFAMILY)","F:GO:0003676","F:nucleic acid binding","GO:0003723",0.0264883518621786,0.991358113452853,7,122,"RNA binding","MF",71,97,61,103,82,67,48,53,49,61,48,136,51,843,73.9053786496837,-1.40790065526919,0.375509720527707,-3.74930548612872,0.000177324973879759,0.016896258873063,"CvsT2"
"993","Acerv_evm.model.Segkk999_pilon.5",280,1,"XP_015747683.1",8.1e-154,98.93,NA,NA,NA,NA,NA,5,"RBM19_HUMANProbable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3",1.25e-63,70.18,7,"P:GO:0000398; F:GO:0003723; C:GO:0005694; C:GO:0005730; C:GO:0005737; C:GO:0016607; P:GO:0040019","P:mRNA splicing, via spliceosome; F:RNA binding; C:chromosome; C:nucleolus; C:cytoplasm; C:nuclear speck; P:positive regulation of embryonic development",NA,NA,"IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR034421 (CDD); IPR035979 (SUPERFAMILY); IPR035979 (SUPERFAMILY)","F:GO:0003676","F:nucleic acid binding","GO:0000398",0.0349575951395509,0.994443688270107,3,31,"mRNA splicing, via spliceosome","BP",71,97,61,103,82,67,48,53,49,61,48,136,51,843,73.9053786496837,-1.40790065526919,0.375509720527707,-3.74930548612872,0.000177324973879759,0.016896258873063,"CvsT2"
"994","Acerv_evm.model.Segkk999_pilon.5",280,1,"XP_015747683.1",8.1e-154,98.93,NA,NA,NA,NA,NA,5,"RBM19_HUMANProbable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3",1.25e-63,70.18,7,"P:GO:0000398; F:GO:0003723; C:GO:0005694; C:GO:0005730; C:GO:0005737; C:GO:0016607; P:GO:0040019","P:mRNA splicing, via spliceosome; F:RNA binding; C:chromosome; C:nucleolus; C:cytoplasm; C:nuclear speck; P:positive regulation of embryonic development",NA,NA,"IPR000504 (SMART); IPR000504 (PFAM); IPR012677 (G3DSA:3.30.70.GENE3D); IPR012677 (G3DSA:3.30.70.GENE3D); IPR000504 (PROSITE_PROFILES); IPR034421 (CDD); IPR035979 (SUPERFAMILY); IPR035979 (SUPERFAMILY)","F:GO:0003676","F:nucleic acid binding","GO:0040019",0.0243690839693054,1,1,1,"positive regulation of embryonic development","BP",71,97,61,103,82,67,48,53,49,61,48,136,51,843,73.9053786496837,-1.40790065526919,0.375509720527707,-3.74930548612872,0.000177324973879759,0.016896258873063,"CvsT2"
